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ABSTRACT 
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Doctor of Philosophy 
 
CHARACTERISATION OF THE HUMAN RENAL TIGHT JUNCTION BARRIER 
AND THE INFLUENCE OF TGFβ1 AND CYCLOSPORINE A 
 
by Adam Kirk 
 
Renal tubular epithelial cells contribute to the host environment through the use of 
transcellular and paracellular pathways regulating the excretion and reabsorption of 
material filtered through the glomeruli.  The epithelial tight junction complex that 
incorporates claudin and occludin proteins tightly regulates this paracellular pathway.  
Through immunohistochemical assessment of glycolmethacrylate embedded renal tissue a 
selection of claudins was mapped along the renal tubule alongside other more established 
regionally expressed surface or junctional proteins.  Human renal tubular epithelial cells 
were then grown in culture on solid and semi-permeable surfaces.  Expression of these 
junctional proteins was assessed and the effects transforming growth factor β1 (TGFβ1) or 
cyclosporine (CsA) had on them, and the epithelial monolayer physical characteristics.  
Results demonstrated the repertoire of claudins changed along the human nephron and 
represented the nature of the paracellular junction in that region.  When exposed to TGFβ1 
or CsA cells became more fibroblast-like, most pronounced in the presence of TGFβ1.  
Epithelial monolayers tightened up, after exposure to both TGFβ1 and cyclosporine, on 
transepithelial electrical resistance assessment.  Dextran fluxes appeared unaltered.  
Despite the more aggressive changes observed in cells exposed to TGFβ1 none of the cells 
underwent significant lysis (MTS assay).  The thesis has added to immunohistochemical 
techniques using glycolmethacrylate embedded sections cut in series and to the current 
knowledge regarding the function of the tubule, highlighting human renal tubular epithelial 
cells can be used successfully to demonstrate changes similar to those observed in vivo.  3 
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1  Introduction 
1.1  Overview 
Renal tubular epithelial cells (RTECs) constitute a cellular barrier that regulates the 
absorption and movement of solutes across the tubule into the interstitium.  They utilise an 
active transcellular reabsorption route and a passive paracellular route.  The active 
transcellular route creates a concentration gradient down which the solutes move via the 
paracellular pathway.  Proteins involved in the tight junctions that form between RTECs 
(1) regulate this paracellular pathway.  By regulating the passive movement of solutes back 
into the interstitium, the tubule modifies the body composition and reabsorption of filtered 
solutes (2).  To maintain these concentrations the epithelial barrier function also acts to 
prevent backleak of solutes returning from the interstitium (3). 
 
Renal failure is characterised by the loss of renal function, interstitial fibrosis and a decline 
in the hormonal/homeostatic properties of the kidney.  The process of renal fibrosis is the 
final common pathway leading to end-stage renal disease (ESRD) regardless of the cause 
(4-6).  This decline can be the result of endogenous or exogenous pathology of either an 
acute or a chronic nature.  Chronic kidney disease (CKD) is defined as kidney damage for 
more than three months as defined by structural or functional abnormalities with or without 
a decline in the estimated glomerular filtration rate (eGFR).  This can be manifest by either 
pathological abnormalities or markers of kidney damage, including abnormalities in the 
blood or urine composition or abnormalities in imaging tests.  It is also defined as a 
glomerular filtration rate of <60mL/min/1.73m
2 for ≥3 months with or without kidney 
damage (Kidney Disease Outcomes Quality Initiative, 2008).  As CKD progresses the urea 
and creatinine continue to rise and the hormonal function continues to decline.  When the 
deterioration in function is so severe that the kidneys are unable to perform their roles the 
patient will require renal replacement therapy (RRT) or a kidney transplant.  
 
Transplants have been attempted since the turn of the 20
th century.  Vascular anastomosis 
work done by Alexis Carrel (1875 – 1944) made possible the re-implantation of organs 
from a donor into a recipient.  For this work he was awarded the Nobel Prize in 1912.  
Further work continued on transplantation through the 20
th century and in 1954, in Boston, 
USA, the first successful transplant was done between two identical twins.  This transplant   23 
required no anti-rejection therapy as the donor and recipient were identical twin brothers.  
This procedure highlighted the need for anti-rejection therapy and in 1959 the first kidney 
transplant with immune suppression was undertaken, using total body irradiation and bone 
marrow transplantation.  In 1960 azathioprine was used alongside irradiation.  This 
produced a 16 month survival.  Roy Calne made the major “breakthrough” in the 1960s, 
using azathioprine with prednisolone.  He then went on to set up the transplantation 
programme at St Mary’s Hospital, London, based on this anti-rejection regimen.  From that 
point on anti-rejection therapies were introduced.  In 1982 cyclosporine was introduced 
worldwide as a standard member of the anti-rejection therapy and revolutionised the 
survival times. 
 
Now cyclosporine forms the mainstay of immunosuppressant therapy but, unfortunately, it 
is associated with acute and chronic kidney insufficiency.  In the acute setting it can 
produce a reversible interstitial nephritis that causes a transient tubular dysfunction.  
Chronic dysfunction is associated interstitial nephritis and renal fibrosis, reviewed by 
Pascual et al (7).  Interstitial nephritis is thought to be the consequence of afferent 
arteriolar vasoconstriction and the stimulation of tubulointerstitial cells to secrete TGFβ1 
causing the development of interstitial fibrosis (8).  This interstitial fibrosis is known as 
striped fibrosis as the pathophysiology causes this characteristic appearance on 
histopathological examination.  International experience suggests a successful kidney 
transplant can last life-long but that chronic allograft nephropathy is present in a significant 
proportion of the recipient population, thus complicating the clinical course and shortening 
the lifespan of the graft. 
 
In 1995 the concept of nephrological epithelial mesenchymal transition (EMT) was 
conceived in a paper by Frank Strutz et al (9).  They proposed murine fibroblastic cells 
near areas of inflammation in the kidney had possibly arisen from the local epithelial cell 
population, swapping their phenotype from epithelial to mesenchymal (reducing the 
cytokeratin expression and increasing FSP-1 and vimentin expression).  This introduced 
the concept of EMT as a response to inflammation rather than a developmental process.  
They questioned, if this was true in mice, did human primary renal tubular epithelial cells 
have the capacity to switch phenotype and was that redifferentiation a direct effect of the 
original pathological insult or an act to protect cellular integrity?   24 
This study looks at the effects of TGFβ1 or CsA on unselected RTECs in culture.  TGFβ1 is 
a profibrotic cytokine capable of affecting cellular differentiation. Its expression can be 
related to the administration of CsA (10).  If TGFβ1 is the cytokine through which CsA has 
its deleterious effects, then it may be possible to intervene in this process and stop, by 
blocking the TGFβ1, the iatrogenic failure of the transplanted kidney. 
 
1.2  The Kidney 
 
Figure 1.1.  The kidney 
 (http://www.columbiakidneytransplant.org/img/novartis_313.jpg)   
Macroscopically each kidney has a cortex and a medulla.  These two structures are 
intimately related, the cortex sitting around the medulla.  Within the cortex and the 
medulla lie the components of the functioning kidney, the nephrons.  Each kidney has 
about one million nephrons.  Nephrons include a filtration system consisting of a 
glomerulus surrounded by a Bowman’s capsule, which catches the filtrate from the 
glomerulus and directs it into the tubule.  The renal tubule consists of the proximal 
convoluted tubule, the Loop of Henle, and the distal convoluted tubule. The distal   25 
convoluted tubule enters a collecting duct, which receives many tubules.  The collecting 
duct drains via the renal papilla into the ureter then to the bladder.  
 
Along the nephron the tubule is lined by epithelium responsible for specific functions.  In 
the proximal tubule the epithelium is responsible for the reabsorption of 95% of the filtered 
solute. In the Loop of Henle the epithelium concentrates the urine by utilising a counter-
current multiplier system, facilitating the exchange of solutes and fluid.  The distal 
convoluted tubule is responsible for fine adjustments to urinary concentration.  With the 
varying nature of the function of the RTECs along the tubule there is a corresponding 
change in the nature of the epithelial cells lining the tubule and their junctions.  Chapter 
three identified some of the junctional proteins responsible for the changes in epithelial 
barrier properties observed along the nephron. 
 
 
Figure 1.2.  The nephron  
This figure depicts the functional unit of the kidney, the nephron. It highlights the different regions 
of the nephron and the different functions that take place in those regions.   26 
1.3  Epithelial Cell Adhesion and Function 
Simple epithelial cells are polarised with zonular tight and adherens junctions situated at 
the subapical lateral borders of the cells.  Adherens junctions are primarily responsible for 
cell adhesion, but also play a role in cell signalling and the initiation of tight cell-cell 
adhesion (11-13).  Tight junctions, sitting superiorly to adherens junctions, have three 
functions. They act to selectively regulate the paracellular passage of solutes present within 
the filtrate back into the host system, the so called “gate” property (14); they form a barrier 
to the movement of proteins and lipids between the apical and the basolateral domains of 
the plasma membrane, thus creating the polarity across each epithelial cell, the “fence” 
property (14) and they are involved in cellular signalling and with the TGFβ-receptor 
complex (15, 16) 
 
Figure 1.3.  Apposing renal tubular epithelial cells  
Diagram of the organisation of the epithelial cell monolayer that lines the luminal surface of the 
renal tubule 
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1.3.1  The Adherens Junction 
The adherens junction is composed of the adherens proteins that form homophilic 
intercellular bonds.  These proteins, situated at the subapical region of the lateral walls, 
form junctions that are the principle mediators of cell-cell adhesion (17).  These proteins 
have many roles that include cellular differentiation or de-differentiation (18, 19); cell 
signalling (20-23); development or progression of malignancy (24-26) and cell sorting and 
identification through the formation of homophilic junctions (27, 28). 
 
Cadherins are a family of calcium dependant adhesive glycoprotein expressed by a wide 
variety of cells (28, 29).  Classical cadherins in epithelia include E-, N- and P-cadherin.  In 
the kidney tubular epithelium the most studied of these are E-cadherin and N-cadherin 
(29).  There are other cadherins present in the kidney such as K-cadherin, a cadherin 
associated with the assembly of homophilic junctions, cell sorting and hepatocellular and 
renal carcinoma, Ksp-cadherin (kidney specific), a cadherin associated exclusively with 
the kidney and the branching of the ureteric bud (30) and R-cadherin (retinal cadherin), a 
cadherin associated with brain segmentation and neuronal growth (27, 31-33).  These 
transmembrane glycoproteins form homophilic, calcium-dependant cell-cell bonds that are 
responsible for the formation of the epithelial monolayer and may play a role in cell fate 
(34). 
 
The distribution of the cadherins along the renal tubule has been shown to display 
differential localization - E-cadherin being utilised in the distal tubule and N-cadherin in 
the proximal tubule (29).  It is unclear as to why this distribution exists but may relate to 
the function of the tubule.  E-cadherin is used to define epithelial cells.  N-cadherin is 
associated more with fibroblasts or neuronal cells.  Their distribution along the nephron 
may reflect the roles of the different regions, potentially relating to the tightness of the 
intercellular junction or the plasticity of the cells needed.  
 
Cadherins have three domains, extracellular, transmembranous and intracellular.  The 
extracellular domain comprises five sub-domains with calcium binding repeats that form 
the homophilic, calcium dependent bonds between cells (35-37).  The transmembranous 
domain is a single pass alpha helix.  The intracellular domain is responsible for binding to 
the cytoskeleton via the cadherin-catenin complex, one of which is beta catenin (28, 38)   28 
and this binding interaction stabilizes cell-cell adhesion.  This adhesion is essential for the 
formation of a confluent functioning epithelial monolayer.  The intracellular relationship 
with beta-catenin is part of an intracellular signalling system (38-40).  If the interaction 
between E-cadherin and beta-catenin is disrupted the increased intracellular concentration 
of beta-catenin may result in increased translocation to the nucleus, with binding to T cell 
factors (TCF) and altered gene expression associated with changes in cell phenotype (38, 
41), reduced cell-cell adhesion and increased migratory potential (17). 
 
The integrity of cell-cell adhesion may be essential to the process of EMT.  Having 
established that TGFβ1 is capable of instigating EMT (42, 43) it was demonstrated that 
rendering an epithelial monolayer non-confluent, through wounding, removing calcium or 
growing to sub-confluence, produced an exaggerated cellular response to TGFβ1 (44).  In 
the converse situation, in a Mardin-Darby canine kidney (MDCK) cell line, the up-
regulation of Rap-1, a small GTPase usually associated with its role as a critical regulator 
of integrin-mediated cell adhesion, restored the cadherin mediated cell adhesion in cells 
that had undergone mesenchymal change (45) reproducing a monolayer.  
 
The significance of these relationships may be that the instigation of EMT is multifactorial 
and that epithelial cell interactions may contribute to this in one of two ways.  Firstly, 
having many epithelial cells present, means that the factors required for instigating EMT 
are all in close proximity.  However, the confluent epithelial monolayer acts as a physical 
barrier to the exposure of the TGFβ1 receptor complex TβRI/II that is located inferiorly to 
the tight junction on the lateral cell membrane.  Or, secondly, that the disruption to the 
confluent monolayer exposes the TβRI/II complex, facilitating phenotypic switches, and 
subsequently the epithelial cell takes on a phenotype sufficiently robust to withstand the 
pathological environ.  
 
1.3.2  The Tight Junction 
Tight junctions are the epithelial cell-cell junctions that create the paracellular gate 
between the apical/mucosal and the basolateral/serosal surfaces between neighbouring 
epithelial cells.  They consist of a complex of many proteins including plaque proteins ZO-
1, ZO-2 and ZO-3, transcription factors AP-1 and zonab, signalling molecules including c-
yes and atypical PKC with polarity proteins, Par3 and Par6, and three main transmembrane   29 
proteins; claudins, occludin and the junctional adhesion molecules (JAMs) (16, 46-48). 
The functions of tight junction are - 
i)  To create the paracellular adhesion that facilitates the formation of an epithelial 
barrier. 
ii)  “The Gate Function.”  The tight junction proteins create a paracellular route 
that is selective for both size and charge of the solute.  This selection is dictated 
by the nature of the first loop of the extracellular domain of the claudin 
molecule (49). 
iii)  “The Fence Function.”  The tight junction itself creates a barrier preventing the 
diffusion of membrane lipids and/or protein from one surface domain to another 
(separating apical and basolateral domains), thus facilitating the establishment 
of an apical-basolateral potential gradient in the epithelial cells (16) 
iv)  To be involved in cell signalling and the localisation of TGFβ receptors (15). 
 
Paracellular passage of solutes is regulated by the nature of the tight junction.  Freeze-
fracture electron microscopy has shown tight junctions are extremely close appositions that 
represent the extracellular domains of the transmembrane tight junction proteins (50).  
These extracellular domains interlace with like, neighbouring extracellular proteins of 
apposing epithelial cells, forming a complex mesh of interdigitating proteins, the 
complexity of which is responsible for the junction’s “tightness.” (16, 48, 51). 
 
Movement of solutes via the paracellular route is passive as a result of the electro-chemical 
gradient created by both the active, energy dependant transcellular route and by the 
constituents of the mucosal luminal fluid (16, 52, 53).  Tight junction proteins act to 
regulate this with their extracellular domains (54, 55).  Data published supporting this 
came from Furuse et al (56) where MDCK I and MDCK II cells were compared in terms of 
their transepithelial electrical resistance (TER).  MDCK cells I and II express both claudins 
1 and 4, but only MDCK II cells express claudin 2.  In the control situation MDCK I cells 
had the greater TER but when claudin 2 was introduced the TER fell to the level of MDCK 
II cells whilst having similar tight junction strand pattern.  It is also true that claudin 2 
creates a more “leaky” tight junction, facilitating a greater flux across the epithelial 
monolayer (57). 
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1.3.3  Proteins of the Tight Junction 
1.3.3.1 Occludin 
 
Occludin was discovered in 1993 (58).  It is a 65kDa transmembrane protein with four 
transmembrane domains, two extracellular loops and both its carboxy- and amino acid 
terminal domains in the cytosolic compartment.  These extracellular loops are designated 
loop1 and loop2 and consist of characteristic residues that contribute to the function of 
occludin.  Loop1 is predominantly tyrosine and glycine residues and may be involved in 
cell-cell coupling (59).  Loop2 is predominantly tyrosine residues and implicated in 
junctional permeability (60), the localization of the TGFβ receptor 1 to the tight junction 
(15) and as having a potential role in EMT (15).  
 
The phosphorylation status of occludin appears to play a considerable role in its function.  
Influencing the degree of phosphorylation, using low and high calcium containing media, 
facilitated the demonstration that occludin localization and function was dependant on the 
amount of phosphorylation (61).  Highly phosphorylated forms of occludin have been 
shown to be very prevalent in the tight junctions of MDCK type I cells that are associated 
with a high TER (62).  
 
While occludin is important in the permselectivity of the paracellular junction, the 
processes of selecting between charge and molecular size have also been demonstrated as 
separate phenomena.  In work on MDCK cells, Balda et al demonstrated the dissociation 
of TER from the passage of non-charged molecules using the incorporation of truncated 
forms of chicken occludin (63).  In this work truncated occludin produced a greater flux in 
Figure 1.4.  Occludin 
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lower molecular weight uncharged molecules, whilst the TER increased.  In retinal 
pigment cells, occludin was demonstrated to affect the passage of molecules dependent on 
size rather than charge.  Depletion of occludin was achieved using siRNA and lead to an 
increase in the diffusive capacity of the paracellular junction to the low molecular weight 
dextrans used, while there was no recorded increase for the higher molecular weight 
molecules (64). 
 
With respect to the formation of the tight junction, occludin is bound to both ZO-1 (65) 
and ZO-3 (66) in the cytosolic compartment, but tight junctions are seen to form when 
there is no occludin available.  Certainly in models where the occludin has been removed 
(the disruption of both occludin alleles in a mouse model) the formation of tight junctions 
appeared unaffected (67).  However, the mammalian phenotypic consequences are far 
ranging, for example growth retardation, male sterility, failure to suckle pups, chronic 
inflammation and hyperplasia of gastric epithelium, brain calcification and thinning of 
compact bones.  It was this observation by Saitou (67) regarding tight junctions and their 
continued formation, that prompted Tsukita’s group (68) to re-examine the junctions of the 
chicken liver, from which the discovery of occludin had been made, to see whether there 
were other novel proteins involved in the tight junction that might facilitate the junction 
formation in the absence of occludin.  This led to the discovery of a 22kDa protein called 
claudin (68). 
 
1.3.3.2 Claudins 
 
 
Figure 1.5.  Claudin 1 
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Claudins are a 20-27kDa tight junction protein first discovered by Tsukita’s group in 1998 
(69).  There are at least 24 different claudins now reported (16).  All claudins consist of 
four transmembrane domains, two extracellular loops and two cytoplasmic N and COOH 
tails (1).  These loops confer specific functions.  The first extracellular loop determines 
paracellular charge selectivity (54).  Through work using MDCK cells and the over 
expression of different claudins, Van Itallie et al demonstrated the effects different 
claudins had on both the flux of molecules through the paracellular passage and the charge.  
Claudins 8 (70), 11(71) and 14 (72) have all been demonstrated to reduce paracellular 
conductance and discriminate against the passage of cations, while claudins 2 and 15 have 
been shown in increase the sodium permeability (71, 73). 
 
The cytoplasmic tail anchors the claudin transmembrane protein to the scaffolding proteins 
ZO-1, ZO-2 and ZO-3 (74), multiple-PDZ domain protein 1 (MUPP1) (75, 76), and PATJ 
(77).  PDZ domains are a common 80-90 amino-acid domain utilized by signalling 
proteins in bacteria, yeast plants and animals to facilitate anchorage of the protein to 
cytoskeletal proteins (78).  The availability of PDZ domains to bind with may further aid 
the localisation of claudin to the tight junction.  
 
The C terminus may have a role in the physiological half-life of each protein.  In 
experiments with claudin 4/claudin 2 chimeras; claudin 4 was retained in the tight junction 
for longer when the chimeric form combined claudin 4 with the claudin 2 C terminus (73).  
These tails may also be involved in localisation of the claudin protein to the tight junction.  
When claudin 1 had its C terminal end removed and was FLAG-tagged (flag protein is a 
polypeptide protein that can be added to a protein of interest for identification/localisation 
purposes), it still localized to the tight junction (79).  But when the same truncated claudin 
1 protein was tagged with GFP on its N terminus, the protein failed to localise and instead 
formed claudin-containing intracellular vesicles (80). 
 
 Claudins are important in the regulation of the passage of molecules via the paracellular 
pathway.  This regulation is dependent upon many things; pore/molecule size, 
pore/molecular charge and what is being assessed (resistance or flux) (81).  Previous 
published data have shown many molecular sizes can pass through the paracellular   33 
pathway but experimental flaws weakened data – molecules used in the assessment were 
charged (when assessing the size) and epithelial monolayers were non-confluent (82, 83).  
 
Other data demonstrated different claudins regulate the paracellular pathway differently 
(81).  Using an inactivated claudin 5 gene mouse model, Nitta et al demonstrated the size 
of the molecules that could pass through the murine brain vascular endothelial lining was 
increased in comparison to wild type mice.  This was attributed to the fact that the normal 
endothelial tight junctions consisted of claudin 5 and claudin 12, thus implying the relative 
pore size of claudin 12 to be larger than claudin 5 (84).  In the proximal tubule, where 
approximately 95% of the filtered solute is reabsorbed, claudin 2 is expressed, which is 
classically a “leaky” claudin (56, 57).  In the distal tubule, responsible for urinary 
constituent fine-tuning, claudins 4, 7 and 8 are expressed.  This region of the nephron is 
associated with much higher resistance (85). 
 
Many tissues utilise the claudins in tight junctions.  Turksen and Troy summarised the 
claudins and their tissue localisation as follows 
Tissues        Claudin expression (+ve or -ve)  References 
Skin               
  Periderm     6+       (86) 
  Epidermis     1+ 2– 3+ 4+ 6+ 8+  
12+ 17+  
(87-90) 
  Hair follicle     1+       (89) 
  Dermis           
  Endothelium    5+      (91)b 
Cornea             
  Epithelium    1+ 2+ 3+ 7+  
9+ 14+ 
  (92) 
Lung             
  Endothelium    5+       (93) 
Testis      1+       (94, 95) 
  Sertoli cells    1+ 11+      (96) 
  Endothelium    5+       (97)   34 
Retina             
  Vascular endothelium  5+       (98) 
Breast      4+ 7+      (99, 100) 
  Arteries     10+      (101) 
Prostate      4+      (100) 
Bladder      4+      (100) 
Pancreas      4+      (100) 
  Duct epithelia    2+ 3+ 4+    (102) 
  Acinar cells    3+ 4+ 5+    (102) 
Ovary      1+ 3+ 4+    (103, 104) 
Brain      5+       (84) 
  Cerebral endothelia cells  1+      (105) 
  Myelinating Schwann cells         
    Paranodal loop  1+      (106) 
    Incisures   5+       (106) 
Kidney             
  Nephron    7+ 8+      (85, 107) 
  Distal tubule  1+ 3+ 8+    (108, 109) 
  Collecting duct  1+ 3+ 4+ 8+    (108, 109) 
  Proximal tubule  2+ 10+ 11+    (108, 109) 
  Thin descending limb of LOH  2+      (108) 
  Thin ascending limb of LOH  3+ 4+ 8+    (108) 
  Thick ascending limb of LOH  3+ 10+ 11+ 16+  (108, 110) 
  Bowman’s capsule  1+ 2+      (108) 
  Vasculature    5+ 15+      (108, 109) 
Inner ear             
  Cochlea      1+ 2+ 3+ 9+ 10+ 12+ 14+ 18+  (111) 
    Inner hair cells  14+      (72) 
    Outer hair cells  14+      (72) 
    Supporting cells  14+      (72) 
  Organ of Corti    1+ 2+ 3+ 9+ 10+ 12+ 14+ 18+  (111) 
  Stria vascularis           
    Marginal cells  1+ 3+ 8+ 9+ 10+ 12+ 14+ 18+  (111, 112) 
    Basal cells  11+      (111)   35 
  Reissner’s membrane  1+ 2+ 3+ 8+ 9+ 10+  
12+ 14+ 18+ 
(111) 
  Spiral limbus    1+ 2+ 3+ 8+ 9+ 10+  
12+ 14+ 18+ 
(111) 
  Vestibule           
    Sensory  
epithelium 
1+ 3+ 9+ 12+ 
14+ 18+ 
  (111) 
    Dark 
cells 
  1+ 3+ 9+ 12+ 
14+ 18+ 
  (111) 
Lung        1+ 3+ 4+ 5+ 
18+ 
  (113-115) 
  Type II alveolar epithelium  3+ 4+ 5+    (115) 
  Alveolus    5+      (115) 
Liver      1+ 2+      (102, 116, 117) 
  Hepatocytes    2+ 3+ 4–    (102) 
  Endothelium    5+       (102) 
Gut             
  Gastrointestinal mucosa  4+      (100) 
  Peyer’s patches           
    Follicle associated 
epithelium 
2+ 3+ 4+    (118) 
Placenta      23+      (119) 
Stomach      23+ 18+    (114, 119) 
Uterus             
  Epithelium    1+      (120) 
 
Table 1.1.  Localisation of claudins in Tissue 
Table adapted from Turksen and Troy, 2004 (121). 
 
Regulation of claudins takes place at both a transcriptional level and through humoral 
factors.  The transcription factors Snail (12, 122, 123), GATA-4 (124) and T/EBP/NKX2.1 
(a homeodomain transcription factor expressed in lung, thyroid and brain) (114) have been   36 
shown to affect claudin expression.  In the context of this work, Snail is the most relevant 
factor as it has effects on other junctional proteins and may play a significant role on EMT 
and claudin selection (12).  Humoral factors, such as hepatocyte growth factor or epithelial 
growth factor (125), have also been shown to regulate the expression of claudins (126). 
 
1.3.3.3 Junctional Adhesion Molecules 
   
JAM 1-4 are four isoforms of a molecule that assist with junctional assembly in different 
cells.  They are approximately 43kDa glycosylated proteins.  JAM-1 has a carboxy 
terminal that binds PDZ 3 of Zo-1 and PDZ9 of MUPP1.  The extracellular domain 
contains two immunoglobulin loops and the N-terminus.  Immunoglobulin loop1, the loop 
nearest the membrane, is responsible for forming homophilic bonds with neighbouring 
epithelial cells.  JAM-2 is present in endothelial cells (127) while JAM-3 is present on T 
cells (128) and acts to facilitate the movement of lymphocytes between endothelial cells 
(129).  JAM-4 is present in glomerular and intestinal epithelial cells (130).  It binds PDZ1 
and 4 of the membrane associated guanylate kinase 1 (MAGI-1) protein (131, 132).  For 
full review see Schneeberger, 2004 (133). 
 
The association of JAM-1 with the tight junction appears important, but not integral.  
JAM-1’s association to the tight junction is via ZO-1 and MUPP1 to claudin.  JAM-1 
however, then recruits partitioning defect protein 3 (PAR-3), a regulator of cell polarity, to 
Figure 1.6.  JAM’s  
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the tight junction along with PAR6 and atypical PKC.  This may be essential in the 
formation of membrane polarity (134). 
 
1.4  Renal Tubular Function 
Renal tubular functions are the excretion of waste/water, maintenance of blood pressure 
and homeostasis through the management of acid-base concentrations.  The active 
transcellular pathway and the regulation of the paracellular pathway facilitate these 
functions.  Sodium, potassium, chloride, calcium, phosphate, bicarbonate and amino acids 
are primarily reabsorbed in the proximal convoluted tubule.  The Loop of Henle 
concentrates the urine by utilising the counter-current multiplier system.  In the distal 
convoluted tubule, the presence of two types of epithelial cells contributes to its function.  
Principal cells regulate the sodium-potassium exchange and the intercalated cells regulate 
the hydrogen-bicarbonate exchange. 
 
As reported earlier, the paracellular pathway is regulated in part by claudins.  Different 
types of claudin are located in specific regions of the tubule and are important 
determinants of the differing permselectivity in these regions.  Claudin presence along the 
tubule has been reported in the mammalian kidney.   38 
 
 
 
 
Table 1.2.   Localization of claudin proteins in mammalian kidney.  
Localization data were summarized from the following studies: claudins 1, 3, 4, and 11(108), 
claudin-2 (57), claudin-6 (135, 136), claudins 7 and 8 (85), claudin-9 (135), claudin-10 (137), 
claudin-14 (72), claudin-16 (138-140), and claudin-19 (138, 141, 142).  Tubule expression of 
claudins 6 and 9 is only found in neonatal kidney (135).  Many of these claudins have not been 
rigorously examined in all nephron segments so the data shown are not comprehensive.  Macula 
densa claudin expression is from our own unpublished results.  Claudins 5 and 15 are confined to 
endothelial cells of the vasculature and glomeruli (108) and so are not shown.  Claudins 12, 18, and 
20–24 have not yet been examined.  Figure modified from Angelow et al (141) (copyright 
Lippincott, Williams & Wilkins, 2007).  
 
More recently work from this thesis was published, looking at the distribution of claudins 
along the human nephron. This study showed the localisation of different claudins in 
specific regions along human tubules from nephrectomy specimens (143).  39 
Proximal Tubule  Thick Ascending 
Limb 
Distal Convoluted 
Tubule 
Collecting Duct 
LTA  EMA  Aquaporin 2 
    Calbindin 
N-cadherin  Strong DB  Intermittent DB   
                Weak                                                  E-cadherin                                                     Strong 
Discrete Zo-1      Strong Zo-1 
  THP     
    Claudin 1 
Claudin 2       
Weak Claudin 3  Claudin 3 
    Claudin 4 
    Claudin 7 
    Claudin 8 
Discrete Claudin 10  Strong Claudin 10     
Weak cytoplasmic 
Claudin 11 
Strong Claudin 11     
    Claudin 14   
  Claudin 16     
 
Table 1.3.  The distribution of certain claudins along the human renal tubule.  
LTA, Lotus tetragonolobus albicans; DB, Dolichos bifluorus; EMA, epithelial membrane antigen 
and THP, Tamm Horsfall Protein (143). 
 
1.5  Renal Failure 
The function of the kidney is six fold.  These functions are: - 
i)  To maintain fluid balance within the human body.  Fluid homeostasis is achieved 
through filtration of fluid through the kidney, approximately 180L/day. Of this 
volume about 1-2 litres are excreted as urine; the rest is reabsorbed through the 
tubules back into the host system. 
ii)  To maintain electrolyte balance, including the excretion of waste products such as 
urea and creatinine. This function is facilitated by the nephron. Molecules are 
filtered through the glomerulus and then selectively reabsorbed along the route 
of the tubules. The amount reabsorbed is dictated by the concentration gradient   40 
established within the tubules. This is a function of the transcellular and 
paracellular pathways. 
iii)  To maintain the optimum acid-base balance within the host. The tubules facilitate 
this through the excretion and reabsorption of hydrogen ions and bicarbonate 
molecules. 
iv) To maintain the optimum phosphate and calcium balance, maintaining bone health 
and physical well being through the production of 1,25-dihydrocholecalciferol 
and calcium/phosphate homeostasis. 
v)  To produce erythropoietin, the hormone responsible for stimulating bone marrow to 
produce haemoglobin. 
vi) To monitor and adjust blood pressure through fluid balance, electrolyte balance, 
acid-base balance and through the renin-angiotensin-aldosterone axis.  
 
Renal failure is subdivided into acute and chronic.  Acute kidney injury (AKI), the term 
replacing acute renal failure (ARF), is characterised by a rapid reduction in the excretory 
function of the kidney associated with a variety of aetiological factors (refer to Acute 
Kidney Injury Network, AKIN for formal definition, (144)).  These aetiological factors are 
usually subdivided again into pre-renal causes, intrinsic renal causes and post-renal causes.  
By definition the AKI has an element of reversibility.  Chronic kidney disease (CKD) is 
the product of non-reversible changes to the renal parenchyma resulting in a persistently 
elevated serum creatinine and urea.  This condition may progress to end-stage renal failure 
(ESRF) regardless of its aetiology (4). 
 
During the progression of CKD to ESRF, the physician has the opportunity to slow the rate 
of deterioration by controlling such factors as blood pressure, body mass index and 
glycaemic control.  Despite these measures CKD will relentlessly progress to ESRF.  At 
ESRF the function of the kidney, listed above, have to be replaced by interventions, 
namely dialysis and hormonal supplementation. 
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1.6  Renal Replacement Therapy 
Renal replacement therapy (RRT) consists of managing the functions of the kidney 
through iatrogenic means.  Patients are asked to monitor and reduce their fluid intake.  
They are provided with medication to control blood pressure, calcium/phosphate 
homeostasis, acid-base balance and hormonal replacement through erythropoietin, which 
they inject themselves.  If these measures do not maintain the situation and the excretory 
function continues to decline, the patient then will require dialysis.  Dialysis is the process 
by which blood is cleaned of its waste products by either being passed over an external 
semi-permeable membrane (haemodialysis) or through a process of peritoneal dialysis, 
where the peritoneal membrane is utilised as a semi-permeable membrane.  
 
Once the kidneys have completely failed and their function is totally being replaced by 
iatrogenic therapies or if the decline to ESRF can be predicted, the patient can be 
counselled and assessed for the possibility of a kidney transplant.  Transplantation offers 
much better physiological control and quality of life, at less financial expense but is 
dependent on life-long medication with anti-rejection therapies and their associated side 
effects. 
 
1.7  Immune Suppression 
Renal transplants require significant immune suppression to prevent rejection.  The 
mainstays of this immunosuppression are the calcineurin inhibitors, CsA and tacrolimus. 
Unfortunately, CsA can cause acute and chronic renal failure; one of the latter’s 
characteristics being interstitial fibrosis (7, 145).  The caveat to this is the profound 
improvement in one-year graft survival observed since the discovery and use of CsA (146-
148). 
 
The mechanism of action for calcineurin inhibitors is through blocking the 
dephosphorylation of calcineurin by forming heterodimeric complexes with their 
respective immunophilin receptor protein, cyclophilin (149) and FK-binding protein 
(FK506) (150, 151).  Inhibition of the calcineurin, a calcium and calmodulin sensitive 
serine phosphatase, occurs as these complexes interact with it (152-154).  This prevents the 
dephosphorylation and nuclear translocation of members of the NFAT family preventing   42 
the synthesis of products required in the immune response to non-self by T-cells (155-
159). 
Other immune suppressant drugs used in the regimen are the corticosteroids that target T 
cells for their immune suppressive properties, azathioprine and mycophenolate mofetil 
(MMF) that target cellular proliferation to reduce rejection and OKT3, a monoclonal 
antibody that targets T cells specifically.  Corticosteroids, as well as affecting the T cell 
population, reduce the production of cytokines (160-162). 
 
The limitations with CsA are four-fold.  CsA is capable of causing acute toxicity, over-
exaggerated immune suppression, acute renal failure and chronic renal failure.  Acute 
toxicity is characterised by the recipient suffering with tachyarrhythmias, nausea, 
vomiting, non-specific abdominal pain and tremors.  Being overly immune suppressed can 
render the recipient susceptible to opportunistic infections such as fungal infections or viral 
reactivations.  Acute toxicity is characterised by a reversible, dose-dependent decline in 
glomerular filtration rate and renal blood flow, caused by the direct effect of the CsA on 
the renal vasculature (163-167).  This is characterised clinically by a rise in urea and 
creatinine that is reversed on reduction of the therapy.  Chronic nephrotoxicity is 
characterised by tubulointerstitial lesions and vacuolation within the arteriolar smooth 
muscle cells (168, 169).  This is reviewed in Mihatsch et al (168). 
 
Certainly, it is accepted that CsA causes renal failure, but it is unclear what is taking place 
at a cellular level.  One stimulus for this appears to be TGFβ1 (8, 170, 171).  In vitro 
experimentation demonstrated that the exposure of two cell lines, murine proximal tubular 
cells and syngeneic tubulointerstitial fibroblasts, to CsA produced TGFβ1 and a steady-
state in TGFβ1 mRNA (8).  In vivo, mice receiving CsA also produced an elevation in the 
serum TGFβ1 concentration (170).  Another explanation examined is the direct effect of 
CsA itself on RTECs.  Exposure of LLC-PK1 cells (a virally transformed pig cell-line that 
resembles proximal tubular epithelial cells) to low doses of CsA lead to the production of 
hydrogen peroxide and was the source for hydrogen radicals that damaged the RTEC 
directly (172).  Further evidence suggesting TGFβ1 is the mediator through which CsA 
produces cellular growth arrest and fibrosis is through the use of neutralising antibodies.  
These antibodies conferred a protection against the damage that could be done with the 
additional TGFβ1 being synthesised (10, 173).    43 
In assessing the effects of CsA on LLC-PK1 and MDCK cells, CsA exposure produced 
less viable cells (the LLC-PK1 cells suffering more – i.e. representing the proximal RTEC) 
and changed the cellular environment to a more catabolic one, as evidenced by the 
increased production of lactate dehydrogenase, even in the presence of oxygen (174).  
When human proximal RTEC and LLC-PK1 cells were treated with varying doses of CsA, 
both cells lines underwent cell cycle arrest and cell death.  The nature of cell death was 
dose-dependent and could have been related to an up regulation in the surface expression 
of the Fas protein (a cell surface protein that stimulates apoptosis) that took place at low 
concentrations of CsA and then was lost (175), making way for necrotic cell death (as 
opposed to apoptosis).  More recent work on HK2 cells by Michael Ryan’s group has 
demonstrated the effects of CsA, producing a full EMT.  This was evidenced by a dose-
dependent, morphological and phenotypic change seen in these cells when treated with 
CsA (176, 177). 
 
Despite CsA being the mainstay of immunosuppression for solid organ transplantation, its 
relationship with kidney insufficiency and fibrosis have made it less viable for long-term 
use. It may be however, that other possible stimulants of EMT are responsible in these 
pathological settings.  Those studied include angiotensin II and endothelin-1.  Angiotensin 
II was implicated by its elevated concentration and the selective vasoconstriction of the 
juxtaglomerular apparatus (JGA).  It may also have stimulated the proliferation of the 
smooth muscle cells in the afferent glomeruli, altering the glomerular filtration pressures 
and the transmural cellular stimulation (165, 178, 179).  Similarly, endothelin-1 produced 
vasoconstriction and proliferation of the smooth muscle cells (179-181) and demonstrated 
elevated levels in rats and humans receiving CsA (179, 182-184).  
 
1.8  Hypotheses 
1.  Claudins are differentially expressed in the renal tubule to reflect changes in 
paracellular permeability required for the normal kidney function and human 
homeostasis. 
2.  TGFβ1 and CsA modify the expression of claudins in a model of primary renal 
tubular epithelium (RTECs) with changes in TER and permeability to solutes. 
3.  TGFβ1 and CsA modify the expression of epithelial genes in cultured RTECs (not 
simply the junctional proteins but those relating to cellular fate/differentiation). 
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1.9  Aims 
1.  To stain renal tissue with a panel of claudin antibodies in order to characterise the 
expression in human kidney. 
2.  To culture RTECs as a model of renal epithelium to study barrier function in 
response to TGFβ1 and CsA. 
 
1.10  Objectives 
1.  To establish a fixation and immunohistochemical technique for claudin antibodies 
in human renal tissue. 
2.  To establish the cellular morphology and claudin expression in cultured RTECs. 
3.  To record the expression in claudins in RTECs with respect to TGFβ1 and CsA 
using immunofluorescence and western blotting. 
4.  To test the effect of TGFβ1 and CsA on expression of phenotypic gene markers in 
RTECs. 
5.  To use a model of RTECs on Transwell filters in order to measure paracellular 
permeability and transepithelial electrical resistance (TER) to assess the effects of 
TGFβ1 and CsA on those physical characteristics.  45 
2  Materials and methods 
2.1  Introduction: - 
The vast majority of work in this field utilised cell-lines for the experimentation.  In this 
work all experimentation used primary cells from human nephrectomy specimens.  The 
nature of this work facilitates a study of normal kidney and the natural responses of human 
primary renal cortical tubular epithelial cells to the challenges of TGFβ1 and cyclosporine 
(CsA), within this model. 
 
2.2  Acquisition and Processing of Specimens: - 
4x2x2cm mass of cortical renal tissue was excised from the human nephrectomy specimen, 
obtained from consenting adults undergoing a kidney resection for unipolar renal cell 
carcinoma, under strict ethical guidelines.  Ethics agreement was granted from 
Southampton University 2000, amendment 2003 (Ref No. 192/00/w.  R&D Ref No. RHM 
PAT/194).  It was processed in the following ways: -  
i)  Ten 2x2x2mm pieces were cut from the main mass and immersed in acetone, 
containing 2mM phenyl methyl sulphonyl fluoride, and 20mM iodoacetamide, 
to prevent further intracellular enzymatic activity.  This was left for up to 24 
hours and then embedded in the glycol methacrylate (GMA). 
ii)  A single piece of tissue was cut from the main mass and immersed in 
formaldehyde for wax embedding.  Once embedded, these specimens remained 
at -20
oC until required for experimentation.  
iii)  Two 2x5x5mm masses were cut and wrapped in foil and “snap-frozen” in 
liquid nitrogen for future frozen immunohistochemistry. 
iv)  The remaining mass of tissue underwent homogenisation, collagenase 
degradation and cell culture to produce RTECs to freeze at passage 0, ready for 
use in culture experiments at a later date. 
 
2.3  Isolation of RTECs: - 
The remaining tissue was then cleaned of obvious medullary tissue and capsule and placed 
in a Petri dish with a small volume of a basal medium containing 10% v/v FCS solution.  
This tissue was homogenised, employing the crossed scalpels technique, until all the 
particles were <1mm
3.  It was then suspended in RPMI with antibiotics (2 iu/ml penicillin   46 
and 2mg/ml streptomycin) and centrifuged for ten minutes at 1100rpm.  The supernatant 
was discarded and replaced with fresh RPMI (and antibiotics) and this process repeated 
twice.  After the third centrifugation, the pellet was suspended in 20mls of PBS containing 
0.1% v/v collagenase IV solution.  This mixture was then orbitally incubated for one hour, 
sterilely exchanging the air in the tube every 20 minutes. Once incubated 20mls of PBS 
containing 0.15% v/v soya bean trypsin inhibitor (SBTI) was added and centrifuged for 
five minutes at 1100rpm.  The resulting pellet was suspended in RPMI and centrifuged 
twice further and then suspended in a small volume of RPMI to be strained sequentially 
through 70µl and 40µl filters.  The resulting filtrate was then re-suspended with 
Dulbecco’s Modified Eagles Medium: Ham’s F12 1:1 ratio (DMEM:H-F12) with 2mmol/L 
glutamine, 100iu/ml penicillin, 100mg/ml Streptomycin, 2% v/v Ultroser G (USG, a 
synthetic serum substitute, BioSepra, France) and defined additives (see table 2.2).  This 
constituted “half-defined medium” or “proliferation medium”.  These cells were then 
plated into 25cm
3 flasks.  After 24 hours the serum-containing medium was exchanged for 
chemically-defined serum-free medium.  These cells were then left to grow to confluence 
and then passaged into freeze medium for storage and reconstitution at a later date. 
 
2.4  Immunohistochemistry 
Human renal tissue was obtained in the above manner and mounted on slides for 
immunohistochemistry (IHC).  Frozen sections, wax and GMA embedded slides were used 
in this work.  Standard indirect immunohistochemical protocol was followed for both 
frozen section staining and wax embedding staining.  These were intended to identify 
recognised regionally specific proteins (29).  For GMA, the Britten protocol was used with 
both standard antibodies (as originally intended) and lectins (a novel method) (185).  This 
is described below. 
 
2.4.1  IHC for Frozen Sections 
Frozen human renal tissue was cut and mounted on slides then supported in a humidified 
chamber and allowed to thaw to room temperature (RmTp).  The sections were fixed using 
a 50:50 solution of ice-cold anhydrous acetone and methanol.  400µl of solution was 
applied to each slide and left to evaporate.  The slides were then rehydrated with TBS, 
drained and then endogenous peroxidases blocked with a solution of methanol and 
hydrogen peroxide (0.3%v/v H2O2 in methanol).  This was incubated for five minutes and 
then washed off, using TBS with three three-minute washes.  Avidin block (Avidin-Biotin   47 
Blocking Kit, Vectastatin Laboratories Inc., Peterborough, UK) was applied and incubated 
for 20 minutes at RmTp.  This was flicked off and replaced with biotin block (Vectastatin), 
again incubated for 20 minutes at RmTp.  Biotin block was flicked off.  The final block 
was then applied, a horse serum protein block (TBS containing 1% v/v horse serum) for 20 
minutes at RmTp.  This was removed and the primary antibodies applied at 1:100 stock 
concentrations.  The negative control was non-immune mouse immunoglobulin at 1:100 
stock concentration and the positive control, cytokeratin antibody Cam 5.2, used neat.  The 
slides were then incubated at 4
oC overnight. 
 
Following overnight incubation, the primary antibodies were removed with three three-
minute washes using TBS.  Utilizing the Vectastatin ABC “Elite” Kit (PK6200 Universal, 
Vectastatin, Peterborough, UK) the universal biotinylated secondary antibody solution was 
made up and applied to each slide.  After incubation for 30 minutes the slides were 
washed, using TBS, three three-minute washes, and Vectastatin complex A and B solution 
applied.  This was incubated for 30 minutes and then washed off.  The chromagen 3,3’-
diaminobenzidine (DAB, BioGenex) was applied and incubated at RmTp for ten minutes 
before being rinsed off with distilled water and counterstained with Meyer’s haematoxylin 
for one minute.  Slides were then dehydrated through alcohol (70%, 90%, 100% and 
100%) for three minutes in each solution and then placed in low tox for three minutes, 
allowed to dry and then mounted with coverslips. 
 
2.4.1.1 Analysis 
Prepared slides were examined microscopically, using a Nikon Eclipse E600 microscope at 
magnifications of x40, x100, x200 and x400.  The slides were studied with Dr JE Collins 
(Senior Lecturer and Supervisor, Department of Infection Inflammation and Repair, 
Southampton University, UK) and Dr P Bass (Consultant Histopathologist, Pathology 
Department, Southampton University Hospitals Trust, Southampton, UK).  Images were 
recorded using a Nikon Coolpix 950 digital camera.  Analysis was undertaken looking for 
staining, demonstrating the presence and localisation of antigens being studied.  
 
2.4.2  IHC for Wax Embedded Tissue 
Human renal specimens were embedded in paraffin and cut by Leica Reichert Ultracut S 
cryostat (Leica Microsystems) into 5µm sections and mounted on glass slides.  From   48 
RmTp storage, these slides were rehydrated through xylene, low tox and alcohol solutions 
(100%, 100%, 90%, 90% and 70%).  The slides were then supported in a humidified 
chamber and rehydrated with TBS.  Endogenous peroxidases were blocked, to prevent 
non-specific antibody binding, using a methanol and 0.3% v/v hydrogen peroxide solution 
and incubated at RmTp for ten minutes.  The slides were then placed in a plastic slide rack 
and immersed in a solution of EDTA pH 8.0, citrate pH 6.0 or citrate pH 9.0.  Two other 
containers of slides containing the same solution were prepared and the three containers 
were placed in a microwave (Panasonic NN-6450 – 800 watts) and microwaved at 
“medium” for 25 minutes.  Taking care replacing the slides in the humidified chamber, 
they were given time to cool and washed with TBS (three three-minute washes). 
 
After washing, avidin block (Vectastatin, Blocking Kit) was applied and incubated for 
20minutes at RmTp.  Excess avidin was shaken off and biotin block (Vectastatin, Blocking 
Kit) applied for 20 minutes at RmTp.  The slides were then shaken vigorously, removing 
all the excess fluid.  Horse serum solution (TBS containing 1% v/v horse serum) was 
applied, incubated for ten minutes, before having the primary antibodies applied, at the 
required titration, to incubate overnight at 4
oC. 
 
NB: -  Difficulties were experienced with antigen retrieval so other methods of retrieval 
were attempted.  Rather than using EDTA as the immersion fluid during microwaving, 
citrate pH6 and pH9 was used and, rather than microwaving altogether, Pronase was used 
(at 0.05% Pronase Working Solution). 
 
On the second day, the slides were washed with TBS (three three-minute washes with 
TBS).  Universal antibody solution was then applied to each slide (Vectastatin ABC Kit, 
Elite PK6200) and incubated for 30 minutes.  The slides were washed again and DAB 
applied for ten minutes.  Before counterstaining with Meyer’s haematoxylin, the slides 
were rinsed with distilled water.  Once counterstained, the slides were bathed in a running 
tap water bath for five minutes.  Dehydrated with alcohol solutions (70%, 90%, 90%, 
100% and 100%) and xylene, the slides were then mounted with coverslips. 
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2.4.2.1 Solutions used for antigen retrieval: - 
EDTA 1mM pH 8.0 
EDTA       0.37g 
Nanopure water    1000ml 
pH adjusted using 0.1M NaOH (to pH 8.0) 
 
Citrate 0.01M 
Citric acid crystals    2.1g 
Nanopure water    1000ml 
pH adjusted using 1M NaOH (to pH 6.0 0r to pH 9.0) 
 
2.4.2.2 Analysis 
Prepared slides were examined microscopically, using a Nikon Eclipse E600 microscope at 
magnifications of x40, x100, x200 and x400.  The slides were studied with Dr JE Collins 
(Lecturer and Supervisor, Department of Tissue Inflammation and Repair, Southampton 
University, UK) and Dr P Bass (Consultant Histopathologist, Pathology Department, 
Southampton University Hospitals Trust, Southampton, UK). Images were recorded using 
a Nikon Coolpix 950 digital camera.  Analysis was undertaken looking for positive 
staining, demonstrating the presence and localisation of antigens being studied.  
 
2.4.3  Immunohistochemistry for GMA 
Human renal specimens, embedded in glycolmethacrylate (GMA), were cut into two 
micron sections using a Leica Reichert Ultracut S cryostat (Leica Microsystems Ltd, 
Milton Keynes, UK), mounted on glass slides, two sections per slide, and stored at -20
oC. 
The slides were cut such that sections were mounted in series along each row.  On the days 
of staining, the slides required were removed from storage and allowed to acclimatize to 
RmTp, whilst supported in a humidified chamber. 
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Endogenous peroxidases were inhibited using a solution of 0.1% v/v sodium azide and 
0.3% v/v hydrogen peroxide in nanopure water.  This incubated for 30 minutes at RmTp. 
The slides were then washed three times with TBS each for five-minute wash.  For a 
further 30 minutes the slides were then blocked at RmTp with a solution of TBS containing 
1% w/v BSA and 5% v/v FCS (Invitrogen, Paisley, UK).  Once blocked, primary 
antibodies were applied to each slide and incubated overnight with coverslips.  For 
monoclonal antibodies, this incubation was done at RmTp.  For polyclonal antibodies, this 
incubation was done at 4
oC.  The positive control, Cam 5.2 (BD Biosciences, Cambridge), 
was used neat.  The negative control was secondary antibodies alone. 
 
Once the slides had incubated and come to RmTp, they were washed again with TBS three 
five-minute washes.  Biotinylated second stage antibodies were then applied and incubated 
for two hours at RmTp.  For the monoclonal antibodies, these were titrated to 1:700 using 
rabbit anti-mouse (Dako, Cambridgeshire, UK).  For the polyclonal primary antibodies, 
claudin 2 polyclonal antibody was a rabbit anti-claudin 2 and e-cadherin was goat anti-e-
cadherin. Thus, the biotinylated secondary antibodies were swine anti-rabbit (Dako, 
claudin 2) used at 1:1200 and rabbit anti-goat (Dako, e-cadherin) used at 1:10,000.  After 
three further five-minute washes, the slides were drained and had a streptavidin and biotin-
peroxidase complex solution (0.5% v/v, both BioGenex/Menarini Diagnostics, 
Wokingham, UK) in Tris-HCl pH 6.7 applied and were incubated for a further two hours.  
The slides were then drained, washed with TBS (three five-minute washes) and DAB 
applied.  This incubated for ten minutes at RmTp.  Slides were then rinsed in TBS, bathed 
in running tap water for five minutes, counterstained with Meyer’s haematoxylin for two 
minutes and then bathed again in running tap water for five minutes.  Crystal mount was 
then applied to each slide and they were baked at 80
oC for 20 minutes. After baking, the 
slides were allowed to cool and coverslips applied. 
 
2.4.3.1 Analysis 
Prepared slides were examined microscopically, using a Nikon Eclipse E600 microscope at 
magnifications of x40, x100, x200 and x400.  The slides were studied with Dr JE Collins 
(Lecturer and Supervisor, Department of Tissue Inflammation and Repair, Southampton 
University, UK) and Dr P Bass (Consultant Histopathologist, Pathology Department, 
Southampton University Hospitals Trust, Southampton, UK).  Images were recorded using   51 
a Nikon Coolpix 950 digital camera. Analysis was undertaken looking for positive 
staining, demonstrating the presence and localisation of antigens being studied.  
 
2.4.4  IHC in GMA and the Lectins 
Stored slides were retrieved from the freezer and allowed to reach RmTp.  These slides had 
two 2mm
2 pieces of renal tissue embedded in GMA on them.  Once at RmTp, the 
endogenous peroxidases were blocked using a solution of 0.1% v/v sodium azide with 
0.3% v/v hydrogen peroxide in nanopure water.  After incubation at RmTp for 30 minutes, 
the slides were washed (three three-minute washes in TBS) and had avidin block applied.  
This was incubated for 30 minutes at RmTp.  The slides were then washed again and had 
biotin block applied to incubate at RmTp for 30 minutes.  After incubation, the slides were 
washed and had their lectins applied (Vector Lab’s, UK).  These markers for regional 
carbohydrates were applied and incubated overnight at a titration of 1:1500 stock solution.  
The lectins used were Lotus tetragonolobus, for proximal tubules, and Dolichos biflorus, 
for distal tubules. 
 
The following morning the slides were washed and a streptavidin-biotin complex (0.5% 
v/v, both BioGenex/Menarini Diagnostics, Wokingham, UK) applied for two hours at 
RmTp.  This was then washed off and DAB applied for ten minutes.  Once incubated, this 
was rinsed off and the slides then bathed in a running tap water bath for five minutes, 
before being placed in Meyer’s Haematoxylin for two minutes and then re-bathed.  After 
second bathing in running tap water, the slides were baked at 80
oC for 20 minutes, and 
then mounted with coverslips. 
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Antibody  Make & 
model 
Species & 
Clonality 
Stock Solution 
concentration 
Titration of 
antibody used 
Anti-human N-
cadherin 
Zymed 
33-3900 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/100 
Anti-human E-
cadherin 
Zymed 
33-4000 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/100 
Anti-human Claudin 
2 
Zymed 
32-5600 
Mouse 
monoclonal 
IgG2b 
100µg/200µl  1/100 
Anti-human 
Epithelial Membrane 
Antigen 
Dako 
M0613 
Mouse 
monoclonal 
IgG2a 
240µg/1ml  1/100 
Anti-human ZO-1  Zymed 
22-9100 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/100 
Anti-human 
Cytokeratin 18 
Dako 
M7010 
Mouse 
monoclonal 
IgG1k 
  1/100 
Anti-human 
Occludin 
Zymed 
33-1500 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/250 
Cam5.2  BD 
Biosciences 
349205 
Mouse 
monoclonal 
IgG2a 
Pure 
Concentrate 
1:25 
Neat 
Anti-human αSMA  Abcam 
(ab7817) 
Mouse 
monoclonal 
IgG2a 
250µg/500µl  1/100   53 
Lotus  
tetragonolobus 
Vector 
B-1325 
Anti-
carbohydrate 
2mg  1/1500 
Dolichos  
bifluorus 
Vector 
B-1035 
Anti-
carbohydrate 
5mg  1/1500 
 
Table 2.1.  Antibodies used, species & clonality and their titrations in IHC in GMA 
 
Secondary Antibodies were used dependant on the primary. 
Monoclonal Primary: -  Dako, rabbit anti-mouse (E0413), 1:700. 
Polyclonal Primary: -   Dako, swine anti-rabbit (E0431), 1:1200. 
  Dako, rabbit anti-goat (E0466), 1:10,000. 
NB: -  For the Lectins the secondary system implemented the streptavidin-biotin complex, 
and for DAB no biotinylated secondary antibody was required. 
2.4.4.1 Analysis 
These slides were examined alongside the above slides. 
 
Figure 2.1.  Diagrammatic representation of the layout and cutting order of the specimens 
for GMA IHC.  
Specimens numbered 1 – 9 along the top of each slide were sequential, as were specimens 10 – 18.  
Note that the cutting order facilitates serial comparisons between renal tissues cut 2µm apart.  The 
rectangle at the base of each slide represents the labelling.  
1  2  3  4  5  6  7  8 
10  11  12  13  14  15  16  17  18 
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2.5  RTEC Culture and Experimentation: - 
Previously frozen primary RTEC were defrosted and spun in 10mls of DMEM:F12 
medium at 1000rpm for five minutes to wash off the DMSO in the freeze medium.  The 
supernatant was then discarded and replaced with 5mls filter-sterilised, half-defined 
medium (FSHDM), reconstituting the pellet formed.  This volume of cell-containing 
medium was then split between two 25cm
2 flasks, already holding 4mls of warmed 
FSHDM.  After 24 hours of growth in FSHDM, the medium was exchanged for filter-
sterilised, serum-free, chemically defined medium (FSDM).  These cells were then grown 
to confluence before being passaged to the experimental vesicles for experimentation. 
NB: Each 25cm
2 flask, when confluent, contained 3 million cells from haemocytometer 
measurements. 
Supplement  Stock 
Concentration 
Defined 
Medium 
(Final 
Conc.) 
Volume to 
add 
(µl) 
Half Defined 
Medium 
(Final Conc.) 
Volume 
to add 
(µl) 
Selenite  5µg/ml  5ng/ml  50µl  2.5ng/ml  25µl 
EGF  10µg/ml  10ng/ml  50µl  5ng/ml  25µl 
Hydrocortisone  36µg/ml  36ng/ml  50µl  18ng/ml  25µl 
Iron-loaded 
Transferrin 
500µg/ml  5µg/ml  500µl  2.5µg/ml  250µl 
Insulin  10mg/ml  5µg/ml  25µl  2.5µg/ml  12.5µl 
PGE1  10µg/ml  10ng/ml  50µl  5ng/ml  25µl 
Tri-iodothyronine  20ng/ml  5pg/ml  12.5µl  2.5pg/ml  6.25µl 
USG  1ml  -  -  1% v/v  500µl 
 
Table 2.2.  Recipes for the Culture medium used 
Notes: - 
•  EGF  -  Epithelial Growth Factor 
•  PGE1  -  Prostaglandin E1   55 
•  FSHDM -  Filter-sterilized, half defined medium (contains UltroSer-G, a serum 
substitute) 
•  FSDM -  Filter-sterilized, chemically defined medium (all constituents 
known) 
 
 
 
 
 
2.6  Challenge Experiments using TGFβ1 and CsA and 6 well plates: - 
Initial experimental work was undertaken using primary RTECs grown in 6 well plates for 
protein analysis and on glass coverslips to facilitate immunofluorescence staining.  Cells 
were cultured in the experimental plates for a maximum of five days.  This time period 
consisted of 
-  Passage into the plates in half-defined medium. 
-  Exchange from half-defined medium to defined medium, 24 hours later. 
-  Commencement of the experiment the following day. 
-  Harvest of “day 0” coverslips and cell lysates demarcating the beginning of 
the challenge experiment. 
-  Daily exchange of medium containing TGFβ1, CsA or neither. 
-  Harvest of the remaining coverslips and cell lysates at 72 hours. 
 
Renal tubular epithelial cells were cultured on glass coverslips (BDH, UK) in 6 well plates 
and in 6-well plates alone.  Cells were grown initially with medium containing USG, a 
serum substitute, for a day to facilitate anchoring.  After 24hours, this medium was 
changed to serum-free, chemically defined medium.    2mls of medium was used in each 
exchange.  Some were fixed at 70 – 80% confluence.  This denoted Day 0 and the start of 
the experiment.  Medium was exchanged daily with warmed chemically defined, serum-
free medium containing TGFβ1 (2ng/ml; Merck Biosciences, UK), CsA (100ng/ml; Merck 
Biosciences, UK) or neither.  Images were captured at Day 0 and daily thereafter following 
each medium change.  At 72 hours the remaining cells were fixed with acetone and stained 
using immunofluorescence to assess protein expression and distribution.  Specific regional 
junctional proteins were labelled as well as positive and negative controls.     56 
 
2.6.1  Coverslip Drying and Preparation for Immunofluorescence staining 
Coverslips were harvested at day 0 and 72 hours.  Day 0 represents the baseline with which 
to compare the 72 hour morphology and staining patterns observed.  Preparation of the 
coverslips for immunofluorescent staining required the medium to be removed and 
replaced with phosphate buffered saline (PBS) containing 3mM CaCl2.  CaCl2 was 
included to preserve the cell junctions that had formed during incubation.  This was then 
repeated and the PBS with CaCl2 discarded and replace by fresh PBS with CaCl2.  Each 
bathing period was three minutes long.  After the second bathing, the coverslips were 
removed from the solution, drained of excess fluid and then placed on absorbent paper to 
dry overnight for staining the following day. 
2.6.2  Immunofluorescent Labelling with the Coverslips 
Coverslips with cells from either day 0 or 72 hours had their medium removed and were 
washed twice in PBS containing 3mM CaCl2.  The coverslips were then taken out of the 
plates and dried on absorbent paper overnight.  The following day the coverslips were 
transferred on to glass slides in a humidified chamber and fixed with ice-cold acetone for 
15 minutes.  Once the acetone had completely evaporated, the cells were incubated for an 
hour in PBS containing 5% v/v goat serum (Dako, UK).  After an hour this was removed 
and the primary antibody applied (made up with PBS containing 1% w/v BSA) for one 
hour, at RmTp (antibody titrations as above).  The slides were washed with three five-
minute washes prior to the secondary antibody being applied for one hour (made up in PBS 
– 1%w/v BSA).  Three five-minute washes were completed before incubating with 7-
Aminoactinomycin D (7AAD), a nuclear counterstain, for ten minutes.  Three five-minute 
washes completed the protocol before mounting the coverslips by securing them face-
down to the clean slides with mowiol (Calbiochem, UK). 
 
2.6.2.1 Analysis 
Prepared slides were examined microscopically, using a Leica DMLB microscope at 
magnifications of x40, x100, x200 and x400 with fluorescence.  The slides were studied 
with Dr JE Collins (Lecturer and Supervisor, Department of Tissue Inflammation and 
Repair, Southampton University, UK).  The images were created and stored using a 
Hamamatsu C4742-95 camera and the Wasabi image program, version 1.5, supplied by 
Hamamatsu.    57 
2.6.2.2 Dual-Staining Immunofluorescence 
Dual staining immunofluorescence followed the same protocol as for the single staining 
(chapter 2.6.2) with primary antibody solutions containing both primaries (monoclonal 
mouse and polyclonal rabbit) and secondary antibody solutions containing both 
secondaries (goat anti-mouse and goat anti-rabbit).  The only alteration was the block used 
was PBS with 10%v/v FCS rather than 5%v/v goat serum to avoid any interaction.  This 
staining protocol was carried out by Michelle Hardyman. 
 
MONOCLONAL ANTIBODIES  POLYCLONAL ANTIBODIES      
EMA (1:3200)  E-cadherin (1:100) 
N-cadherin (1:100)  E-cadherin (1:100) 
E-cadherin (1:100)  Claudin 2 (1:100) 
EMA (1:3200)  Claudin 2 (1:100) 
N-cadherin (1:100)  Claudin 2 (1:100) 
 
Note: - i)  All secondaries were 1:500 stock solution. 
o  Goat anti-mouse (Invitrogen, UK) – 546nm 
o  Goat anti-rabbit (Invitrogen, UK) – 488nm 
  ii)  All monoclonal antibodies were represented by red. 
  iii)  All polyclonal antibodies were represented by green. 
 
2.6.2.3 Analysis of Dual-Staining Immunofluorescence 
Images were captured using a Leica SP5 confocal microscope at 488nm and 546nm 
wavelengths, under the guidance of David Johnston (BIU, Southampton University).  
Areas demonstrating good antibody labelling were identified through the microscope, then 
using Z-sectioning intervals of 0.2µm multiple images were captured to create z-stacks.  
These stacks were up to 20µm in height and demonstrated the spatial relationship between 
the proteins at epithelial appositions.  They were used to produce the plan and elevation 
views of the antibodies.  Images were then studied with Dr JE Collins (Lecturer and   58 
Supervisor, Department of Tissue Inflammation and Repair, Southampton University, 
UK).   
 
2.6.3  Protein Extraction of Cells Harvested at Day 0 and 72 hours 
Cells were washed twice in PBS containing 3mM CaCl2 and then drained completely of 
excess fluid.  Sample Buffer (250µl) plus a protease inhibitor cocktail (10µl) were added to 
each well.  The cells were mixed with this fluid using a sterile syringe plunger and the 
resultant viscous mixture transferred into a clearly labelled 1.5ml eppendorf.  This was 
then heated to 93C for five minutes and cooled rapidly to RmTp.  Once at RmTp the 
solution was spun in a centrifuge for five minutes at 1300rpm. Aliquots of 25µl were then 
pipetted into 500µl aliquots, making sure not to disturb the sediment at the bottom of the 
eppendorf.  These samples were then stored at -80C for protein assay and blotting at a later 
date. 
 
2.6.4  Protein Concentration Assay 
Determination of the protein concentration in the protein samples was undertaken using the 
biocinchoninic acid (BCA; Perbio Science Ltd, Tattenhall, UK) method using the 
Beckman DU 530 mass spectrophotometer (Beckman Coulter Ltd, High Wycombe, UK).  
Solutions for assay consisted of a set of standard albumin dilutions (serial dilutions from 
2mg/ml to 0.0312mg/ml), to create the standard curve, a negative control of nanopure 
water and the sample proteins diluted 10% v/v in nanopure water.  A twenty-fold larger 
volume of the BCA Protein Assay Reagent was added to all these solutions.  All solutions 
were then incubated at 37C for 30minutes.  Using the albumin dilutions to create a 
standard curve, the protein samples (taking into account the initial dilution factor) were 
measured relative to this. 
Note: - BCA Protein Assay Reagent contained 
  Sodium carbonate, sodium bicarbonate, BCA, sodium tartrate in 0.2M 
sodium hydroxide, mixed in a ratio of 50:1 with a solution of 4% cupric 
sulphate. 
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2.7  Sodium dodecyl sulfate Polyacrylamide Gel electrophoresis (SDS-PAGE) and 
Western Blotting 
2.7.1  SDS-PAGE and Transfer 
SDS-PAGE and western blotting were carried out using a Hoefer MiniVE system 
(Amersham Biosciences, Chalfont St Giles, UK).  10% acrylamide (National Diagnostics 
UK Ltd, Hessle, UK) resolving gels were mixed and allowed to polymerise under 100µl of 
water-saturated n-butanol for one hour.  The butanol was removed and the gel washed with 
nanopure water.  A stacking gel was then mixed and poured over the resolving gel.  Into 
this was placed a comb containing ten teeth to create lanes for protein loading.  The gel 
polymerised for one hour before the comb was removed.  The complete gel was then 
placed in the tank, the lanes washed with electrophoresis buffer and the tank filled with 
electrophoresis buffer to create a circuit.  The first lane was 10µl of Benchmark Prestained 
Protein Ladder (Invitrogen).  The next eight lanes were loaded with 16µg of sample 
proteins mixed with 10% v/v of bromophenol blue (BPB), as an indicator of protein 
location during electrophoresis.  Electrophoresis was carried out at 150V until the BPB had 
reached the bottom of the gel.  The voltage was then removed and the gel transferred to 
transfer buffer to soak for ten minutes before western blotting commenced.  
Note:   Gel orientation was determined by the marker lane being on the left side of the gel 
and by cutting off the top right corner of the gel. 
Transfer of the proteins from the gel to a polyvinylidene difluoride (PVDF) membrane was 
carried out in a module, sandwiching the gel with the PVDF membrane between two 
pieces of Whatman filter paper (Whatman International Ltd, Maidstone, UK) and ensuring 
apposition using transfer buffer-soaked pieces of sponge.  In the module the gel faced the 
cathode and the membrane faced the anode.  The module was filled with transfer buffer 
and bubbles eliminated, then a voltage of 25mV applied to it for 2
3/4 hours.  Assessment of 
protein transfer was made by inspecting the transfer of the prestained protein ladder used 
to identify band mass.  Once satisfied the transfer of protein from gel to membrane was 
complete, blotting could be undertaken. 
 
2.7.2  Western Blotting 
The membrane was incubated in blocking solution (PBS-Tween 20 with 5% w/v non-fat 
milk powder) for one hour at room temperature, continuously agitated.  This was then 
rinsed twice in PBST and incubated in the primary antibody, made up with PBST plus 1%   60 
w/v BSA, agitated for one hour (antibody titrations – see table 2.3).  Two PBST rinses 
followed, each of five minutes duration, followed by two 15-minute washes with PBST.  
Three further rinses were then done before the secondary antibody, attached to horseradish 
peroxidase, was applied to the membrane for one hours agitated incubation.  The 
secondary antibody was then washed off with two further rinses, one 15-minute wash and 
three further five-minute washes.  The membrane was then developed using ECL Plus 
Western Blotting Detection Reagents (Amersham Biosciences, UK), a chemiluminescent 
detection system.  Each blot underwent multiple blotting procedures, comparing the 
different proteins being blotted for.  Equality of protein loading was verified by blotting for 
cytokeratin 19 or β-actin that are both unchanged by the experimental treatments. 
 
2.7.3  Stripping and Reprobing 
For multiple blotting to take place, the membranes were stripped of the prior blotted 
antibodies.  This was achieved by bathing the membrane in a stripping buffer solution 
containing 100mM β-mercaptoethanol for 30 minutes at 55C.  Once this had been 
undertaken, the membrane was then washed with two rinses (each five minutes in PBST) 
and two washes (each 15 minutes in PBST).  The membrane was then ready for blocking 
and reprobing once the washes were complete.   
 
2.7.3.1 Analysis of the Western Blot 
Using the Amersham ECL Plus Western Blotting Detection Kit (Amersham Biosciences, 
Bucks, UK), chemiluminescent detection of the bands was undertaken.  Once the bands 
had been labelled and identified using the Versadoc Imaging System (Bio-Rad, UK) 
utilizing a Nikon AF Nikkor 50mm lens, images were captured.  Once captured, the 
images were then analysed using Quantity One.  Measurements of each band were taken 
for peak intensity and average intensity.  These values were multiplied to provide the 
“band value”.  If there was more than one band in the lane that corresponded to the 
antibody, then the bands were treated individually but the band values added together 
creating the “total band value”.  These bands were labelled left to right and, in the case of 
multiple bands per lane, from bottom to top. 
 
The control for these figures was β-actin.  This is a cellular protein that is not regulated by 
either TGFβ or CsA.  Consequently, its detection was totally dependent upon the amount   61 
of protein present within that lane.  Thus, if the loading of lanes were uneven, this would 
be reflected in the total band value for β-actin. 
 
“Normalisation” was the process whereby the total band values for other antibodies was 
divided by the total band values for β-actin, thus creating the “normalised band value”.  
This meant any inequality in the protein loading was allowed for.  Comparison between the 
different antibody total band values could then be undertaken, using SPSS, a statistical 
analysis tool. 
 
Antibody  Make & 
model 
Species & 
Clonality 
Stock Solution 
concentration 
Titration of 
antibody used 
Anti-human N-
cadherin 
Zymed 
33-3900 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/4000 
Anti-human E-
cadherin 
Zymed 
33-4000 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/4000 
Anti-human Claudin 
2 
Zymed 
32-5600 
Mouse 
monoclonal 
IgG2b 
100µg/200µl  1/4000 
Anti-human ZO-1  Zymed 
22-9100 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/4000 
Anti-human 
Cytokeratin 19 
Dako 
M0772 
Mouse 
monoclonal 
IgG1k 
100µg/250µl  1/4000 
Anti-human 
Occludin 
Zymed 
33-1500 
Mouse 
monoclonal 
IgG1k 
100µg/200µl  1/5000   62 
Anti-human αSMA  Abcam 
(ab7817) 
Mouse 
monoclonal 
IgG2a 
250µg/500µl  1/200 
Anti-human βActin  Abcam 
(ab8227) 
Rabbit 
polyclonal 
IgG 
25µg/50µl  1/5000 
 
Table 2.3.  Antibodies used, species and clonality and their titrations in western blotting. 
 
Secondaries used to probe Primary antibodies: - 
Secondary antibodies were dependent upon the primary used 
-  Monoclonal Primary  -  Dako, rabbit anti-mouse HRP (P0260), 1:2000. 
-  Polyclonal Primary  -  Dako, goat anti-rabbit HRP, (P0448), 1:1000. 
 
2.8  CONSTITUENT SOLUTIONS 
All chemicals supplied by Sigma (Poole, UK), unless otherwise stated. 
Tris-Buffered Saline (TBS) 
Trisma               5mM 
Sodium Chloide            137mM 
pH 7.60 
NB: -  Corrected with 0.1M Hydrochloric acid. 
Phosphate-Buffered Saline and Tween20 (PBS) 
Sodium Chloride            120mM 
Di-sodium hydrogen orthophosphate       24.2mM 
Potassium hydrogen orthophosphate       5.8mM 
Tween-20              0.1% v/v   63 
 
SDS Sample Buffer 
Tris HCl              100mM 
Sodium Dodecyl Sulphate (SDS)        5% w/v 
Glycerol              20% v/v 
DTT                5mM 
 
Protease Inhibitor Cocktail 
[4(2-aminoethyl-)benzenesulfonyl fluoride, pepstatin A, transepoxysuccinyl-L-
leucylamido(4-guanidino)butane, bestatin, leupeptin, aprotinin)  10% v/v 
 
Resolving Gels 
Tris HCl (pH 8.8)            375mM 
SDS                0.1% w/v 
Ammonium persulphate          0.05% w/v 
N,N,N’,N’-tetramethylethylenediamine (TEMED)    0.05% v/v 
Bis:mono acrylamide (29:1)(40%) (National Diagnostics)  31% v/v 
 
Stacking Gels 
Tris-HCl (pH 6.8)            125mM 
SDS                0.1% w/v 
Ammonium persulphate          0.05% w/v 
TEMED              0.1% v/v 
Bis:mono acrylamide (29:1)(40%)(National Diagnostics)  30% v/v 
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Bromophenol Blue 
Bromophenol Blue            5% w/v in absolute ethanol 
 
Electrophoresis Buffer 
Tris                25mM 
Glycine              192mM 
SDS                0.1 % v/v 
 
Transfer Buffer 
Tris                25mM 
Glycine              192mM 
Methanol              20% v/v 
 
Blocking Solution 
Non-fat Milk Powder (Marvel)        5% w/v 
(Made in PBS-T) 
 
Stripping Buffer 
SDS                2% w/v 
Trisma               62.5mM 
2-mercaptoethanol            100mM 
NB: -  pH corrected with 1M HCl. 
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2.9  6- and 12-well Transwell Insert Work 
Cells were defrosted and grown to confluence in the 25cm
2 flask.  Once at confluence, 
cells were passaged onto with 6 well or 12 well inserts.  These inserts were soaked in 
DMEM:F12 for one hour prior to having cells put on them.  After this the DMEM:F12 was 
replaced with FSHDM.  The plate was then incubated at 37
oC for 15 minutes, to warm the 
medium.  Once warmed, the cells were prepared as before and reconstituted into an 
appropriate volume, such as 2.4mls for 12x6 well inserts.  The cells were transferred from 
the medium and gently put into the warmed medium in the insert by 1000µl pipette.  Cells 
were then transferred to the incubator and left overnight to settle.  For the first 24 hours 
plates were not disturbed at all.  At 24 hours incubation, medium was then exchanged for 
FSDM and the cells monitored daily for growth towards confluence.  Medium was 
changed on alternate days whilst establishing the confluent monolayer.   
 
The challenge experiments began when the cells were at confluence.  Daily images were 
captured and the medium exchanged daily for medium containing TGFβ1 (2ng/ml), CsA 
(100ng/ml) or neither.  At 72 hours or 144 hours (3 or 6 days), cells were used for 
experimentation.  During the challenge experiments, the medium removed daily was kept 
for further ELISA analysis. 
 
 These inserts provided a system whereby the cells could be exposed to the medium both 
apically and basally.  This is more akin to the system in vivo.  Cell numbers were 
calculated from the original work using plastic wells.  The following calculations were 
used. 
  Cells per 25cm
2 flask -  3million 
  Surface area used over-  6 x 9.6cm
2  
          =  57.6cm
2   =  52,083cells/cm
2 
  One flask was used per 6 well plastic plate.
  
Therefore, for the inserts, surface areas were slightly different. 
  12 well surface area  -  ~1.0cm
2   =  52,083cells 
  6 well surface area  -  ~4.6cm
2   =  239,583cells   66 
The number/volume of cells used per well was calculated accordingly from above 
for the surface area. 
Example: -  For a 6 well insert experiment, the final pellet was reconstituted with 
1.2mls.  That way 200µl could be allocated to each of the wells in two 6 well plates.  In the 
plastic experiment, the same volume would have been split between the wells of one 6 well 
plate. 
 
Volumes in the insert experiments: - 
  12-well  Insert = 500µl 
      Well = 1800µl 
  6-well   Insert = 1000µl 
      Well = 2000µl 
 
2.9.1  Immunofluorescent Labelling with Transwell Inserts 
When the experiment was complete, membranes were dried rapidly by removing the 
medium and touching their edge lightly on an absorbent piece of tissue paper.  Whilst 
remaining slightly moist, using forceps and a scalpel, the membranes were cut from the 
plastic mount and cut into six equal sized pieces.  Each triangular piece was then mounted 
on its own glass slide.  Membranes were then left to dry until the time of staining.  This 
took place either the following day or with the other harvested membranes (in the case of 
those membranes cut and dried at day 0).  
 
Mounted membranes were kept covered until the day of staining.  Ice-cold, 100% 
anhydrous acetone was applied to each membrane to fix the cells.  This was left for ten 
minutes covered, to prevent evaporation.  At ten minutes incubation, the lid was removed 
and the acetone allowed to evaporate over the next 15minutes.  Once totally dry, the 
membranes were rinsed with three three-minute washes with PBS.  They were then 
incubated with PBS containing 1% w/v BSA and 1% v/v goat serum for one hour.  Once 
complete, the primary antibodies were applied to each membrane and incubated for two 
hours RmTp covered.  Three three-minute washes then followed and the secondary   67 
antibody applied at 1:500 stock solution in PBS for one hour.  This was then washed off 
with three washes and 7 AAD, the nuclear counterstain, applied, at 1:250 stock solution, 
for ten minutes.  Slides were then washed and mounted with coverslips and mowiol. 
 
2.9.1.1 Analysis 
Prepared slides were examined microscopically, using a Leica DMLB microscope at 
magnifications of x40, x100, x200 and x400 with fluorescence.  The slides were studied 
with Dr JE Collins (Lecturer and Supervisor, Department of Tissue Inflammation and 
Repair, Southampton University, UK).  The images were created and stored using a 
Hamamatsu C4742-95 camera and the Wasabi image program, version 1.5, supplied by 
Hamamatsu.  
 
2.10  SDS-PAGE and Western Blotting 
This was carried using the cells present on the surface of the insert.  250µl of sample buffer 
and 10µl protease inhibitor cocktail was put onto the cells.  The monolayer was then mixed 
and treated as before (see above – SDS-PAGE Western Blotting for the aliquot preparation 
2.6.3) to produce quantified aliquots of protein for electrophoresis and western blotting 
analysis (for multiple proteins to be studied). 
 
2.11  Transepithelial Electrical Resistance (TER) 
RTECs were cultured in 12-well Transwell plates to confluence.  At day 0 medium was 
exchanged for pre-warmed FSDM.  Having recorded the ambient temperature, the TER 
was measured using the EVOM meter (World Precision Instruments, UK) in each well 
three times, in rotation. Thereafter the medium was changed daily.  Transwells were 
divided into equal numbers to facilitate the comparison of the effects of TGFβ1 or CsA 
with medium containing neither.  The TER was recorded thrice on each well each day for 
up to six days and at each measurement, the ambient temperature was recorded.  
Electrodes were kept clean by rinsing them in dilute HCl, then washing them in sterile 
water and allowing them to air dry before measuring the next TER measurement.  
The control for this experiment was undertaking the same experiment with no cells present 
in the Transwell.  This provided a measure of the inherent resistance in the Transwell 
membrane. This was 60mOhms/cm
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2.11.1.1 Analysis 
Means were calculated for each individual treatment set within the group and then 
combined for a group mean.  Standard deviations were then calculated alongside standard 
error of the means.  Using ANOVA (with Bonferroni Correction), comparisons were made 
between the different treatment groups from data created using area under the curve 
(AUC).  When comparing single variant ANOVA is equivalent to Student’s T Test. 
 
2.12  Dextran Flux Measurements 
The number of 12-well wells required was at minimum 18.  This provided 3 wells for the 
day 0 measurements, 3 wells for 72 hours measurements, 6 for the TGFβ1 challenged cells, 
and 6 for the CsA challenged cells, both measured at 72 hours.  This number of wells was 
required to facilitate sacrificing the cells for the dextran experiments, which were terminal 
experiments.  
 
Cells were grown to confluence in 12-well Transwells.  One hour prior to adding the 
dextran medium was exchanged for pre-warmed equivalent medium.  FITC-labelled 
Dextran solution, containing dextrans of 20, 40 or 70kDa, was then added to achieve a 
final concentration of 2mg/ml in the superior chamber.  This was then incubated for four 
hours.  
 
Standards for the experiment were made up using medium plus a known concentration of 
dextran of each molecular weight.  The range of standards was serial dilutions of 4mg/ml 
to 0.03125mg/ml.  Once made, the standards were then loaded into a 96-well clear plate in 
preparation for the samples to be loaded into the same plate.  200µl of standard was loaded 
in duplicate into the plate. 
 
Once the samples had incubated at 37
oC for four hours, 200µl from both the bottom and 
top wells were loaded into the plate in triplicate taking care to record the orientation of the 
plate and its contents.  Plates were then read at 420nm.  The remaining wells were then 
cultured for a further 72 hours before they were sacrificed for dextran flux assessment. 
   69 
At 72 hours, medium was exchanged one hour prior to commencing the experiment.  
FITC-labelled dextrans were added to the superior chamber to make a concentration of 
2mg/ml.  Each molecular weight dextran was added to two wells.  Plates were incubated 
for four hours then samples read as before.  Again standards were made and loaded into the 
96-well plate, between the addition of the dextran to the medium and pipetting the 200µl 
into the plate, to be read at 420nm. 
 
2.12.1.1 Analysis 
Using the standard curve to determine the concentration of dextran present in the solutions, 
assessment of the flux was done by recording the percentage dextran to pass through the 
semi-permeable membrane at time 0 and at 72hours.  AUC was calculated from the time 0 
value and the 72hours value for the different experimental conditions.  ANOVA (with 
Bonferroni Correction) was used to assess statistical difference between the AUC values 
observed between the different treatment groups.  
 
2.13  MTS Cell Proliferation Assay  
Cells were grown to confluence in a 12-well plate and assessed using the MTS Cell 
Proliferation Assay - CellTiter 96
(R) AQueous One Solution Reagent (Promega, UK).  One 
hour prior to the addition of CellTiter 96
(R) AQueous One Solution Reagent (a tetrazolium 
compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, inner salt; MTS(a)]), medium was exchanged for the equivalent pre-
warmed medium.  At one hour, 80µl of reagent was added to the 400µl in the upper 
chamber.  This was then incubated for 30 minutes at 37
oC.  After incubation, 100µl of 
solution was pipetted from the 12-well plate into a 96-well plate, taking care to record the 
position of the solution in the plate.  Plates were then read for colorimetric analysis.  
Samples were controlled by subtracting the colorimetric analysis of medium containing 
reagent alone, having not been exposed to cells, from the original result.  
 
2.13.1.1 Analysis 
Analysis was done by calculating the area under the curve, using the trapezium rule, for 
each condition over the experimental timeframe.  Standard deviation and SEM’s were 
calculated.  Each result was compared with the control medium (neither TGFβ1 nor CsA in 
it) using ANOVA (with Bonferroni Correction).   70 
2.14  TGFβ1 ELISA Assay 
Method adapted from R&D systems UK, DuoSet (catalogue no. DY240) and carried out 
by Sara Campbell. 
Supernatant was collected from cultured RTECs at 24, 48 and 72 hours.  This supernatant 
was kept and latent and activated TGFβ1 was assayed. 
 
2.14.1  Plate Preparation 
1.  Capture Antibody was diluted to the working concentration in PBS without carrier 
protein then used immediately to coat a 96-well microplate
5 with 100µL per well of the 
diluted Capture Antibody.  Plate then sealed and incubated overnight at room temperature. 
2.  Each well was then aspirated and washed using Wash Buffer three times. 
3.  Plates blocked by adding 300µL of Block Buffer to each well, incubated at room 
temperature for a minimum of 1 hour.  
4.   Plates were then re-washed (stage 2). 
 
2.14.2  TGFβ1 Assay 
2.14.3  Activation of TGFβ1 
Note: - The activation stage was utilized to determine the quantity of activated TGFβ1 
present compared with the total latent TGFβ1 present.  This was achieved by first assaying 
the sample un-activated, as this would identify the already activated TGFβ1.  The 
remaining TGFβ1 was then activated and quantified, giving the total TGFβ1 present in the 
sample. 
1.  0.1mL 1N HCl added to 0.5mL sample. 
2.  Sample well mixed. 
3.  Mixture incubated at RT for 10 minutes. 
4.  Sample neutralized by adding 0.1mL 1.2N NaOH/0.5M HEPES. 
5.  Mixture well mixed. 
6.  Assay. 
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2.14.4  Assay Procedure 
1.   100µL of sample in Reagent Diluent was added per well then covered and 
incubated for 2 hours at room temperature. 
2.  The plate was then washed (as per stage 2 above). 
3.  100µL of the Detection Antibody, diluted in Reagent Diluent was added to each 
well and incubated 2 hours at room temperature. 
4.  Repeat wash as in step 2 of Plate Preparation. 
5.  100µL of the working dilution of Streptavidin-HRP to each well and covered to 
incubate for 20 minutes at room temperature.  Plate kept away from direct light. 
6.  Repeat wash as in step 2. 
7.  100µL of Substrate Solution added to each well and incubated for 20 minutes at 
room temperature. 
8.  50µL of Stop Solution added to each well.  Thorough mixing was achieved using 
gentle agitation. 
9.  The optical density of the plate was then measured using a microplate reader at 
wavelength 450nm. 
 
2.15  LDH Assay 
(Method adapted from Roche Cat No. 1 644 793) 
1.  Standards prepared by serial dilution of commercial LDH from 2U/ml – 0.25U/ml. 
2.  Freshly prepared medium used as blank. 
3.  Using Softmax-Pro 4.8 software template set up. 
4.  100ml of blank, standard or unknown sample added to templated 96 well plate. 
5.  100ml of reaction mixture (prepared as per kit instructions) added to each well and 
mixed using a plate shaker. 
6.  Plate incubated at room temperature for 30mins with shaking. 
7.  50ml 1N HCL added to each well and mixed to stop the reaction. 
8.  Absorbance measured at 490nm with a reference wavelength of 690nm using a 
plate reader. 
9.  Results analysed using dedicated software.   72 
2.15.1.1 Analysis 
Using the trapezium rule, the area under the curve (AUC) was calculated for the each 
experimental condition.  Standard deviations were calculated and SEMs.  Comparison was 
made between each AUC using ANOVA with Bonferroni Correction (to allow for multiple 
test comparisons). 
 
2.16  Quantitative Polymerase Chain Reaction (qPCR) assessment of mRNA 
expression in response to the exposure to TGFβ1, CsA or neither. 
 
Note:  qPCR protocols were carried out Michelle Hardyman 
2.16.1  RNA extraction 
Epithelial monolayers were grown on plastic, and the RNA extracted using Trizol 
(Invitrogen) reagent.  The cell lysates were transferred to eppendorf tubes.  To these, 200µl 
of chloroform per ml of Trizol was added, and the samples were vigorously shaken by 
hand then incubated for ten minutes at RmTp.  The samples were then spun at 13,000g for 
15 minutes at 4ºC.  The aqueous layer was transferred to a fresh eppendorf and 500µl of 
isopropanol per 1ml Trizol was added to it.  After shaking, the samples were incubated 
overnight at -20ºC.  The samples were then incubated at RmTp for 15mins, vortexed and 
spun at 13,000 rpm at 4ºC for 30 minutes.  The supernatant was discarded, and the pellet 
washed in 70% ethanol.  The samples were spun at 7500g for five minutes at 4ºC, then the 
ethanol discarded and the pellet allowed to air dry for 20 minutes.   
 
2.16.2  DNAse treatment 
The samples were DNAse 1 treated using a DNA-free kit (Ambion (Applied Biosystems), 
UK). A master mix containing DNAse 1, 10x buffer and RNA/DNA free water was made 
and 20µl added to each pellet.  The samples were incubated for 1 hour at 37ºC and then 5µl 
of neutralisation buffer added to block DNAse activity.  The samples were then incubated 
for two minutes at RmTp, and finally spun before the supernatant was aliquoted and stored 
at -80ºC. 
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2.16.3  Reverse Transcription of RNA into cDNA 
The RNA was reverse transcribed using an RT kit (PrimerDesign, Southampton, UK).  For 
each of the experimental samples, two 5µl RNA aliquots were used.  In addition 5µl of 
RNA from each sample was used to run a minus reverse transcriptase (RT) control (RT-).  
Each of the samples had 2µl Oligo dT primer/ dNTP mix and 3ul water added to it in a thin 
walled tube to give a final volume of 10µl.  This was heated to 65ºC for five minutes, then 
immediately cooled on ice.  10µl of a mastermix, with or without MMLV enzyme, was 
then added to each of the samples on ice.  The samples were then incubated at 42ºC for 60 
minutes.  Following this the cDNA was stored at -20ºC. 
 
2.16.4  qRT-PCR 
For the RT-qPCR UBC and GAPDH ‘perfect probe’ primers with a dual FAM and CY-5 
label were used as the housekeeping genes.  All other genes assayed used primers with 
SYBR green detection chemistry and all primers were designed by PrimerDesign.  Each of 
the cDNA samples was diluted 1:10 with PCR grade water.  Diluted cDNA (5µl) for each 
sample was loaded on to a 96 well plate (Biorad) in triplicate, with 5µl water samples used 
as a control.  Each RT- control (5µl) was loaded to control for genomic DNA 
contamination.  A mastermix of all the qPCR reagents was made up and 15µl of this was 
added to each well.  The plate was run on a Biorad iCycler plate reader.  At the end of each 
reaction the calculated threshold (CT) value was derived.  The data was analysed using 
Biorad software. 
 
2.16.4.1 qPCR Statistical Analysis 
The statistical analysis of qPCR data utilised the δδCt method of normalising and 
comparing data.  GTPase Activating protein mRNA (GAP) and ubiquitin mRNA (UBC) 
were used as controls.  Geometric means from the controls were calculated, combining the 
two sets of results.  mRNA of interest was assayed in duplicate in each experimental 
condition and then the mean calculated.  From this result, the geometric mean of the 
controls was subtracted to create δCt.  δδCt was then calculated by subtracting δCt from 
this value.  In the control experiment, δδCt is 0.  This gives you a fold difference of 0.  To 
enable comparison between the different experimental conditions, δδCt is calculated.  This 
is calculated by subtracting δCt (control) from δCt in each of the experimental conditions.   74 
Fold differences in the expression of mRNA, compared with the controls were then 
possible using the equation,  
Fold value = 2
(-δδCt) 
The control experiment produces a δδCt of 0, thus providing a value with which the other 
δδCt values can be compared.  The fold value for the control experiment is 1 I.E.  2
(-0) 
(=1). 
Statistical significance was assessed using ANOVA (with Bonferroni Correction – to 
minimise the effects of multiple comparisons) comparing the areas under the curves of the 
different experimental conditions with the control.  Graphical representation was made 
using histograms of the mean values with error bars representing 1 SEM.   75 
3  Characterisation of the Renal Tubule using Epithelial Junctional 
Markers, with Emphasis on the Expression of Claudins in Renal 
Tight Junctions 
3.1  Introduction 
The tubule is lined by a single layer of polarised renal tubular epithelial cells (RTECs).  It 
consists of regions quite distinct from one another in their function.  In the proximal 
regions of the tubule RTECs are responsible for the vast majority of solute reabsorption 
from the glomerular filtrate.  The distal nephron RTECs are responsible for the fine-tuning 
of solute reabsorption, which can occur under the influence of specific hormones (2).  The 
interposing region, the Loop of Henle, is responsible for the majority of water reabsorption 
and the gross concentration of urine. 
 
Significant differences in the nature of cell adhesion molecules exist between cells in these 
regions and certain junctional proteins have been shown to discriminate between them 
(29).  In 1993 Nouwen et al used immunohistochemistry to illustrate this point and 
demonstrated the regional variation of proteins expressed along the tubule.  From this 
paper classical regional markers were established.  A-CAM (N-cadherin) and tissue 
unspecific alkaline phosphatase were associated with the proximal tubule; Tamm Horsfall 
protein and human milk fat globulin 1 and 2 (epithelial membrane antigen) were associated 
with the thick ascending loop; and L-CAM (E-cadherin) and human milk fat protein (1 and 
2) were associated with the distal convoluted tubule.  In addition to cadherins in adherens 
junctions, tight junction proteins have also been localised in the renal tubule as outlined in 
the introduction (108, 186). 
 
3.1.1  Aims 
The aims of this chapter were to confirm the specific localisation of N-cadherin and E-
cadherin reported by Nouwen et al and to assess the reactivity of a panel of claudin 
antibodies in morphologically normal human kidney tissue.  Initially, methods of tissue 
fixation, embedding and immunohistochemistry, that best facilitated the labelling of the 
tubule were established.  Considerations were made as to the morphological preservation 
and the reliability and reproducibility of staining of the tubular junctional proteins.  Three 
methods were considered: snap freezing in liquid nitrogen and frozen sections;   76 
formaldehyde fixation and wax embedding; and acetone fixation with glycolmethacrylate 
(GMA) embedding.  
 
3.1.2  The objectives of this chapter 
1.  To establish the optimal method for tissue fixation and embedding that would 
facilitate antibody reactivity and tissue preservation. 
2.  To stain human kidney with E-cadherin, N-cadherin, Lotus tetragonolobus (LTA), 
Dolichos bifluorus (DB) and epithelial membrane antigen (EMA) to confirm 
expression patterns previously reported (29). 
3.  To localise antibody reactivity to claudins 2, 3, 4, 8, 10 and 11 in morphologically 
normal kidney. 
 
3.2  Comparison of the Methods of Fixation and Immunohistochemistry 
3.2.1  Introduction 
Three techniques of tissue fixation and slide preparation were examined to establish which 
of the three provided the best morphology and preservation of antigenicity for 
immunohistochemistry to be undertaken. 
1.  Snap frozen specimens labelled using a standard indirect immunohistochemistry 
protocol (IIHC). 
2.  Formaldehyde-fixed, wax embedded specimens using EDTA, citrate and pronase 
for antigen retrieval, labelled using IIHC. 
3.  Acetone-fixed, GMA embedded specimens, labelled using IIHC. 
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3.2.2  Results 
 
Figure 3.1.  Photomicrographs of renal cortical tissue stained using an isotype non-specific 
IgG antibody (A) and Cam5.2 (staining cytokeratin 7 and 8, B)  
Images illustrate the tubular destruction (black arrows) in frozen sections and the poor staining 
quality.  Mag bar = 100µm 
 
 
 
Figure 3.2.  Photomicrographs of renal cortical tissue stained for N-cadherin (A) and E-
cadherin (B).  
Images show the tubular destruction in frozen sections and the poor staining differentiation 
between tubules stained for N-cadherin and E-cadherin (arrows).  Mag bar = 50µm 
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Figure 3.3.  Photomicrographs of renal cortical tissue stained for E-cadherin using EDTA 
pH8 antigen retrieval (A), citrate pH6 antigen retrieval (B) and pronase antigen retrieval (C). 
Images show the lack of antibody reactivity throughout the tissue specimens.  Mag bar = 200µm 
 
Figure 3.4.  Photomicrographs of renal cortical tissue stained for N-cadherin (A), β-
catenin (B) and E-cadherin (C) having undergone pronase antigen retrieval. 
Images show discrete staining in the cell-cell contact regions for N-cadherin (black triangle), 
basolateral staining for β-catenin (black arrows) and E-cadherin (pink arrows).  Mag bar = 100µm 
 
Figure 3.5.  Photomicrographs of renal cortical tissue mounted in GMA cut in serial 
sections with a biotinylated anti-mouse secondary applied alone (A) and Cam5.2 (B). 
Images show the absence of staining with the secondary antibody alone and the two patterns of 
staining present when stained with Cam5.2 (plum and black arrows).  Mag bar = 100µm   79 
 
Figure 3.6.  Photomicrographs of renal cortical tissue stained for N-cadherin (A, C, E) 
and E-cadherin (B, D, F) using frozen sections (A, B), wax-embedded sections (C, D) and 
GMA-embedded sections (E, F).  
Images show the differences in antibody reactivity between the different methods of tissue 
preservation.  Mag bar = 100µm 
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Figures show the differences between the three techniques of immunohistochemistry 
employed.  Frozen section provided tissue that labelled for antigens (see figure 3.2 N- and 
E-cadherin) but failed to preserve parenchymal structure.  Three repeat experiments were 
done to ensure this was not a product of a single poor sample.  Tissue from H93, H78 and 
H82 were all tested.  Figure 3.1 illustrates the tubular destruction caused by the technique 
and the labelling, subsequent to that, by the positive and negative controls appearing to 
produce the same staining patterns in the tissue.  Staining was observed to produce a 
brown discolouration with both the negative and positive controls that involved most of the 
tubules present.  
 
When the anti-cadherin antibodies were used on frozen sections, there was some 
differentiation between the junctional markers (see figure 3.2 arrows) N-cadherin and E-
cadherin.  Figure 3.2 demonstrates the poor delineation between tubules staining for a 
target protein and those not.  The N-cadherin antibody distinguished between tubules 
containing N-cadherin and those not more ably than the E-cadherin antibody.  
 
When wax-embedded tissue was used, the preservation of morphology was significantly 
improved however the antigen reactivity of certain target proteins was lost.  Due to the 
better preservation of renal parenchyma, multiple experiments were undertaken to attempt 
improve the antigen retrieval for antibody labelling. 15 different experiments were done 
(using nine tissue blocks – H69A, H69B, H93, H98, H103, H104, H106, H109 and H113), 
utilising different antigen retrieval methods as described in chapter 2.  
 
Figure 3.3 shows the comparison between the three antigen retrieval techniques employed.  
With the formation of covalent bonds between proteins and formaldehyde caused by the 
fixation process of formaldehyde, antigen retrieval techniques had to be employed to 
reconfigure the proteins for the target antigen to be made available for binding by 
antibody.  In these experiments the retrieval techniques did not influence the availability of 
the antigen for binding.  Morphology was retained when fixed and embedded in wax, but 
the staining was not.  Instead the tissue took on a non-specific diffuse staining pattern with 
only the cytosolic compartment of the cells taking on the brown discolouration. 
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The most successful of the antigen retrieval techniques employed in wax-embedded tissue 
was the application of pronase.  Figure 3.4 demonstrates N-cadherin, E-cadherin and β-
catenin reacting with their antibody, giving specific staining patterns.  β-catenin was 
observed at the basement membrane and extending along the intercellular regions to 
terminate at a sub-apical point along the lateral border of the cell (black arrows).  N-
cadherin was observed in some of the sub-apical regions along the cellular appositions, 
while E-cadherin was stained at the basement membrane and along the lateral borders 
(black arrows). 
 
GMA-embedded sections showed clear antibody labelling of target proteins (see figure 3.5 
and 3.6) in tissue where tubular morphology had been retained.  In addition, no possible 
tissue damage through the process of antigen retrieval took place as no retrieval was 
required.  Eleven tissue blocks were examined (H116 – 123, H128, H129 and 140) and 42 
experiments undertaken in total.  Inter-subject variation was not an issue in the 
immunohistochemistry results as staining results were repeated through the different 
tissues used. 
 
Figure 3.5 shows the staining associated with Cam5.2.  In this plate, image B illustrates 
two populations of tubules being stained by Cam5.2.  One group stains along the basement 
membrane, while the other stains far more intensely and in a lattice-like pattern. 
 
Figure 3.6 illustrates the comparison between the different embedding and staining 
techniques.  Images A and B show the parenchymal destruction inflicted by the process of 
freezing and cutting for frozen section.  C and D illustrate the lack of antigenic reactivity 
present when the tissue was embedded in wax, despite employing antigen retrieval 
techniques to reconfigure the antigen of interest.  E and F show the morphological 
resolution retained by embedding the tissue in GMA and the antigenic reactivity achieved 
with this tissue, even without employing antigen retrieval techniques. 
 
3.2.3  Conclusions 
Having attempted to label renal cortical tissue using frozen sections, wax-embedded 
sections and GMA-embedded sections, it was clear the GMA-embedded tissue was the   82 
superior technique for both tissue preservation and antigen reactivity.  This technique did 
not require antigen retrieval methods to be employed and, due to the support offered to the 
tissue structure by the resin, facilitated serial sections of such proximity that comparisons 
between single stained sections was possible, comparing microanatomy. 
 
3.2.4  Discussion 
Frozen sections provided a method easily available, cost effective and that did not require 
antigen retrieval.  However, it also had some limiting problems.  It did not preserve the 
structural integrity of the sections; causing significant damage to the tubules to the extent 
structures became unrecognisable.  This meant that any slides cut in series were not of a 
sufficient quality that facilitated the comparison of sections from which to draw 
conclusions, as the coincident anatomical landmarks had not been retained between slides. 
 
With that structural disruption, the antibodies used stained in an apparently non-specific 
manner.  Consequently, this reduced the possibility of distinguishing between those tubules 
staining for an antibody and those not (see figure 3.2).  This may have been as a result of 
the exposure of otherwise intracellular proteins or the fracture of proteins present within 
the normal, now disrupted cells.  This is highlighted in figure 3.1.  The comparison of 
negative and positive controls in this plate shows a brown discolouration present 
throughout the tubules, which is present to the same intensity in both images.  There 
appears no observable difference between the relatively homogenous staining produced.  
 
When these sections were then stained with N- and E-cadherin, some tubular 
differentiation was observed.  Figure 3.2 highlights this staining pattern. Staining of N-
cadherin produced a greater delineation between those tubules containing N-cadherin and 
those not.  In the E-cadherin image the tubular disruption is so gross; distinguishing 
between stained and non-stained tubules was very difficult.  When there was delineation 
between tubules with staining, the nature of that staining was not discrete; the staining 
simply labelled the cytoplasmic compartment of the tubular cells.  Expected staining was 
to observe the brown discolouration labelling target proteins present at the inter-cellular 
regions representing junctional proteins.  This may well have been due to damage done to 
the proteins by the process when producing a frozen section.  This may also explain why 
so much of the sections stained in a non-specific manner involving the cytosolic areas too.   83 
 
Since the quality of the frozen sections was not sufficient to proceed with the 
characterisation of the human tubule, formaldehyde-fixed, wax-embedded sections were 
used.  Again, like frozen sections, wax-embedded tissue provided a well-established, cost-
effective way to study the tubular staining patterns.  Unlike frozen sections, wax 
embedding provided a material in which the renal tissue could be supported whilst staining 
was undertaken.  This facilitated the preservation of the renal parenchyma for 
immunohistochemistry. 
 
The use of formaldehyde fixed, wax embedded tissue was far superior in the preservation 
of the renal morphology, but the addition products produced by the covalent bonds 
between formaldehyde and protein meant the additional stage of antigen retrieval had to be 
employed.  There were four methods of antigen retrieval used in an attempt to reveal the 
antigens for reliable reproducible staining.  The methods of antigen retrieval attempt to 
reconfigure the molecules to provide the antibody with the opportunity to find and bind to 
the epitope of interest.  Pronase acts to cleave bonds that may obscure the epitope from 
discovery by the antibody.  
 
Figure 3.3 shows three images of renal cortical tissue having undergone antigen retrieval 
techniques comparing their outcomes (citrate pH9 gave the same result as pH6).  This plate 
demonstrates the excellent preservation of renal parenchyma alongside the complete lack 
of staining.  The antigen retrieval techniques failed to reveal the antigens under 
investigation.  In these images there are no regions of discrete staining indicative of 
junctional proteins, simply diffuse discolouration in the cytosolic compartment.  As 
previously observed in other work (29), this type of staining is not characteristic of the 
junctional proteins recognised in the tubule.  One would have expected to see inter-cellular 
punctate discrete staining joining the cells, representing the junctional proteins.  
 
Of the antigen retrieval techniques attempted, pronase offered the most promising results. 
As seen in figure 3.4, staining for N-cadherin and E-cadherin showed clear high intensity 
areas between tubular epithelial cells at areas of intercellular apposition.  This was 
observed in both the N-cadherin and E-cadherin slides.  In image A, tubules taking on the   84 
brown stain have small discrete high intensity areas at the apico-lateral junction of the 
tubules that have taken on more of the stain.  In image C, E-cadherin staining involves the 
basement membrane of all tubules and extends towards the luminal surface, along the 
intercellular apposition in some of those tubules.  It does not involve the apical surface.  
Staining for β-catenin does not occur in the blood vessel that is marked in image B 
(identified by the triangle).  In image C, the tubular epithelial cells highlighted with the 
pink arrows show very intense basal and baso-lateral staining.  Those highlighted by the 
black arrows show a diffuse cytosolic staining pattern, with no structures or junctions 
identified within or between the cells.  
 
Figure 3.4 is more representative of what would be expected with N-cadherin and E-
cadherin staining.  Both cadherins appear to be involved in intercellular interactions and 
certainly staining is more prominent at the apico-lateral borders.  The pattern of staining 
with E-cadherin may represent intercellular staining (pink arrows) in one set of tubules and 
non-specific in the other (black arrows).  Alternatively, E-cadherin may well be present in 
all the tubules, just in different distributions.  The reliability and reproducibility of Pronase 
preparation meant it was not suitable to perform the bulk of the immunohistochemical 
characterisation (compare figures 3.3 and 3.4).  This meant GMA-embedded tissue 
immunohistochemistry was utilised. 
 
Acetone-fixed, GMA-embedded renal tissue provided the most superior way of fixing, 
stabilising the morphology and maintaining epitope antigenicity, without antigen retrieval 
techniques, between the three methods (185).  There were some problems associated with 
its use.  GMA is not cheap, it is both costly and time consuming and lectin staining had 
never previously been done using GMA-embedded tissue.  However, by the nature of 
GMA being a resin based preparation, it offered the structural support needed to facilitate 
the cutting of two micron serial sections of tissue to undertake single stained comparisons 
of renal tissue. 
 
Figure 3.6 (E, F) illustrates the staining observed with GMA.  This method of tissue 
preparation utilised the best aspects of the other two methods.  It provided the structural 
support required for close proximity serial sections and fixation that did not render the 
epitope under investigation non-antigenic.  Staining was observed in a mutually exclusive   85 
manner between regionally specific antibodies labelling opposing regional protein 
markers.  The staining observed was specific enough to identify punctate, discrete 
intercellular staining representative of adhesion molecules.  Figure 3.6 (E, F) shows the 
coincident anatomical landmarks present in the slides cut at such a proximity that 
facilitated comparison of staining patterns.  In the N-cadherin staining there is sparing of 
the central peri-glomerular tubule.  When E-cadherin was stained the previously spared 
tubule is stained and the others spared.  Interestingly, the pattern of staining observed with 
N-cadherin and E-cadherin was seen with Cam5.2 staining.  Labelling epithelial cells 
meant that both tubular populations were labelled by Cam5.2, thus the lattice-like staining 
of E-cadherin (plum arrow) was seen alongside the less specific staining associated with 
N-cadherin (black arrows). 
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3.3  Localisation of E- and N-cadherin and claudin 2 in normal human kidney 
3.3.1  Introduction 
The primary aim of this section was to confirm reported data regarding the localisation of 
certain junctional proteins along the nephron and to determine the GMA method gave 
reliable, reproducible results in adult human kidney.  Antibodies used were monoclonal 
mouse anti-human antibodies to N-cadherin, E-cadherin, claudin 2 and epithelial 
membrane antigen (EMA).  Of these antibodies, the regional localisation of E-cadherin 
(29) and EMA (29, 187-191) are recognised as distal nephron markers. N-cadherin is 
reported as a proximal marker in one paper (29).  Its localisation along the renal tubule is 
not otherwise reported on. 
 
The relevance of investigating the regional variation in junctional proteins was to attempt 
to relate this junctional variation with the function of the nephron at that point in the 
tubule.  Adherens and tight junctions both have roles in the relationships of epithelial cells 
with their neighbouring cells.  In the kidney, cadherins proteins act to anchor the 
epithelium (192, 193).  Other cadherin roles include modulation of malignant invasiveness 
and metastasis (26, 194), neural development, function and repair (195, 196) and 
facilitation of communication between different cells types, through hydrophilic junctions 
(26). 
 
Lectins are a type of receptor protein of a non-immune origin that interacts with 
carbohydrates.  They are recognised by the sugar with which they interact and are present 
in plants, animals and humans.  Their role in humans includes binding soluble intra- and 
extra-cellular glycoproteins thus regulating the amount of sugar moieties in the blood, 
regulation of cell adhesion and for their recognition of specific carbohydrates that are 
present on the surface of certain pathogens.  This is possibly why “higher” lectins are 
utilized by natural killer cells as their receptors. 
 
In the kidney specifically, LTA recognises α-L-fructose that is present on the luminal 
surface of proximal tubular epithelial cells (197, 198).  This means it can be used to label 
the proximal tubule.  It can also therefore be used as a reference for other antibodies for 
which the labelling localisation is unknown as yet or not yet recognised.  DB recognises α-  87 
D-galactosyl-N-acetyl-D-galactosamine (α-D-gal-N-Ac), which is present in the distal 
nephron (199-201).  These two lectins give a reliable pattern of staining that can be utilized 
to recognise regions of the nephron and thus orientate other antibodies. 
 
In figure 3.7, the lectins have been used in series to demonstrate the nature of their 
mutually exclusive staining pattern.  Here LTA has labelled the luminal surface of the 
proximal tubules and their basement membranes.  In image B, DB can be seen to label 
those tubules not stained by LTA in image A.  This mutual exclusivity makes these 
antibodies excellent reference markers. 
3.3.2  Results 
 
Figure 3.7.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for LTA (A) and DB (B). 
Images show the mutually exclusive pattern of tubular labelling in coincident tubules on the serial 
slides highlighted by the green stars.  Mag bar = 100µm 
 
Figure 3.8.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for N-cadherin (A), LTA (B) and claudin 2 (C). 
Images show the similar pattern of tubular labelling in coincident tubules on the serial 
slides and the non-staining distal tubules (stars).  Mag bar = 100µm   88 
 
Figure 3.9.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for N-cadherin (A) and claudin 2 (B). 
Images show the similar pattern of tubular labelling in coincident tubules on serial slides.  Note 
also the extracellular staining of the perimeter of the non-staining and staining tubules by N-
cadherin and not claudin 2 (arrows).  Mag bar = 50µm 
 
 
Figure 3.10.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for E-cadherin (A), DB (B) and EMA (C). 
Images show the similar staining pattern observed in these established distal tubular markers 
(stars).  Mag bar = 100µm 
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Figure 3.11.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for E-cadherin (A) and EMA (B). 
Images show the staining of E-cadherin and EMA on coincident tubular structures.  The nature of 
their staining is very different with E-cadherin being junctional and EMA labelling molecules 
present on the apical brush border.  Mag bar = 50µm 
 
 
Figure 3.12.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections stained for N-cadherin (A) and E-cadherin (B). 
Images show the complete lack of staining by the anti-N-cadherin antibody in coincident tubules 
stained with E-cadherin.  Whilst E-cadherin has labelled the coincident but mutually exclusive 
tubule, centrally situated, it has also labelled coincident tubules labelled for N-cadherin at a far less 
intensity (star).  Mag bar = 25µm 
 
 
   90 
Anti-human, N-cadherin and claudin 2 antibodies labelled similar tubules, with proximal-
type brush borders, to those labelled by LTA (Figure 3.8).  Their staining patterns were 
different from each other.  N-cadherin stained predominantly discrete punctate apico-
lateral junctional markings with some of the basement membranes and cytosolic 
compartments (Figure 3.9).  Claudin 2 stained basement membrane and tended to extend 
along the intercellular border towards the luminal surface, terminating in a discrete 
punctate junctional marking (Figure 3.9).  
 
At higher magnification, the patterns of N-cadherin and claudin 2 staining are very similar 
(Figure 3.9).  Image A shows the pattern of staining for N-cadherin, showing the apico-
lateral densities of junctional proteins and the baso-lateral staining of the basement 
membrane.  In this image, N-cadherin present at the basement membranes of tubules is 
interrupted.  In image B, claudin 2 staining is very similar on coincident tubules stained by 
N-cadherin (Figure 3.9).  Claudin 2 stains the basement membranes more intensely, with 
fewer interruptions, than N-cadherin (figure 3.9).  Additionally, N-cadherin is observed 
staining along the extracellular perimeter of the non-staining tubules in A. Claudin 2 does 
not do this (Figure 3.9). 
 
E-cadherin, EMA and DB showed very similar patterns of staining in similar regions of the 
tubule.  E-cadherin was labelled in the inter-cellular regions of the distal tubule, while both 
EMA and DB were both apically situated.  Figure 3.10 shows the similar staining patterns 
of these regional proteins, involving tubules previously unlabelled by the proximal 
regional protein antibodies.  The tubule highlighted by the star illustrates a coincident 
anatomical tubule stained by all three distal tubular antibodies.  
 
The nature of the staining, though is very different between E-cadherin and EMA. Figure 
3.11 illustrates the uninterrupted apical staining of the distal tubular structures by EMA, 
labelling the milk fat proteins present on that surface.  E-cadherin, however, is present 
along the lateral border taking part in the adherens junctions that are located sub-apically 
on the lateral borders and also in some instances along the basement membrane and the 
lower aspects of the lateral membrane.  This however, is not always the case. 
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Figure 3.10 compares the staining patterns of E-cadherin with DB and EMA.  In this plate, 
the image reporting staining for E-cadherin appears less clear.  There is staining present for 
E-cadherin in tubules that stained for the proximal tubular proteins, N-cadherin and claudin 
2.  Figure 3.12 demonstrates two sections of the same tubules having been stained for N-
cadherin and E-cadherin proteins.  Staining in these images is present for N-cadherin in 
one population of tubules, while staining for E-cadherin predominantly involves another 
population of tubules, but also stains the coincident tubules labelled by the anti-N-cadherin 
antibody.  This coincident staining is of a much less intense nature and labels small 
structures along the intercellular junction.  The pattern of this staining is very similar to 
that of the anti-N-cadherin antibody staining seen in image A.  
 
3.3.3  Conclusions  
The use of GMA facilitated the preservation of renal cortical parenchyma and the 
reactivity of the antigens being investigated.  In addition to standard techniques of indirect 
immunohistochemistry, a novel technique of labelling GMA-embedded tissue with Lectins 
enabled confirmation of the reported data regarding the regional localisation of some of the 
proteins referred to in Nouwen et al (29).  GMA-embedding also provided sufficient 
support to the tissue to allow two-micron sections to be cut, thus making comparison of 
serial-section staining possible.  In combination, these factors provided a basis around 
which to investigate the localisation of some of the claudins present along the human 
tubule. 
 
3.3.4  Discussion 
Having utilised the positive aspects of GMA-embedding of tissue, the aim of this section 
was to confirm the regional expression some of the proteins reported by Nouwen et al (29).  
The quality of the sections and their proximity to one another made it possible to undertake 
serial staining of tissue to compare the localisation of proteins to each other, by studying 
their labelling in coincident tubules, across multiple slides.  With fixation being achieved 
through acetone emersion, rather than formaldehyde fixation and the creation of sulphide-
bridge, no antigen retrieval was required, further aiding the retention of antigenicity.  
 
   92 
In conjunction with this method of embedding the tissue, labelling with Lectins was 
possible by extending the incubation times of the slides in the antibody solutions.  This 
was not complicated by the need for antigen retrieval techniques as antigenicity was 
conferred by the specific carbohydrates being present in the RTECs brush borders (197-
201) and not interfered with by the process of fixation.  This was a new technique. 
 
The staining with the Lectins provided the orientation to begin to localise the other 
regional proteins.  LTA and DB labelled mutually exclusive regions of the nephron, LTA 
being proximal and DB being distal, consistent with the reported data (29).  When LTA 
was compared with the staining observed for N-cadherin and Claudin 2, common regions 
were labelled, as evidenced by coincident tubular staining (figure 3.9). 
    
DB is recognised to label the carbohydrates in the brush border of the distal tubule (29).  
EMA, staining epithelial membrane antigen, is reported to localise to the distal tubule 
(191).  This protein, being situated on the apical surface of the RTECs in a similar nature 
to the Lectins, made staining appear very similar to that of DB, involving both the apical 
surface and the same population of tubules.  
 
In this work E-cadherin was labelled in the distal tubule, and in the proximal tubule at 
much less intensity.  This data is different from that reported in Nouwen et al.  In the 
published work, E-cadherin is reported as only present in the distal tubule.  Figure 3.12 
shows N-cadherin labelled in a single population of tubules, while E-cadherin is labelled in 
both a mutually exclusive group and the same population of tubules.  Staining between 
these two E-cadherin staining tubular populations appears to differ significantly in 
intensity, but the localisation of the less intensely staining population appears to label the 
proximal tubular population.  This result may be due to cross-reactivity between the E-
cadherin antibody and the N-cadherin protein or a real result.  In order to clarify this one 
would have to study a reaction between the E-cadherin antibody and a recombinant form 
of the N-cadherin protein.  
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The implications of this result would mean the use of E-cadherin as a renal RTEC marker 
in experimentation is sensible as it is expressed by both proximal and distal tubular cells.  
It would, though, be fortuitous, as this has not been reported previously.  The presence of 
E-cadherin in the proximal cells may have other functional purposes.  It may be that E-
cadherin is present to offer additional support to epithelial cell adhesion, beyond what is 
possible with N-cadherin (38).  E-cadherin has been linked with a role in regulating 
epithelial plasticity (21, 43, 202, 203).  It may be that E-cadherin is present in these cells to 
facilitate this plasticity, whereas N-cadherin, not having been associated with renal 
epithelial plasticity, is present as a cell adhesion molecule only. 
 
Functional proteins of regional specificity were not utilised, as this work was an 
investigation into the junctional proteins only, and LTA and DB were the orientating 
molecules around which the others marker proteins have all been segment specified.  Other 
possibilities might have been gamma-glutamyl transpeptidase (GGT) (204) or tissue-
unspecific alkaline phosphatase (TUAP) (205). 
Combinations of the adhesion molecules within regions may contribute to the function of 
the nephron at that point.  The combination of N-cadherin and claudin 2 in the proximal 
tubule would seem to facilitate the reabsorption of the majority of the filtered solutes from 
the glomeruli.  Claudin 2 is attributed with creating a less “tight” tight junction (56) and N-
cadherin is associated with less tight cellular junctions and neural cell adhesion that 
facilitates neuronal development (194).  Cell adhesion in the distal tubule appears to be 
tighter given that E-cadherin is the regionally specific CAM there (29).  
 
The presence of the less tight proteins in the proximal tubule may act as part of the innate 
immune system.  If the presence of a noxious substance in the proximal tubular lumen 
damages the epithelial cells, pro-inflammatory and pro-fibrotic cytokines would be 
released.  Having a more permeable paracellular pathway means more access to the TGFβ 
receptor (TβR) that is involved in epithelial plasticity (206, 207) and thought to be 
associated spatially with the tight junction (15).  This may form part of a survival 
mechanism to preserve the RTEC, creating a faster transit time for the noxious substance 
through the tubule and thus, to be excreted.   94 
3.4  Localisation of specific Claudins along the human adult nephron 
3.4.1  Introduction 
The claudins are a family of tight junction proteins that play a role in paracellular 
permselectivity.  There are approximately 24 members that form transmembrane 
homotypic junctions.  Each claudin type creates a junction of differing characteristics.  The 
claudins themselves, or a combination of claudins, dictates the permselectivity of the 
paracellular pathway. 
 
Reported data shows some of the localisation of claudins along the mouse (57, 85, 108, 
142, 208-210), bovine (186) and rabbit (211) nephron.  In these reports authors have 
identified regional variations in the expression of different members of the claudin family. 
 
Other reports focus on the functions or influences of the claudins, and thus draw from that 
the contributions such claudins might make to the regional function of the epithelial 
membrane at that point.  In the proximal tubule, for example, the predominant claudin is 
claudin 2, which is associated with creating a “leaky” tight junction (56, 57, 212).  Claudin 
8 is associated with a “tighter” tight junction and can alter the paracellular characteristics 
of a tight junction containing claudin 2 (110, 213, 214) making it a tighter tight junction.  
 
In addition to these functional relationships, claudins can be influenced by hormones, 
which may have implications in the localisation of the claudins along the nephron.  
Claudins 4 and 8 are both aldosterone sensitive and localised to the distal tubule.  This 
region is under hormonal control that is responsible for fine-tuning of urinary acidification 
(85, 215).  
 
Investigating the expression of claudins along the adult human nephron gives some insight 
into the regional variation of claudins along the tubule and has not been done before.  In 
conjunction with reported data, one could propose the function of the tubule at a point 
along its route by the contribution made to the tight junctions from the claudins identified 
within that region.  For example, claudin 2 being present in the proximal tubule facilitates 
a large paracellular flux and a low TER in this region (57).   95 
To facilitate this work, GMA embedded sections were cut in series.  At 2µm apart, these 
could be used to assess staining between the different target proteins being investigated, on 
landmarks present in more than one slide.  In this series, antibodies to claudins 2, 3, 4, 8, 
10 and 11 were used alongside antibodies to N-cadherin, E-cadherin, LTA, DB, EMA and 
Tamm Horsfall Protein (THP) for reference. 
 
3.4.2  Results 
Results for this section were grouped such that comparisons could be made between 
proteins reported in specific regions along the tubule.  With the 2µm sections, coincident 
tubular staining could be assessed to draw conclusions regarding claudins being expressed 
in the same regions. 
 
 
 
 
 
Figure 3.13.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections labelled for N-cadherin (A), E-cadherin (B), Claudin 2 (C), LTA (D), Claudin 10 (E), 
DB (F), Claudin 11 (G) and biotinylated secondary antibody alone (H) comparing the 
staining associated with the proximally expressed proteins A, C, E and G and established 
regional markers B, D and F.  
Note the coincident tubular staining between E and G, and A and C (red stars), but also the 
coincident tubular staining between E and G, and B and F (orange stars).  Mag bar = 200µm 
Image on page 96.   96 
 
Figure 3.13 – annotation page 95.   97 
 
 
Figure 3.14.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections labelled for N-cadherin (A), claudin 10 (B) claudin 2 (C), and claudin 11(D) 
comparing the distribution of tubular staining for these claudins.  
Note the additional tubular staining by B and D indicated by the red stars.  Mag bar = 50µm 
 
Figure 3.15.  Photomicrographs of GMA embedded cortical renal tissue cut in serial 
sections labelled for E-cadherin (A), N-cadherin (B), Claudin 8 (C), DB (D), Claudin 4 (E), 
LTA (F), Claudin 3 (G) and biotinylated secondary antibody alone (H) comparing the 
staining associated with the distally expressed proteins A, C, E and G and established 
regional markers B, D and F.  
Mag bar = 200µm 
Image on page 98. 
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Figure 3.15 – annotation page 97.   99 
 
 
Figure 3.16.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections labelled for E-cadherin (A), claudin 3 (B), claudin 4 (C) and claudin 8 (D) comparing 
the staining patterns of these three claudins with that of E-cadherin, which has labelled 
tubules in three different intensities, identified by the stars.  
The arrows highlight punctate discrete staining present in a second population of tubules in B and 
C.  The star highlight the different intensity of E-cadherin staining observed in different regions of 
the tubule (A).  Mag bar = 50µm 
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Figure 3.17.  Photomicrographs of GMA embedded renal cortical tissue cut in serial 
sections labelled for N-cadherin (A), E-cadherin (B), claudin 10 (C), THP (D), claudin 11 (E) 
and EMA (F) comparing the staining for claudin 10 and 11 with that of N- and E-cadherin 
and THP.   
Note the coincident tubular staining between claudins 10 and 11 and N-cadherin (orange star) but 
also the coincident tubular staining by claudin 10 and 11 of a different population of tubules with 
E-cadherin, EMA and THP (red arrows).  Mag bar = 200µm 
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The coincident tubular staining observed conferred regional distribution of claudin 
expression.  Figure 3.13 demonstrated the coincident tubular staining observed between N-
cadherin and claudins 2, 10 and 11.  Staining for N-cadherin and claudin 2 showed 
involvement of the basolateral cellular surfaces, terminating in a punctate discrete intense 
structure at the subapical intercellular region.  Claudins 10 and 11 gave rise to brown 
discolouration of the cytoplasmic region of these tubular cells.  Claudin 10 did stain 
intense punctate discrete structures in the intercellular subapical region, claudin 11 did not. 
 
Antibodies to claudins 10 and 11 stained more intensely a second population of tubules not 
stained by antibodies to either N-cadherin or claudin 2.  These staining patterns of claudins 
10 and 11 differed from the previous staining.  Staining for claudin 10 produced intense 
staining of the basolateral regions, while antibodies to claudin 11 stained the apical 
surfaces of this population of tubular cells.  This additionally stained population of tubules 
were stained by antibodies to E-cadherin and DB.  These staining patterns were further 
confirmed by figure 3.14, showing claudin 10 staining intense punctate discrete structures 
in the subapical intercellular region, but claudin 11 not. 
 
Antibodies to E-cadherin stained populations of tubules in three separate intensities.  
Figure 3.16 shows the different intensities of staining for E-cadherin.  Populations of 
coincident tubules stained for both E-cadherin and EMA gave the most intense staining 
(red star).  Those stained by both E-cadherin and THP gave an intermediate staining 
intensity (orange star), while the least intense E-cadherin staining (yellow star) was 
identified in the coincident tubules stained for E-cadherin and N-cadherin or claudin 2. 
 
Figures 3.15 and 3.16 show claudin 8 labelled a population of tubular cells along their 
basal and intercellular surface, terminating in a discrete punctate subapical structure.  
Antibodies to E-cadherin and EMA also stained this population of tubules, E-cadherin 
most intensely. 
 
Claudin 4 antibodies stained two populations of tubules.  The first population stained the 
basolateral surface of the tubular cells in a less intense manner and terminated in discrete 
punctate intense subapical structures in the intercellular region.  Staining of the second   102 
population of tubules labelled for claudin 4 identified the coincident tubules stained by the 
intermediate E-cadherin labelling.  The staining pattern of claudin 4 here was discrete 
punctate subapical structures in the intercellular region with no basolateral staining in this 
population (figure 3.15 and 3.16).  
 
The pattern of staining for claudin 3 identified two populations of tubules.  The first 
population was those that were coincident tubules staining intensely for E-cadherin.  Here 
claudin 3 labelled discrete punctate structures in the intercellular subapical region (figure 
3.15 and 3.16).  The second population of tubules was those coincident tubules that stained 
intermediately for E-cadherin.  Claudin 3 was labelled only in discrete punctate structures 
in the subapical intercellular region of these tubular cells (figure 3.16). 
 
All three claudins, claudins 3, 4 and 8, gave rise to discolouration of the cytoplasm of the 
tubular cells that coincident tubules stained for N-cadherin.  None of these claudins stained 
any structures on epithelial cell membranes. 
 
Figure 3.17 showed the comparison between claudins 10 and 11 and E-cadherin, EMA and 
THP.  THP expression is reported in the thick ascending limb of the Loop of Henle (191).  
Coincident tubular staining showed THP to stain a similar population to the intermediate 
E-cadherin staining.  Staining by claudins 10 and 11 labelled coincident tubules stained 
also by THP and E-cadherin, giving it a regional localisation.   103 
3.4.3  Conclusions 
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Figure 3.18.  Table illustrating claudin distribution in adult human kidney tubule. 
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Figure 3.19.  Representation of the reported data pertaining to the regional localisation of 
claudins in bovine and mouse nephrons (108, 186). 
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Common distributions of claudins were shared between the human adult tubule, the mouse 
nephron and the bovine nephron – claudins 2 was expressed in the proximal convoluted 
tubule; claudins 3 was expressed in the thick ascending limb of the Loop of Henle; claudin 
10 was expressed in the thick ascending limb of the Loop of Henle and THP was expressed 
in the thick ascending limb of the Loop of Henle.  
 
N-cadherin was observed in the proximal tubule only.  E-cadherin extended from the distal 
convoluted tubule to the proximal tubule, reducing in its staining intensity.  Claudin 2 was 
stained in the proximal tubule only.  Claudins 3 and 4 were both present in the thick 
ascending limb of the Loop of Henle and the distal convoluted tubule.  Claudin 8 was 
identified in the distal convoluted tubule.  Claudins 10 and 11 were both identified in the 
proximal convoluted tubule and the thick ascending limb of the Loop of Henle. 
 
3.4.4  Discussion 
The role of claudins in the adult human nephron is to regulate the movement of solutes 
through the paracellular pathway.  This movement of solute is a passive motion determined 
by the concentration gradient created by the tubular epithelial cells through active transport 
mechanisms utilising the transcellular route.  The gradient created across the tubular 
epithelium, produces the “solute drag”, down which the solutes pass.  In normal renal 
physiology the function of the tubule along its route alters, undertaking different functions 
in the production of normal urine. 
 
This work confirms the variation in the expression of claudins along the human adult 
tubule.  This type of variation has been observed in other mammals, namely the mouse (57, 
85, 108), rabbit (109, 211), and cow (186).  Data from the mouse and cow showed very 
similar distribution of the claudins along the tubule, while the reported expression of 
claudins along the rabbit tubule was significantly different.  Reyes reported the expression 
of claudins 3, 4 and 8 in the proximal convoluted tubule.  This was in contrast to Ohta 
(186), Kiuchi-Saishin (108) and this work, where claudins 3, 4 and 8 were distal 
convoluted tubule claudins, with claudins 3 and 4 extending into the thick ascending loop 
of Henle.  
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This type of variation in the expression of claudins may represent the physiological 
contribution the claudins make to the tight junctions.  Along the tubule it is accepted the 
proximal tubule is more leaky than the distal (216, 217).  It is also accepted the 
predominant claudin in this region is claudin 2 (29) and that claudin 2 is characteristically 
a leaky claudin (56, 57, 110, 212).  In this work, claudin 2 was identified in the proximal 
tubule alongside claudins 10 and 11.  Very little is known regarding the functional 
contribution of claudins 10 and 11 to tight junctions other than claudin 10 appears to 
exhibit cationic permselectivity and undergoes splice variation that determines its 
distribution (137). 
 
In the other regions of the nephron, combinations of claudins were identified as collocating 
to the same populations of tubules.  Their relative contributions to the tight junctions in 
those regions may determine the paracellular permeability of those regional junctions (1, 
218).  In the thick ascending limb of the loop of Henle, claudins 3, 4, 10 and 11 were 
identified.  This region of the nephron is responsible for the reduction in tubular fluid 
concentration from approximately 1200mmosml/kg H20 to 220mmosml/kg H20 through 
the active reabsorption of sodium chloride.  Producing this concentration reduction may 
not be a consequence of claudins 3 and 4 alone, as this combination of claudins has been 
reported in a dog jejunal cell model to be leaky (219).  The addition of claudin 10 (and 
possibly 11) in this region may have facilitated a tighter junction.  Independently, claudin 4 
has been identified as a tight tight junction protein (220). 
 
The distal convoluted tubule is responsible for the final concentration and acidification of 
urine.  Of the claudins studied in this work, claudins 3, 4 and 8 were identified in this 
region.  In addition to the reported characteristics of the combination of claudins 3 and 4, 
claudin 4 has been reported to be influenced by its phosphorylation status (215, 221).  One 
of the factors responsible for this is aldosterone, a steroid hormone.  It is this hormone that 
is physiologically active in this region. 
 
Claudin 8, also identified in this region, has two reported characteristics useful for this 
region.  The first is that claudin 8 acts to limit the back leak of protons, ammonium and 
bicarbonate aiding to the acidification of urine (213).  The second characteristic of claudin 
8 was to have direct effects on the expression and trafficking of claudin 2 (110, 214).  In   107 
the presence of claudins 2, claudin 8 has been reported to replace claudin 2 in tight 
junctions (214); this would maintain the junctions of the distal convoluted tubule free from 
claudin 2 and thus maintain their tightness.  
 
The regional variation in the expression of claudins and their physiological characteristics 
provide an insight into the regional function of the nephron.  Claudins provide the 
regulatory function that enables active transport mechanisms to create a concentration 
gradient across the epithelial membrane of the tubule and subsequently reabsorb specific 
filtrate solutes.  Abnormalities of claudins can then cause very specific anomalies in 
tubular function, such as the loss of claudin 16 or 19 from the thick ascending loop of 
Henle giving rise to a hypomagnesaemic hypercalciuria and nephrocalcinosis condition.  
These claudins were not examined in this work. 
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4  Phenotypic Characterisation of Human Primary Renal Tubular 
Epithelial Cells 
 
4.1  Introduction 
The regional expression of junctional proteins along the human renal tubule was confirmed 
in GMA fixed renal tissue with claudins 2, 3, 4, 8, 10 and 11.  The objective of this chapter 
was to assess primary renal tubular epithelial cells (RTECs) in culture by characterising 
them in terms of their morphology, phenotype and junctional protein expression, with a 
view to using them in studies of tight junction biology.  Previously published data has 
shown that human primary renal tubular epithelial cells can be isolated from normal human 
kidney and cultured successfully with apparently normal phenotypic characteristics (222-
225).  
 
In this chapter, RTECs were isolated from adult kidneys that had been excised for renal 
cell carcinoma (RCC).  This type of malignancy occurs typically unilaterally, in a well 
circumscribed encapsulated mass at one pole of the affected kidney and metastasizes 
slowly.  This means the surrounding tissue is “normal” and can be used for these 
experiments.  With ethical agreement and patient consent, cells from these nephrectomy 
specimens were isolated, cultured, frozen and stored. 
 
4.1.1  Aim 
The aim of this chapter was to study the RTECs in culture over the 72 hour experimental 
timeframe.  Cells were assessed by studying the morphology of the developing sub-
confluent monolayer in culture and their expression of junctional proteins, as previously 
described in chapter three. 
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4.1.2  Objectives 
1.  To capture images of the developing RTECs in culture using a phase contrast 
microscope. 
2.  To stain the cultures for junctional proteins known to be regionally expressed 
along the nephron using single stained, indirect immunofluorescence 
techniques. 
3.  To dual-stain the RTECs in culture using an indirect immunofluorescent 
technique showing co-localisation or mutually exclusive staining of these 
proteins with Alexa Fluor 488 (Invitrogen, Paisley, UK) or Alexa Fluor 546 
(Invitrogen, Paisley, UK) conjugated secondary antibodies. 
 
4.2  Assessment of the morphology of the RTECs in culture 
4.2.1  Introduction 
RTECs are responsible for forming a polarised confluent monolayer along the luminal 
surface of the kidney tubule.  This monolayer that acts as a barrier to the unregulated 
passage of solutes from the tubule back into the host system and it creates two means by 
which passage of solutes can be regulated, namely the transcellular and paracellular routes.  
The transcellular route involves active transport mechanisms, regulating transport across 
cells, often in conjunction with other molecules (226).  The paracellular route is regulated 
by the tight junctions between the RTECs, the physical characteristics of the particulate 
being transported, and the influence of solute gradients that maybe created by active 
transport processes (226). 
 
To create a successful model of RTECs in culture, a polarised epithelial monolayer had to 
be established, with adherens and tight junctions between the cells.  In order to assess these 
cells and their propensity to form polarised epithelial monolayers in experimental 
conditions, cultures were set up to assess whether these characteristics were maintained.  
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4.2.2  Results 
 
Figure 4.1.  Phase contrast microscopy of cultured RTECs, having been plated down in 
HDM (A) for 24 hours and having grown in DM (B) for a further 24 hours.  
Note the sparse nature of the cells having been plated for 24 hours and the way in which they 
“reach” (highlighted by arrows) for one another in order to create the small populations seen in B, 
in order to start to create the epithelial monolayer.  Mag bar = 100µm 
 
Figure 4.2.  Phase contrast microscopy of cultured RTECs, 72 hours after having been 
plated down, showing the sub-confluent epithelial monolayer (A) and at higher magnification 
(B).  
Image A demonstrates the propensity these cells have to organising themselves into recognisable 
groups.  This is further exemplified by image B, where cells have formed a tightly apposing 
population of cells (black arrow) surrounded by a perimeter of larger, more elongated cells (red 
arrows).  This has previously been referred to as a “hemicyst” (227).  A = 200µm mag bar; B = 
100µm mag bar 
Figure 4.3.  Phase contrast images of cultured RTECs at day 0 (A, B), 24 hours (C, D), 48 
hours (E, F) and 72 hours (G, H).  
Note the formation of a “hemicyst” (D, diamond) by the clustering of cells surrounded by a second 
population of more elongated cells.  These same elongated cells may line the perimeter of 
discontinuities in the epithelial monolayer (E, F arrows).  A, C, E, G = 200 µm mag bar; B, D, F, H 
= 100µm mag bar      Image on page 111.   111 
 
Figure 4.3 – annotation page 110. 
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RTECs formed sub-confluent monolayers over three days.  The cells, initially sparse, 
proliferated quickly to come into contact with other cells and then form populations that 
expanded in numbers to cover the surface area.  This was observed with all tissue samples 
examined (N>6) from which the images were captured.  Figure 4.1 illustrates the cells 
“reaching” for one another, when plated down initially.  At 24 hours the same culture is 
already starting to create small populations of cells that have come into contact with one 
another through this process of forming tendrils and “reaching” for other cells.  
 
Figure 4.2 illustrates the sub-confluent monolayers that are present in culture by the third 
day.  Cells have proliferated sufficiently to cover 70-80% of the surface area of the culture 
dish and are in apposition with one another.  Figure 4.2 B shows the formation of a 
hemicyst within this culture.  The cells have organised into two populations.  The first 
population is present in the centre of the hemicyst and forms a tightly apposed cluster of 
cells.  The second population of cells are larger and more elongated than the first and form 
a perimeter surrounding the first. 
 
Figure 4.3 chronologically illustrates the development of the culture during the 
experimental timeframe of 72 hours.  Initially (A, B) cells are disorganised, with the 
retention of some tendrils to close remaining gaps in the monolayer.  By 24 hours the cells 
have organised themselves into groups of cells that start to create hemicysts (C, D).  This 
reorganisation sees the creation of further gaps in the monolayer through increased 
organisation and tightening of the cellular apposition.  These gaps in the monolayer are 
also surrounded by a population of elongated larger cells, similar to those involved in the 
hemicyst (E, F).  At 48 – 72 hours, the cells are densely packed in the monolayer, creating 
areas where they alter the refraction of the light through the culture, giving the impression 
the cells may be lying on top of one another.  
 
4.2.3  Discussion 
The aim of this section was to confirm the growth of RTECs in defined medium, by 
establishing epithelial monolayers capable of forming hemicysts (227) or “domes” (52), a 
characteristic of functional RTECs in culture.  
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To ensure the growth of RTECs, a chemically-defined medium was used.  This medium is 
a mixture of required hormones and growth factors (227), which has been refined over 
time (223, 224), resulting in a medium that not only preferentially supports the growth and 
differentiation of RTECs, but selects against fibroblast growth as it contains no foetal calf 
serum.  
 
In terms of the medium and the RTECs culture, this model appeared to be a good one for 
primary RTECs.  A successful cell-based model should facilitate the growth of the 
epithelial cells in a polarised manner with the proper distribution of membrane-based 
enzymes and transport systems, producing normal transcellular and paracellular passage of 
water and solutes.  These characteristics were evidenced by the creation of “domes” 
(hemicysts) in the monolayer.  Previous work has shown that RTECs cultured in this way 
retain their nephron-specific characteristics; metabolic activities, transport properties and 
hormone responsiveness (228). 
 
As the monolayers matured in culture, there was a tendency for them to create 
discontinuities in the confluency when grown on glass or plastic.  This type of response to 
growth on a solid support has previously been reported as “cord-like cells” breaking the 
confluent monolayer (52).  The support upon which a culture grows does have significant 
effect on the size, shape and differentiation of cells cultured (229).  In this model it 
appeared that some cells underwent a morphological change growing on the glass 
coverslips or plastic.  These cells appeared to congregate around regions of discontinuities 
in the monolayer or around a dome/hemicyst.  Once the cells had altered their morphology 
to these cord-like, curved cells, continuing the culture or re-passaging could not retrieve 
them (52). 
 
These discontinuities in the epithelial monolayer on a solid base may have a significant 
role in the development of the culture.  In the normal situation, the epithelial cells grow on 
a basement membrane that facilitates the feeding of cells from the basolateral aspect.  In 
this model the cells are grown on a surface that does not provide basolateral access to 
constituents of the medium when the tight junctions have developed.  Thus, in order to 
feed, the cells must transfer food from the apical side to the basal surface or maintain gaps 
in the monolayer through which the nutrients can pass.  The use of porous Transwell filters   114 
would facilitate feeding of cells from the basal side and encourage differentiation and 
development of polarity (see chapter 6).  
 
In summary, RTECs isolated from human nephrectomy specimens grew quickly to form 
sub-confluent monolayers of cuboidal apposing epithelial cells in the culture experiments.  
Cells created tightly adhering populations by 72 hours.  Their development produced 
hemicysts (227) or a “dome” (230) consisting of two populations of cells, a central 
population and a perimeter forming population.  Discontinuities were produced in the 
monolayer that appeared to be lined by a similar population of cells to those that formed 
the perimeter of the hemicysts. 
 
4.3  Single-stained Immunofluorescence of RTECs in culture 
4.3.1  Introduction 
Having established that unselected isolated epithelial cells underwent sufficient 
proliferation to create confluent polarised epithelial monolayers, the next step was to 
demonstrate the expression of junctional proteins, characteristic of RTECs, originating 
from either the proximal or distal renal tubule.  Single stained, indirect 
immunofluorescence was undertaken to label for N-cadherin, claudin 2, E-cadherin and 
occludin in six different tissues samples.  Identifying the junctional proteins, N- and E- 
cadherin and claudin-2, helped to ascertain whether cells were from the proximal or distal 
parts of the nephron (29).  Cultures were also stained for the presence of claudins 3, 4, 8, 
10 and 11 to establish whether expression of these claudins was maintained in vitro.  This 
experiment was repeated in triplicate.  A negative control was included to exclude non-
specific fluorescence.  With all of the antibodies used, cells were counterstained for their 
nuclei with 7-aminoactinomycin D (7AAD).  
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4.3.2  Results 
 
Figure 4.4.  Epifluorescent micrographs of cultured RTECs at days 0 (A, B) and at 72 
hours (C, D) showing the experimental negative control (secondary antibody alone) and a 
nuclear counter stain 7AAD (red).  
Note there is very little background green fluorescence seen in all images.  A, C = 100µm mag bar; 
B, D = 50µm mag bar 
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Figure 4.5.  Epifluorescent micrographs of cultured RTECs at days 0 (A) and at 72 hours 
(B) labelled for N-cadherin (green Alexa Fluor 488 antibody) and a nuclear counterstain 
7AAD (red).  
The labelling for N-cadherin localises at the cell-cell contacts.  A = 50µm mag bar 
 
 
 
Figure 4.6.  Epifluorescent micrographs of cultured RTECs labelled for E-cadherin 
(green Alexa Fluor 488 antibody) at days 0 (A) and at 72 hours (B) with a nuclear 
counterstain 7AAD (red).  
Note the majority of cells staining strongly for E-cadherin.  The arrows highlight cells staining less 
intensely for E-cadherin and the star indicates cells that do not fluoresce at all.  A = 50µm mag bar 
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Figure 4.7.  Epifluorescent micrographs of cultured RTECs labelled for claudin 2 (green 
Alexa Fluor 488 antibody) at days 0 (A) and at 72 hours (B) and a nuclear counterstain 7AAD 
(red).  
These micrographs were representative of the staining observed for claudin 2 in cultured RTECs.  
At day 0 and at 72 hours claudin 2 staining localised to the regions of cell-cell contact and a degree 
of cytosolic speckling of the cells.  A = 50µm mag bar 
 
 
 
Figure 4.8.  Epifluorescent micrographs of cultured RTECs labelled for occludin (green 
Alexa Fluor 488 antibody) at days 0 (A) and at 72 hours (B) and a nuclear counterstain 7AAD 
(red). 
Note the variation in the intensity of staining (yellow arrow) and cell size (red arrow) highlighted 
by labelling occludin.  A = 50µm mag bar 
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Figure 4.9.  Epifluorescent micrographs of cultured RTECs, four days after plating, 
labelled for claudin 2 (A), 3 (B), 10 (C), 4 (D), 11 (E) and 8 (F) organised into the proximally 
associated claudins 2, 10 and 11 (A, C, E) and the distal associated claudins 3, 4 and 8 (B, D, 
F).  Immunofluorescent staining done by M. Hardyman.  
Note the size difference in the populations of cells stained by claudin 3 antibody (identified by the 
yellow star and below the red star).  Mag bar = 100µm  
 
The staining of N-cadherin shows labelling at the cell-cell contact region, with some 
cytosolic fluorescence.  N-cadherin was observed to be labelled in a population of cells   119 
either surrounding non-staining populations or staining cells that linked populations of 
cells by discontinuities in the monolayer (figure 4.5).  
 
Figure 4.6 shows the staining for E-cadherin.  This staining was observed on the majority 
of cells present in the culture and at varying intensities, although the majority of cells 
stained strongly.  These strongly staining cells were smaller than those stained less 
intensely (yellow arrows).  Within the culture are cells that do not stain at all for E-
cadherin (blue star).  
 
Staining for E-cadherin intensified from day 0 to 72 hours.  Figure 4.6 shows discrete 
staining present at the cell-cell contact region at day 0 for E-cadherin.  At 72 hours, this 
staining appeared to be more intense along the cell-cell contact regions and was in the 
cytoplasm.  Staining also increased in those cells staining less intensely for E-cadherin. 
 
Claudin 2 staining showed a different pattern.  Figure 4.7 shows how claudin 2 staining at 
day 0 is present in specific populations of cells at their cell-cell contact regions and within 
the cytosolic compartment.  At 72 hours, this staining pattern had disappeared and the 
fluorescence was seen as cytosolic discrete dots, appearing to have been sequestered away 
from the cell-cell contact regions into the cytoplasmic compartment.  Some cell-cell 
staining was observed but little compared with other junctional proteins. 
 
Occludin is a tight junction protein that is present at most tight junctions and is not 
epithelial cell subtype specific (231, 232).  Figure 4.8 shows occludin staining all the cell-
cell contact regions.  It highlights the differences in both staining intensity (yellow arrows) 
and cell size (red arrows) that was seen to a lesser extent with E-cadherin.  Over the three 
days of culture the intensity and localisation of the staining did not change. 
 
Figure 4.9 shows staining with the claudin antibodies used to label renal cortical tissue in 
chapter three (claudin 2, 3, 4, 8, 10 and 11).  RTECs stained at day 4, after being seeded, 
showed claudin 2 fluorescent staining at the cell-cell contact regions with some cells 
positive in their cytosolic compartment (A).  Claudin 3 antibody stained the majority of   120 
cells present and revealed two populations of cells in the culture (B).  One population of 
cells are small and appear tightly packed, while the second population are less intensely 
fluorescent and larger in size (as highlighted by the red and yellow arrows).  Claudin 10 
antibody stained both cell-cell contact regions and cytosolic compartments of RTECs (C).  
Claudin 4 antibody was observed to stain the majority of cells in cell-cell contact regions 
(D).  Claudin 11 antibody stained the RTECs diffusely, labelling the cytosolic 
compartments and the plasma membranes (E).  Claudin 8 antibody stained the cell-cell 
contact regions of the RTECs with some diffuse staining in the cytosolic compartments 
(F).  
 
4.3.3  Discussion 
In this section the key junctional proteins, claudins 2, 3, 4, 8, 10 and 11, N- and E-cadherin 
and occludin, identified in chapter 3 have been shown to be expressed in culture through 
single staining immunofluorescence.  Thus, the isolation and culture techniques 
successfully isolated RTECs expressing regionally identified and ubiquitous junctional 
proteins.  
 
The nature of the staining for the proximal junctional protein N-cadherin showed a similar 
pattern to that from GMA-embedded tissue.  Claudin 2, however, appeared to be 
sequestered into the cytoplasmic compartment of the cell, away from the junctional region 
of the cells by 72 hours.  The adherens junctional protein E-cadherin identified two 
populations of cells.  The first population consisted of small, tightly packed cells that 
stained intensely.  The second population were larger and less intensely stained.  There 
were cells situated at the edge of discontinuities in the epithelial monolayer that remained 
unstained to both N-cadherin and E-cadherin (see figure 4.5 and 4.6). 
 
The labelling for occludin labelled the tight junctions in all RTECs.  Staining for occludin 
further highlighted the size and intensity difference identified by labelling for E-cadherin.  
Again smaller cells in compact colonies labelled more intensely. 
 
The single stained immunofluorescence demonstrated the presence of at least two 
populations of cells present in the culture.  This type of staining difference would be   121 
indicative of the populations relating to their origins from the nephron.  In the proximal 
tubule the RTECs are larger, with a greater surface area.  Their junctions are comprised of 
N-cadherin at the adherens junction and claudin 2 at the tight junction, alongside the other 
components of the tight junction – occludin, ZO-1, and ZO-2 (233).  This cellular 
difference was observed in chapter 3.  Further investigation through dual staining was 
undertaken to study the relationship between these junctional proteins (section 4.4). 
 
The establishment of tight junctions in the proximal RTECs population may be dependent 
on the presence of E-cadherin.  It has been reported that E-cadherin is essential in the 
initiation of the formation of the tight junction between homotypic and heterotypic 
populations of epithelial cells (11, 28).  N-cadherin has not been reported to initiate the 
same response in epithelial cells, and stimulate the formation of a tight junction.  This may 
go some way to explaining the expression of E-cadherin in proximal RTECs, as without E-
cadherin it may be that these cells cannot form tight junctions (13).  This finding has been 
challenged however.  Through experiments undertaken on MDCK cells with annexin II 
knocked down, it was possible to form tight junctions in the absence of E-cadherin (234), 
the implications of this being virally transformed cells can make tight junctions without E-
cadherin present. 
 
However, there may be another explanation for the positive staining for E-cadherin in the 
proximal RTECs.  There may be some cross-reactivity between the Zymed monoclonal E-
cadherin antibody and the N-cadherin protein.  This would require further investigation.  In 
order to do so, recombinant N-cadherin protein would need to be exposed to the E-
cadherin antibody to assess whether there was any affinity.  E-cadherin’s presence 
however, in the epithelial population, does indicate these cells are epithelial. 
 
As in the nephron, the expression of junctional proteins in the culture appeared to occur in 
regions.  This phenomenon may have been as a consequence of the mobility of the RTECs 
in culture and the need for the cells to form homotypic adherens junctions in order to 
initiate the formation of tight junctions and create the polarised epithelial monolayer (11).  
The affinity of homotypic E-cadherin adherens junctions being greater than N-cadherin 
adherens junctions may explain the N-cadherin positive staining around the E-cadherin 
positive cells, due to the displacement of the proximal RTECs.   122 
Claudin 2 underwent sequestration into the cytosolic compartment after 24 hours of 
growth.  Having been labelled at the cell-cell contact regions, the staining was observed in 
discrete vesicles present within one population of cells (figure 4.7).  This type of claudin 2 
modulation has been reported in other experimental models and in vivo pathology (235-
238), and the presence of claudin 2 in the tight junction has been demonstrated to 
determine the permeability of the paracellular transport route (56, 110, 212).  In work 
undertaken in our laboratory, claudin 2 was shown to down-regulate in the maturing 
epithelial cells as they rose from the crypts of gut villi to the lateral surfaces of the villi 
(Prasad, PhD data). 
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4.4  Dual-Stained immunofluorescence of RTECs in culture 
4.4.1  Introduction 
Chapter 3 confirmed the previously reported data that RTECs express regionally specific 
junctional proteins.  Section 4.1 showed that isolated epithelial cells from nephrectomy 
specimens could grow in a chemically defined, serum-free medium and had the potential to 
form an epithelial monolayer.  Section 4.2 demonstrated these epithelial cells from 
nephrectomy specimens expressed the characteristic regionally specific junctional proteins 
of the RTECs.  
 
In addition to the expression of regionally specific junctional proteins, these cells 
expressed them in a manner that suggested a degree of organisation, to create populations 
of epithelial cells expressing the same junctional proteins.  This cellular organisation could 
represent the cells’ attempts to create a similar situation to that of the nephron where cells 
expressing the same proteins form the regions along the tubule (adherens junctions are 
homotypic junctional proteins (239)).  Dual immunofluorescent staining was undertaken to 
investigate whether the RTECs expressed these junctional proteins in populations and the 
relationship between these different populations.  
 
4.4.2  Results 
Images follow demonstrating the presence of two protein antigens, stained using 
immunofluorescence, and their relationship to one another.  These plates represent the best 
images from the three tissue samples examined.  Staining was done by Michelle 
Hardyman. 
   124 
 
Figure 4.10.  Dual stained confocal micrographs of cultured RTECs labelled for E-cadherin 
(B; green Alexa Fluor 488 antibody) and EMA (C; red Alexa Fluor 546 antibody) and those 
images overlaid (A).  
Note the staining for E-cadherin (B) produces fluorescence at cell-cell contacts with the central 
population of cells staining far less intensely.  Image C shows the pattern of staining associated 
with EMA, a marker present on the cell surface.  The staining for E-cadherin and EMA co-
localises, although the nature of the staining is different with E-cadherin being along the apposing 
membranes and EMA being present on the cell surface.  Mag bar = 75µm    125 
 
Figure 4.11.  Dual stained confocal micrographs of cultured RTECs labelled for E-cadherin 
(B; green Alexa Fluor 488 antibody) and N-cadherin (C; red Alexa Fluor 546 antibody) and 
those images overlaid (A).  
Note the staining patterns for E and N-cadherin are both at cell-cell contacts but are mutually 
exclusive.  E-cadherin staining cells appear to form populations of cells that were surrounded by N-
cadherin staining cells.  N-cadherin also appeared to encapsulate interruptions to the epithelial 
monolayer (highlighted by the stars in A).  Mag bar = 75µm 
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Figure 4.12.  Dual stained confocal micrographs of cultured RTECs labelled for claudin 2 
(B; green Alexa Fluor 488 antibody) and E-cadherin (C; red Alexa Fluor 546 antibody) and 
those images overlaid (A).  
Note the staining patterns for claudin 2 and E-cadherin both at cell-cell contacts, with claudin 2 
being less well organised.  The staining for these two junctional proteins appeared mutually 
exclusive.  Mag bar = 75µm    127 
 
Figure 4.13.  Dual stained confocal micrographs of cultured RTECs labelled for claudin 2 
(B; green Alexa Fluor 488 antibody) and EMA (C; red Alexa Fluor 546 antibody) and those 
images overlaid (A).  
Note the populations of cells staining for each of the proteins were mutually exclusive (yellow 
arrows) with regions of no staining at all (blue arrows).  Mag bar = 75µm  
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Figure 4.14.  Dual stained confocal micrographs of cultured RTECs labelled for claudin 2 
(B; green Alex Fluor 488 antibody) and N-cadherin (C; red Alexa Fluor 546 antibody) and 
those images overlaid (A).  
Note the co-localisation of claudin 2 and N-cadherin in these images.  Although claudin 2 is more 
prevalent, there are areas of co-localisation evidenced by the alterations to the colour scheme 
observed in image A (yellow arrows).  There are also areas where no co-localisation has taken 
place (blue arrows) for both proteins being investigated.  Mag bar = 75µm  
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Figure 4.15.  Dual stained confocal 
micrographs of RTECs labelled for 
EMA (red, Alexa Fluor 546 antibody) 
and E-cadherin (green, Alexa Fluor 488 
antibody).  Image A shows the plan view 
overlay maximum projection image 
captured using an SP2 Leica confocal 
microscope.  Image B shows an elevation 
view of dual staining patterns in the 
culture.   
Note in the elevation view the EMA 
labelling the apical surface of the 
monolayer.  The E-cadherin labelling is 
seen as independent vertical lines at cell-
cell contacts (Plan view, A).  This 
illustrates EMA labelling superiorly to E-
cadherin and continuously along the apical 
surface in this population of cells, while E-
cadherin labelled at the cell-cell contacts in 
the sub-apical region.  Mag bar = 75µm; Z 
stack interval 0.2µm.   130 
 
 
 
 
Figure 4.16.  Dual stained confocal 
micrographs of RTECs labelled for N-
cadherin (red, Alexa Fluor 546 
antibody) and E-cadherin (green, 
Alexa Fluor 488 antibody).  Image A 
shows the plan view overlay maximum 
projection image captured using an 
SP2 Leica confocal microscope.  Image 
B shows an elevation view of dual 
staining patterns in the culture.  
Note the mutually exclusive staining 
observed when cultures were stained for 
E- and N-cadherin.  B shows the 
elevation view of the same culture, 
showing the position of the two stains in 
relation to one another i.e.; a mutually 
exclusive relationship.  Mag bar = 
75µm; Z stack interval 0.2µm.  
   131 
 
 
 
 
 
Dual immunofluorescence staining demonstrated the relationship between the expressions 
of regionally specific junctional proteins in the culture.  It demonstrated the mutually 
exclusive nature of the staining for proteins from different regions in the nephron, and the 
co-localisation of those from the same regions.  Figure 4.10 illustrates the expression of 
distal RTECs proteins EMA and E-cadherin.  In these images the labelling for EMA and 
E-cadherin co-localises to the same population of cells.  The staining pattern observed with 
these two antibodies sees E-cadherin labelling in a lattice-like pattern, created by labelling 
at the cell-cell contact region, while EMA labels the within the lattice-like labelling.  
 
Figure 4.15 demonstrates this and reinforces the positioning of these proteins on the cells.  
EMA, being an apically expressed surface protein, labels the cells on their apical surface.  
E-cadherin labelled the cell-cell contact region on the lateral surface of the cells in culture.  
This labelling pattern was observed in figure 4.15 B showing EMA (red) staining the 
apical surface of the cells present.  E-cadherin (green) was labelled at the sub-apical level 
in vertical discrete columns at the cell-cell contact regions.  
Figure 4.17.  Dual stained confocal 
micrographs of RTECs labelled for N-
cadherin (red, Alexa Fluor 546 
antibody) and claudin 2 (green, Alexa 
Fluor 488 antibody).   
A shows the plan view overlay 
maximum projection image 
captured using an SP2 Leica 
confocal microscope.  B shows an 
elevation view of dual staining 
patterns in the culture.  
Note the co-localised staining observed 
when cultures were stained for claudin 2 
and N-cadherin. B shows the elevation 
view of the same culture, showing the 
position of the two stains in relation to 
one another.  Mag bar = 75µm; Z stack 
interval 0.2µm.  
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Figure 4.11 shows the mutually exclusive staining observed with a monoclonal N-cadherin 
antibody and a polyclonal E-cadherin antibody.  These adherens junction proteins were 
labelled in the cell-cell contact region within populations of the culture.  There is no 
overlap between these two staining populations.  In this image, the N-cadherin encases the 
E-cadherin staining population of cells. 
 
A similar staining pattern was observed with antibodies to claudin 2 and E-cadherin.  E-
cadherin appeared present on the majority of cells, while the claudin 2 was labelled in a 
smaller, mutually exclusive population of cells.  The staining pattern shows claudin 2 
labelling cells surrounding the tightly packed E-cadherin staining cells.  There was no 
overlap between these populations of cells. 
 
Figure 4.13 shows the staining patterns observed with EMA (monoclonal antibody) and 
claudin 2 (polyclonal).  EMA labelled the majority of the cells present in culture, labelling 
the surface of the cells in two tight populations.  Some EMA positive cells were present 
extending from these two populations into the central region that is essentially EMA 
negative.  Claudin 2 staining was present in a mutually exclusive population of cells in the 
centre of the image.  Staining was observed at the cell-cell contact regions and not at the 
surface of the cells, like that of EMA.  Areas in the culture stained for neither EMA nor 
claudin 2 (highlighted by the blue arrow). 
 
N-cadherin (monoclonal) and claudin 2 (polyclonal) staining was shown in figure 4.14.  
Both antibodies were seen to label similar populations of cells, identifying them at their 
cell-cell contact region.  Highlighted by the blue arrows are areas where the two stains 
were mutually exclusive, while highlighted by the yellow arrows are regions where the two 
antibody stains have overlapped and produced a change in the colour observed by the 
mixing of the red and green labels.  
 
Figures 4.16 and 4.17 confirm the staining patterns observed with N-cadherin 
(monoclonal, red) and E-cadherin (polyclonal, green), and N-cadherin (monoclonal, red) 
and claudin 2 (polyclonal, green) respectively.  In figure 4.16, the elevation view (B) 
showed N- and E-cadherin staining present at cell-cell contact regions with E-cadherin   133 
staining (green) being intense in regions between areas of N-cadherin staining (red), but 
also present at much reduced intensities in the N-cadherin staining areas.  In those areas 
staining for one antibody alone, there was no difference in the height along the cell-cell 
contact borders at which the staining was observed.  Where both N- and E-cadherin 
staining was observed, the E-cadherin was seen positioned more apically. 
 
In figure 4.17 staining for claudin 2 (polyclonal, green) and N-cadherin (monoclonal, red) 
was observed in plan and elevation views.  Figure 4.17A shows the plan view showing the 
co-localisation of claudin 2 and N-cadherin to similar populations of cells in the culture.  
Areas where both claudin 2 and N-cadherin were present at the same cell-cell contact 
region are yellow, from the overlap of green and red.  In the elevation view, figure 4.17B, 
staining for claudin 2 and N-cadherin were observed at the same cell-cell contact regions 
in some of the cells in culture, but they were not co-localised to the same position along 
the contact surface.  In this view the red stain representing claudin 2 was situated at the 
more apical position. 
 
4.4.3  Discussion 
Dual staining confirmed the data produced by the single staining; RTECs in culture retain 
their junctional characteristics, evidenced by the expression of proteins relating to their 
origin in the renal tubule (224, 225, 227, 240).  In addition to this, dual staining 
demonstrated regionally expressed junctional proteins stained in a mutually exclusive 
manner, or co-localised to the same cells, further confirming the origins of cells (241). 
 
Having confirmed the co-localisation of some proteins in these cultures, the elevation 
views then demonstrated the formation of junctions at different positions along the cell-cell 
contact surface in the culture.  This showed EMA to be expressed on the apical surface of 
distal cells and the claudin 2 to label in a more apical position to the N-cadherin on 
proximal RTECs (192, 193, 242).  
 
When N-cadherin and E-cadherin were labelled in the same culture, N-cadherin labelled 
populations of cells in isolation, while the E-cadherin labelled the majority of cells in 
culture.  In the areas expressing N-cadherin, E-cadherin expression appeared to be greatly   134 
reduced, as represented by the intensity of staining for E-cadherin (see figure 3.12).  These 
regions of co-localisation showed there to be no identifiable relationship between the 
positions of the N- and E-cadherin staining in relation to one another, only that the staining 
for N-cadherin was far more intense.  This relationship has been discussed in section 3.3.4. 
 
In addition to staining for claudin 2, staining for claudin 3, 4, 8, 10 and 11 may have been 
useful, as it would have demonstrated the presence of these proteins in relation to the other 
junctional proteins under investigation.  It may also have contributed to an explanation as 
to the organisation of the culture.  The nature of staining of proximal and distal RTECs in 
these cultures showed proximal tubular proteins surrounding the distal tubular cells.  This 
may have been a reflection on the physical characteristics of the cell-cell junctions.  If the 
affinities of the cell-cell junctions for the distal cells are greater than those for the proximal 
RTECs, then they are likely to displace the proximal RTECs in order to migrate into 
contact with one another, displacing the proximal RTECs.  This “self-sorting” 
phenomenon would be further enhanced by the nature of the adherens junctions being 
homotypic cell junctions. 
 
4.5  Summary 
In this chapter RTECs were successfully grown in a defined, serum-free medium 
producing a sub-confluent epithelial monolayer.  These unselected epithelial cells grew in 
culture retaining their regionally expressed junctional proteins.  Expression of these 
junctional proteins was observed to occur in populations of cells within the culture.  In 
dual immunofluorescence staining, cells from different regions of the nephron were seen to 
express their representative junctional proteins and stain in a mutually exclusive manner.  
When staining for junctional proteins of the same regions, these stains appeared to co-
localise when observed from the vertical axis.  On elevation views the established cellular 
architecture was observed, with EMA staining the apical surface, the tight junction 
proteins being labelled sub-apically and then the adherens junctions staining inferiorly to 
that. 
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The establishment of sub-confluent monolayers by unselected RTECs from nephrectomy 
specimens means this would provide a suitable model to assess the effects of CsA or 
TGFβ1 on these cells with respect to their morphology and junctional protein expression.  
These cells retained their regional epithelial phenotype in culture and appeared not to 
undergo any abnormal dedifferentiation. 
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5  The Effect of TGFβ1 and CsA on human RTECs in culture 
5.1  Introduction: - 
TGFβ1, a pro-fibrotic cytokine, and CsA have both been associated with renal fibrosis (8, 
170, 173, 177, 243).  Renal fibrosis is characterised by increased matrix deposition, the 
reduction in numbers of RTECs and tubular isolation.  RTECs are considered to play a role 
in the formation of this fibrosis (19).  In order to assess the pro-fibrotic effects of TGFβ1 or 
CsA, unselected isolated RTECs were cultured in serum-free, chemically defined medium 
containing TGFβ1 or CsA or neither.  The assessment comprised of recording 
morphological changes, immunofluorescence (IF), western blotting and qPCR data.  
TGFβ1 concentrations in the medium were also recorded in response to the addition of 
different concentrations of CsA. 
 
5.1.1  Aims 
The aims of this chapter were to study the direct effects of TGFβ1 or CsA on the cultured 
unselected RTECs.  Cells, cultured on glass coverslips for 72 hours in the presence of 
either TGFβ1 or CsA, were examined with respect to their morphology and phenotype.  
These variables were assessed using phase-contrast microscopy and IF at day 0, 
immediately prior to any exposure, and at 72 hours of exposure. 
 
5.1.2  Objectives 
•  To observe the morphological changes induced when RTECs are exposed to 
medium containing either TGFβ1 or CsA using phase contrast microscopy. 
•  To record the phenotypic changes seen as a consequence of exposure to TGFβ1 or 
CsA through single stained immunofluorescence and epifluorescent microscopy. 
•  To record the changes in protein expression from whole cell lysates as a 
consequence of exposure to TGFβ1 or CsA through western blotting. 
•  To study the changes induced in mRNA levels of specific cellular proteins through 
PCR studies of challenged cells through semi-quantitative Polymerase Chains 
Reaction experiments (qPCR).  
•  To assess whether there is any secretion of TGFβ1 as a consequence of exposure to 
CsA through ELISA assays. 
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5.2  Assessment of the Morphological and Phenotypic Effects of TGFβ1 or CsA on 
RTECs 
5.2.1  Introduction 
RTECs are reported to undergo an EMT when exposed to TGFβ1 or CsA.  EMT is 
characterised by a morphological change from cuboidal epithelial cells to fibroblastic cells 
and an alteration in the phenotype.  RTECs were cultured on solid surface supports until 
70-80% confluence.  The chemically defined, serum-free medium was then exchanged for 
serum-free medium containing either TGFβ1 (2ng/ml) or CsA (100ng/ml) or neither.  This 
medium was changed daily for 72 hours at which time the cells were fixed using acetone.  
These doses used were to represent a clinically relevant dose of CsA and a possible TGFβ1 
concentration that might be achieved in the clinical setting in response to the 
administration of CsA.  With TGFβ1 having no reference range available, this 
concentration was identified in conjunction with other authors (176, 177, 244). 
 
Assessment of the morphological effects to the epithelial monolayer was made by 
capturing images of the cultures daily after the exchanges of medium.  In vivo, the changes 
observed in the kidney are the alterations to tubular epithelium and the expansion of the 
interstitium (19, 245, 246).  In this model, the epithelial cells were studied on a solid 
support (glass coverslip) making the epithelial migration into the interstitium, after 
detachment, impossible.  
 
 
 
 
5.2.2  Results 
Results in this chapter are in two parts; the morphological assessment and the protein 
staining. 
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5.2.2.1 Morphological Assessment of the Effects of TGFβ1 or CsA 
These phase contrast microscope images of cultured RTECs exposed to either TGFβ1 or 
CsA for 72 hours represent multiple (n=6) experiments demonstrating very similar 
changes.  
 
Figure 5.1 shows the effects of having TGFβ1, at 2ng/ml, in the defined medium.  Cells 
underwent very prompt, profound morphological changes.  Initially polygonal epithelial 
cells in a sub-confluent monolayer are present.  These cells became spiculated and 
fibroblast-like in the first 24 hours of exposure, change that involved all the cells present.  
As a consequence of the change in morphology, cellular isolation took place.  There was 
no retention of populations of sub-confluent RTECs maintaining their original polygonal 
architecture. 
 
The effects of CsA on the morphology of the RTECs, at 100ng/ml, are shown in figure 5.2.  
Cells are seen to maintain their polygonal structure for longer into the 72 hour period.  
Morphological changes occurred in the second 24-hour period (C, D).  The changes 
observed showed the epithelial cells at the perimeter of the discontinuities undergoing 
morphological change, becoming elongated and fibroblast-like.  These cells, however, did 
not detach from the main population of cells.  By 72 hours of exposure to CsA, the 
monolayer had many more gaps present, with spiculated cells at the perimeter.  In some of 
the discontinuities cells abridged the gaps, creating cells joined from either side of the 
perimeter. 
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Figure 5.1.  Phase contrast photomicrographs of cultured RTECs growing on glass 
coverslips in medium containing TGFβ1 (2ng/ml) at day 0 (A, B), 24 hours (C, D), 48 hours 
(E, F) and 72 hours (G, H).  
Note the gross changes in the cellular morphology between day 0 and 24 hours.  Cells adopted a 
fibroblast-like morphology, appearing to disengage from one another.  These cellular changes 
remained constant or altered only slightly over the following two days.  A, C, E, G =100µm mag 
bar; B, D, F, H = 50µm mag bar  
Image on page 140. 
 
Figure 5.2.  Phase contrast photomicrographs of cultured RTECs growing on glass 
coverslips in medium containing CsA (100ng/ml) at day 0 (A, B), 24 hours (C, D), 48 hours 
(E, F) and 72 hours (G, H).  
Note the gross changes in the cellular morphology between 24 hours and 48 hours.  The monolayer 
develops gaps surrounded by elongated fibroblastic cells that produce extensions connecting them 
to the cells on the opposite side of the gap.  The majority of cells have remained epithelioid in 
appearance.  A, C, E, G = 100µm mag bar; B, D, F, H = 50µm mag bar 
Image on page 141.   140 
 
Figure 5.1 – annotation page 139.   141 
 
Figure 5.2 – annotation page 139. 
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5.2.2.2 Immunofluorescent localisation of the tight and adherens junction proteins in 
RTECs in cultures exposed to either TGFβ1 or CsA 
 
Controls for the single staining immunofluorescence demonstrated all cells labelled for 
Cam5.2.  Cells showed organisation over the three days incubation.  Initially cells were 
disorganised throughout the culture (figure 5.3b).  After 72 hours in culture the cells 
appeared to take on a degree of organisation.  Rounded more epithelial cells (yellow 
arrows) were observed to occupy the central population, while the more fibroblastic cells 
(red arrows) were observed to form a perimeter around those cells (figure 5.3d). 
 
Figures 5.4 and 5.5 show immunofluorescence staining for N-cadherin and E-cadherin 
respectively.  Both show the development of intense intercellular staining in the control 
situation, but when exposed to either TGFβ1 or CsA the staining became less intense and 
interrupted along the intercellular contact regions.  TGFβ1 appeared to have a greater effect 
on the cells, with marked cellular losses and reduction in the intensity of fluorescence.  
CsA produced a similar response with reduced, interrupted staining with far less cell death.  
Both proteins underwent a degree of redistribution to the cytosol in response to TGFβ1 and 
CsA, again more pronounced with TGFβ1. 
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Figure 5.3.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, anti-mouse secondary antibody alone (A, C) and Cam5.2 (B, 
D) at day 0 (A, B) and at 72 hours (C, D).  
Note the little staining associated with the negative control and the staining of all cells present by 
Cam5.2 and the differences in staining patterns between areas of the image (red/yellow arrows).  
Mag bar = 50µm  
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Figure 5.4.  Epifluorescent photomicrographs of cultured RTECs labelled for N-cadherin 
(green Alexa Fluor 488 antibody) and a nuclear counterstain (7AAD, red fluorescence) at day 
0 (A), at 72 hours unchallenged (B), at 72 hours challenged with TGFβ1 (C) and at 72 hours 
challenged with CsA (D).  
Note the differences in cell numbers and size of the three 72 hour treatment groups (B, C and D) 
and the cellular disruption in the TGFβ1 and CsA treated cells.  Mag bar = 50µm    145 
 
Figure 5.5.  Epifluorescent photomicrographs of cultured RTECs labelled for E-cadherin 
(green Alexa Fluor 488 antibody) and a nuclear counterstain (7AAD, red fluorescence) at day 
0 (A), at 72 hours unchallenged (B), at 72 hours challenged with TGFβ1 (C), and at 72 hours 
challenged with CsA (D).  
Note the differences in cell size and junctional labelling intensity and integrity between the three 
treatment groups (B, C and D).  Mag bar = 50µm  
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In figure 5.4 the unchallenged cultures N-cadherin appeared to increase in presence 
between day 0 and 72 hours (A, B).  When exposed to TGFβ1, the cells underwent a 
significant reduction in their number and amount of fluorescence from labelled N-
cadherin.  This fluorescence labelling appeared to take on an interrupted pattern (C).  
When cultures were exposed to CsA and labelled for N-cadherin, staining was observed to 
remain at the cell-cell contact regions (D).  This staining, however, was not as intense or 
organised as in the control. 
 
Figure 5.5 showed the immunofluorescence labelling for E-cadherin.  In the controls, E-
cadherin was observed in an intense lattice-like pattern at the cell-cell contact regions (A, 
B).  When these cells were exposed to TGFβ1, this organization was retained but the cells 
at the edge of these population clusters demonstrated no staining.  The staining at the cell-
cell contact regions was also interrupted with some cytosolic redistribution (C).  When 
CsA was added to the medium, staining at the cell-cell contact region again became 
interrupted with some cytosolic redistribution.  In this environment, a greater proportion of 
the cells remained and formed a non-staining perimeter around the staining central 
population cluster (D). 
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Figure 5.6.  Epifluorescent photomicrographs of cultured RTECs labelled for claudin 2 
(green Alexa Fluor 488 antibody) and a nuclear counterstain (7AAD, red fluorescence) at day 
0 (A), at 72 hours unchallenged (B), at 72 hours challenged with TGFβ1 (C), and at 72 hours 
challenged with CsA (D).  
Note the changes in claudin 2 staining over the 72 hours (A - B) and the effects of TGFβ1 and CsA 
on that staining, reducing the intercellular staining and increasing the cytosolic component (more 
pronounced in the TGFβ1-challenged culture, D).  Mag bar = 50µm  
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Figure 5.7.  Epifluorescent photomicrographs of cultured RTECs labelled for occludin 
(green Alexa Fluor 488 antibody) and a nuclear counterstain (7AAD, red fluorescence) at day 
0 (A), at 72 hours unchallenged (B), at 72 hours challenged with TGFβ1 (C), and at 72 hours 
challenged with CsA (D).  
Note the increase in occludin staining over the 72 unchallenged hours and the cellular disruption of 
TGFβ1 and CsA causing a reduction in the occludin seen with the challenges.  Mag bar = 50µm  
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Figure 5.8.  Epifluorescent photomicrographs of cultured RTECs labelled for ZO-1 (green 
Alexa Fluor 488 antibody) and a nuclear counterstain (7AAD, red fluorescence) at day 0 (A), 
at 72 hours unchallenged (B), at 72 hours challenged with TGFβ1 (C), and at 72 hours 
challenged with CsA (D).  
Note the increased staining in the unchallenged experiment as compared with disruption caused to 
both cells and staining with TGFβ1 and CsA.  Mag bar = 50µm  
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Claudin 2, figure 5.6, was observed at the intercellular contact region and in the cytosolic 
compartment at day 0 (A).  By 72 hours the staining at the cell-cell contact regions was 
reduced and that in the cytosolic compartment increased (B).  With exposure to TGFβ1, the 
amount of staining on both the cell-cell contact regions and the cytosolic compartment was 
greatly reduced (C).  In culture containing CsA, claudin 2 was observed mainly in the 
cytosolic compartment.  Junctional staining was lost, replaced by more intense cytosolic 
staining (D).  
 
Figures 5.7 and 5.8 show staining for occludin and ZO-1, respectively.  Staining for both 
tight junction proteins was observed at the cell-cell contact regions and to increase over the 
72 hours in the control situation.  Exposure to TGFβ1 produced cellular disorganisation and 
a great reduction in cell-cell contact staining.  Intercellular staining was retained where 
cells remain in apposition and clustered.  This was seen in the CsA plate as more cells 
remained after exposure.  
 
5.2.3  Conclusion 
Both TGFβ1 and CsA had profound effects on the RTECs in culture.  Cells underwent 
gross morphological changes, more so with the TGFβ1.  IF localisation of the junctional 
proteins demonstrated the redistribution of adherens junction proteins and the down-
regulation of the tight junction proteins. 
 
5.2.4  Discussion 
In the presence of TGFβ1 the cells appeared to undergo complete morphological change 
involving all the cells present in the culture.  This change appeared very rapidly, occurring 
in the first 24 hours of exposure to TGFβ1.  When exposed to CsA, the RTECs in culture 
appeared not to undergo the same rapid morphological change.  The effects of CsA were 
observed at the perimeter of discontinuities or at the edge of population clusters in the 
monolayer and occurred in the second 24 hour period.  The magnitude of morphological 
change also appeared to be less dramatic with those cells exposed to CsA rather than 
TGFβ1. 
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Cellular loss was also observed.  This was not quantified at this stage (MTS assays were 
carried out in chapter 6), as culturing cells on glass coverslips was thought to be very 
abnormal for the cells.  Cell loss may have contributed to either the development of 
discontinuities in the monolayer through the inability to remain on the surface while being 
treated (or undergoing experimentation) or simply as a consequence of cell death. 
 
The relationship between both TGFβ1 (44, 173, 247, 248) and CsA (176, 206, 249) and 
renal fibrosis is an established one.  The inter-relationship between TGFβ1 and CsA is also 
established.  Administration of CsA to epithelial cultures stimulates rises in the levels of 
TGFβ1 (8, 250).  In data reported by Saggi et al (250), rats exposed to CsA showed 
increased levels of c-Fos and c-Jun mRNA, two proto-oncogenes that dimerise to form 
AP-1 (a transcription factor responsible for a range of activities such as proliferation and 
differentiation).  Also reported was the chronic administration of CsA causing increased 
TGFβ1 mRNA.  When CsA administration was combined with renal ischaemia a 
synergistic increase in the level of c-Fos was reported, implying that CsA produces the 
raised levels c-Fos through a mechanism independent of ischaemia.  However, the authors 
then reported the calcium channel blocker, verapamil, abrogated the CsA-induced 
elevation in c-Fos possibly suggesting there may be a mechanism involving renal blood 
supply (and thus ischaemia).  Wolf et al (8), reported the administration of CsA to murine 
proximal tubular cells and syngeneic tubular fibroblasts in serum-free medium produced an 
increase in the TGFβ1 concentration. 
 
The relationship between the administration of CsA and the production of TGFβ1 was 
further established by Khanna et al (170).  Data reported showed the administration of CsA 
lead to the increased expression of TGFβ1 and intra-renal expression TGFβ1 mRNA.  
Changes to the epithelial cells present in culture have also been reported in mice models 
(10, 170, 206).  
 
Differences between the effects of the two additives did exist though.  TGFβ1 produced a 
very rapid morphological change (251), while CsA took a further 24 hours to promote a 
similar change in the RTECs.  This may be a consequence of the CsA having to stimulate 
the production of TGFβ1 (8, 250), in order to affect the changes observed.  However the 
changes seen with the two additives were not of the same magnitude.  CsA produced   152 
changes only present in the cells forming the edge of a gap in the epithelial monolayer or 
in those at the perimeter of a population cluster.  It did not appear to influence the centrally 
situated epithelial population.  TGFβ1 affected all the cells present in the culture causing 
cellular disassociation and morphological change promptly. 
 
This difference of effects may be the result of time delay between CsA exposure and 
generating the TGFβ1.  In order for this to be a satisfactory explanation the concentration 
of TGFβ1, as a consequence of CsA addition would have to rise (but not to 2ng/ml) to 
invoke a similar morphological response.  It would also have to do so within the 72-hour 
experimental timeframe.  The less dramatic changes observed with the CsA may be the 
result of the TGFβ1 not reaching the concentrations of 2ng/ml or that they were not 
achieved within the 72hours timeframe.  This does not seem to be the case as the rate of 
change in the morphology of those cells exposed to CsA reduced between 48 and 72 hours, 
suggesting that the maximal effect had been achieved.  (This data is examined in chapter 
6).  
 
Additionally, the lag-phase associated with the instigation of morphological change 
through the exposure to CsA may represent the synthesis of an independent molecule not 
yet recognised, rather than simply the synthesis time for TGFβ1.  This period of time 
provides the opportunity for a multitude of responses to take place.  Unlike TGFβ1, which 
causes an immediate response, likely to be a direct target, CsA may initiate a response 
from multiple cascades affecting its response that way.  There may be another possibility 
that since the addition of CsA does raise the concentration of TGFβ1 but does not produce 
the same effects, does it therefore have protective effects against the TGFβ1?  
 
It is certainly true that the administration of CsA to the cell cultures leads to the secretion 
of TGFβ1 (8, 250).  This TGFβ1 will have an effect on the cellular morphology of those 
cells exposed.  The CsA, however, may affect these changes through separate pathways.  
Slattery et al studied the effects of CsA on cell lines and noted the E2A transcription 
factors E12 and E47 to be unregulated.  When these factors were over expressed, alone or 
together in proximal renal cells, epithelial mesenchymal transition was identified (part of 
which is the morphological alteration of the epithelial cells) (252).    153 
Another possibility is the activation of the protein kinase C molecule (252).  This has been 
reported to be up-regulated by cellular exposure to CsA and act via the MAPK/ERK1/2 
pathway (253).  The activation of this pathway has been intimately related to the down-
regulation of E-cadherin and the expression of TGFβ1 (254).  These types of changes 
occurring in conjunction with one another would cause a multitude of stimuli to degrade 
the cell-cell junctions and create myofibroblast-like cells from epithelial cells.  
 
As observed with the morphological studies, TGFβ1 and CsA have gross effects on the 
cells and consequently the junctional proteins.  Both adherens junction proteins underwent 
redistribution, with staining reduced at the cell-cell contact regions and increased in the 
cytosolic compartment.  The expression of the tight junction protein, claudin 2, decreased 
in the control situation and more so when exposed to TGFβ1 than CsA.  Staining for 
occludin and ZO-1 reduced in the cultures containing TGFβ1 or CsA.  These two additives 
also had profound effects on the cells themselves with regard numbers of cells remaining 
at 72 hours. 
 
The controls for single stained immunofluorescence demonstrated that the cells present 
within the cultures all stained for Cam5.2 indicating their epithelial nature.  Within the 
epithelial cells captured in the plate, the positive control demonstrated a difference 
between populations of cells highlighted by the red and yellow arrows in the image (see 
figure 5.3).  The yellow arrow indentified a central population of cells that appeared more 
polygonal and situated closer to one another.  The red arrow highlighted a second 
population of cells that appeared to surround the previous population.  
 
This organisation of cells appeared to represent at least two populations of cells present 
within the culture.  These populations could represent the proximal and distal populations 
of epithelial cells from the tubule.  The presence of these populations was evidenced by the 
E-cadherin and N-cadherin staining.  Both antibodies identified target proteins in clusters 
of the cells present in the culture and left a significant other population unlabelled (cellular 
presence and lack of staining evidenced by the nuclear staining with no IF). 
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The adherens junction proteins underwent a degree of redistribution in response to both 
TGFβ1 and CsA.  This redistribution may herald the breakdown of the tight junctions.  It 
has been previously published that there is relationship between E-cadherin and the 
establishment of tight junctions (11).  This has not been established for N-cadherin.  Data 
published related N-cadherin to cell-cell adhesion and the maintenance of cellular health 
through work demonstrating the displacement of N-cadherin by bismuth.  If proximal renal 
tubular cells were exposed to bismuth, N-cadherin was lost from the adherens junction at 
1-hour post exposure.  These displacements lead to cell death at 3 hours (255).  This 
relationship was further evidenced by the result of the western blotting showing no 
significant differences between the band intensities for 72 hours control and 72 hours 
TGFβ1 or CsA containing medium.  
 
5.3  Assessment of the Effect of TGFβ1 or CsA on RTECs Translation 
5.3.1  Introduction 
TGFβ1 and CsA have an effect on the morphology and immunofluorescence when 
labelling for key proteins from the tubule.  Western blotting (WB) was carried out to assess 
whether changes occurred in the cellular presence of these key proteins.  Using cultured 
RTECs grown in plastic 6-well plates, cells were cultured in the presence of TGFβ1, CsA 
or neither and harvested at day 0 or at 72 hours.  Western blotting of whole-cell lysates 
was done to compare protein expression to assess whether there was any effect from being 
exposed to TGFβ1 or CsA. 
 
To analyse the bands, a Bio-Rad Versadoc, employing a chemiluminescent technique, was 
used.  The values of the bands from the western blots were calculated from the peak 
intensity and trace value of the band multiplied by each other.  Normalisation was achieved 
by dividing this value by the corresponding band values for β-actin, a cellular protein 
whose expression was not affected by TGFβ1 or CsA.  Statistical analysis was done using 
area under the curve (AUC) and analysis of variance (ANOVA). 
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5.3.2  Results 
5.3.2.1 The Control 
Β-actin was used as the control protein as its expression is unaffected by experimental 
medium the cells were grown in. 
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Figure 5.9.  Western blot of H124 whole 
cell lysates probed for β-actin to 
demonstrate equal loading of wells and even 
transfer of proteins.  
 
Figure 5.10.  Western blots of whole cell 
lysates probed for N-cadherin, E-cadherin, 
occludin and claudin 2 from H124 harvested 
at day 0 (D0) or 72 hours (D3) grown in 
normal medium (D3U), medium containing 
TGFβ1 (D3T) or CsA (D3C).  
Note the adherens junctional proteins appear 
not to be affected by the challenge medium, 
while the tight junction junctional proteins 
appear to be down regulated by both TGFβ1 
and CsA (more so with TGFβ1). Furthermore, 
occludin has multiple bands represented.   156 
5.3.2.2 The Adherens Junctions 
5.3.2.2.1  N-cadherin 
 
Figure 5.11.  Graph to show the band values for whole cell lysates, western blotted and 
stained with N-cadherin antibody, from cells harvested at day 0 (D0) or at 72 hours having 
grown in normal medium (D3U) or medium containing either TGFβ1 (2ng/ml; D3T) or CsA 
(100ng/ml; D3C).  
There were no statistically significant changes observed. (N = 8).  Error bars = 1 SEM 
5.3.2.2.2  E-cadherin 
 
Figure 5.12.  Graph to show the band values for whole cell lysates, western blotted and 
stained with E-cadherin antibodies, from cells harvested at day 0 (D0) or at 72 hours having 
grown in normal medium (D3U) or medium containing either TGFβ1 (2ng/ml; D3T) or CsA 
(100ng/ml; D3C). 
There were no statistically significant changes observed. (N = 8).  Error bars = 1 SEM   157 
5.3.2.3 The Tight Junction Proteins 
5.3.2.3.1  Claudin 2 
 
Figure 5.13.  Graph to show the mean AUC calculated for claudin 2 from whole cell lysates 
extracted from cells grown in normal medium (D3U AUC), or medium containing either 
TGFβ1 (D3T AUC) or CsA (D3C AUC).  
Note the changes associated with the exposure of cells to the additives on the amount of claudin 2 
detected did not reach statistical significance (N=8).  Error bars = 1 SEM 
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5.3.2.3.2  Occludin 
 
Figure 5.14.  Graph to show the mean AUC calculated for total occludin from whole cell 
lysates extracted from cells grown in normal medium (D3U AUC), or medium containing 
either TGFβ1 (D3T AUC) or CsA (D3C AUC).  
Note the changes associated with the exposure of cells to the additives on the amount of occludin 
detected (N=8).  Error bars = 1 SEM 
 
Figure 5.15.   Graph showing the differences between the lower and upper bands of 
occludin on western blotting.  
Note that statistical significance was attained when the comparing TGFβ1 with the control in the 
upper band (higher molecular weight occludin) only (p=0.017023), suggesting there was a 
statistically significant difference after the addition of TGFβ1 between the control and the lower 
molecular weight occludin (the lower band).  The comparison with the lower band did not reach 
statistical significance (p=0.054304).  All others were not statistically significant.  Error bars = 1 
SEM   159 
In two of the experiments (containing data from 4 patients) carried out to investigate the 
changes observed in the expression of occludin, bands were identified representing 
different molecular weight molecules being labelled by the occludin antibody.  
 
Key junctional proteins were western blotted in this work.  Those were the adherens 
junction proteins, N- and E-cadherin, and the tight junction proteins, claudin 2 and 
occludin.  When cells were grown in normal medium with no additive, the expression of 
adherens junction proteins increased (day 0 to 72 hours).  When this expression at 72 hours 
was compared with cells exposed to either TGFβ1 or CsA for 72 hours, the expression of 
these proteins was not statistically different. 
 
When analysing the results regarding the tight junction proteins, claudin 2 and occludin, 
the expression was altered by the presence of TGFβ1 and CsA.  When cells were exposed 
to TGFβ1 the expression of both claudin 2 and occludin was reduced.  For claudin 2 this 
reduction was not statistically significant.  For occludin, when comparing specific bands, 
statistical significance was achieved in the higher molecular weight band, being 
significantly reduced in presence of TGFβ1.  When exposed to CsA both tight junction 
proteins again showed a reduction in their expression however this time neither was 
statistically significant.  
 
Differences between the expression patterns of the tight junction proteins were also seen.  
The expression of claudin 2 at day 0 was much less than that at 72 hours, whereas the 
expression of occludin at day 0 was very similar to that at 72 hours.  Comparing the 
expression of proteins at day 0 and at 72 hours in cells exposed to either TGFβ1 or CsA 
showed claudin 2 expression increased, but significantly less than in the unchallenged 
group.  Occludin expression, however, was reduced from day 0 in response to both TGFβ1 
and CsA. 
 
Occludin was observed to produce multiple bands on some of the western blotting.  Values 
for band intensity in figure 5.14 represent the total intensities identified on western blotting 
from all bands in the same lanes for occludin.  On some of the western blots, multiple 
bands were identified.  The intensities of these bands were observed to change depending   160 
on whether there were additives to the control medium.  Figure 5.15 illustrates the relative 
contributions made to the total band intensities by the upper (heavier) and lower (lighter) 
occludin bands.  In the control environment the contribution of the lower band was 
observed to be greater than the upper band.  When culture medium contained TGFβ1 or 
CsA the contribution to the total band intensity was less from the lower band.  
 
From the IF data, images captured showed the cadherins redistributing in the cells in 
response to both TGFβ1 and CsA.  On western blot, these findings were further 
strengthened by there being no significant differences between the amounts of each protein 
present after exposure to these additives.  In addition, there was not a significant increase 
in the proteins present between day 0 and 72 hours. 
 
For the tight junction proteins, claudin 2 and occludin, both TGFβ1 and CsA have an effect 
on the amount of protein being identified by the western blotting process.  Given the IF 
results in conjunction with these results, it would appear the proteins are lost as a 
consequence of the exposure to TGFβ1 or CsA.  However, due to the variation of the 
normalised results between individual experiments, there is no statistically significant 
difference.  The results give the impression that TGFβ1 and CsA both cause the loss of 
these tight junction proteins from the cell-cell contact regions and from being identified by 
western blotting. 
 
5.3.3  Conclusion 
The exposure of the cultures to TGFβ1 or CsA produced no statistically significant 
alteration in the expression of the adherens junction proteins.  However, the tight junction 
proteins were down regulated by both TGFβ1 and CsA.  This reduction was not statistically 
significant but there was a trend in the data showing a more profound response to TGFβ1.  
 
5.3.4  Discussion 
Figures 5.6, 5.7, 5.8, 5.13 and 5.14 all demonstrate the reduced presence of tight junction 
protein as a consequence of exposure to TGFβ1 or CsA.  This reduction may be contributed 
to by multiple factors.  Firstly, adherens junction proteins play a role in the maintenance of 
the tight junctions (11).  As a consequence of elevated levels of TGFβ1, through direct   161 
addition or through the addition of CsA, factors responsible for the breakdown may be 
transcribed.  Snail is a strong candidate for this role.  This factor has been shown to be 
associated with the reduced expression of claudin 2, occludin and E-cadherin (12, 256, 
257).  This reduction in the expression E-cadherin would then provide further triggers to 
down-regulate the tight junctions (11). 
 
This junctional breakdown would then facilitate the movement of cells away from the 
epithelial monolayer and, in vivo, into the interstitium where the morphological changes 
can then take place through the expression of transcription factors associated with TGFβ1 
receptor stimulation, such as the Ras-MAPK signalling cascade (19). 
 
Interestingly, the identification of multiple bands with occludin may play a significant role 
in the properties of the epithelial monolayer, and the change in those properties after 
exposure to TGFβ1 or CsA.  The representation of multiple molecular weight occludins 
suggests the addition of molecular groups to the main structure.  Occludin does undergo 
phosphorylation to be utilised in the tight junction (15, 61, 62, 256, 258-261) and it may be 
this that is being represented by these bands.  Certainly, the stimulation of different 
cytokines, such as protein kinase C and the Ras-MAPK cascade (259) may act to increase 
occludin phosphorylation in the presence of additives to the medium, and in turn, act as a 
protective mechanism for the population of cells that remain in culture (this concept is 
further examined in chapter 6).  
The relationship demonstrated in this data shows the phosphorylated proportion of 
occludin being increased by the addition of TGFβ1 or CsA to the medium.  Though 
statistical significance was not achieved, the significance at a cellular level may be 
sufficient to alter the physical properties of the membrane as the junctions alter 
accordingly.  The technique of western blotting does not identify whether or not the 
occludin is being utilised in the junctional complex or available for recruitment.  It may be 
that the increased phosphorylated portion is aimed at increasing the tightness of the tight 
junctions in order to maintain the confluency of the epithelial monolayer. 
 
Statistical analysis of these data uses the Student’s T-test for comparison of two means 
with different variances.  For the western blotting, area under the curve was employed   162 
using the trapezium rule.  Given that there are only two time points, day 0 and 72 hours, 
using AUC assumes there to be a linear rate of change between the first and second time 
points.  Thus, given y=mx+c, it is “m” that changes as a consequence of the altered 
medium.  In biological scenarios this may not be the best approximation for statistical 
purposes, but without more time points one cannot assume any other relationship. 
 
 
5.4  Quantitative PCR Assessment of Transcriptional Alterations through the 
Analysis of mRNA  
5.4.1  Introduction 
To further understand and quantify the changes observed in the proteins investigated as a 
consequence of exposure to TGFβ1 and CsA, quantitative PCR (qPCR) was carried out on 
whole cell lysates from cells grown in medium containing TGFβ1 (2ng/ml) and a range of 
concentrations of CsA (100ng/ml, 500ng/ml, 2000ng/ml, 5000ng/ml).  This investigation 
aimed to assess whether changes to the mRNA expression were different to those seen in 
western blotting and whether there was a dose-related affect seen with CsA.  In 
conjunction with the western blotting data, inferences could be made as to the possibility 
of post-translational modification (PTM).  Experiments were carried out on three tissue 
samples in triplicate (data courtesy of Michelle Hardyman). 
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5.4.2  Results 
5.4.2.1 Effect of TGFβ1 and CsA on the Expression of mRNA for adherens junction 
genes 
5.4.2.1.1  N-cadherin 
 
Figure 5.16.  Graph to show the expression of N-cadherin mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Statistically significant differences were observed between TGFβ1 and all other media (p=0.01).  
Error bars = 1 SEM 
5.4.2.1.2    E-cadherin  
 
Figure 5.17.  Graph to show the expression of E-cadherin mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only TGFβ11 and CsA 100ng/ml were significantly different (p=0.03). No other statistically 
significant differences were observed.  Error bars = 1 SEM   164 
In the presence of TGFβ1, N-cadherin mRNA expression was increased.  CsA had no 
statistically significant effect on the expression of N-cadherin mRNA.  This increase in N-
cadherin mRNA with TGFβ1, was a statistically significant increase against all the other 
conditions.  In the case of E-cadherin, the only statistically significant relationship was 
between TGFβ1 and CsA 100ng/ml.  TGFβ1 was shown to increase the expression of 
occludin mRNA and CsA 100ng/ml was seen to reduce it.  When comparing their effects 
with one another, this relationship was statistically different.  No other statistically 
significant changes were observed. 
 
5.4.2.2 The Tight Junctional mRNA 
5.4.2.2.1  Claudin 2 
 
Figure 5.18.  Graph to show the expression of claudin 2 mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Statistically significant differences were observed between normal and TGFβ1 (p=0.02), normal 
and CsA 5000 (p=0.01) and CsA 5000 with CsA 100 (p=0.02), CsA 500 (p=0.01) and CsA 2000 
(p=0.04).  Error bars = 1 SEM 
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5.4.2.2.2  Occludin 
 
Figure 5.19.  Graph to show the expression of occludin mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
No statistically significant differences were observed between any of the media.  Error bars = 1 
SEM. 
 
 
Tight junction proteins did undergo some changes in response to TGFβ1 and CsA.  For 
claudin 2, CsA 5000ng/ml produced a statistically significant reduction in the expression 
of mRNA.  None of the other concentrations of CsA or TGFβ1 produced a statistically 
significant change in its expression.  With regards to occludin,TGFβ1 produced no change 
in the expression of occludin mRNA.  None of the concentrations of CsA produced a 
significant difference in its expression.   166 
5.4.2.3 Additional qPCR Data 
Considering the effects of TGFβ1, as a profibrotic cytokine, and CsA, as a drug that 
induces kidney fibrosis, we investigated other genes that might have a role in the 
development of fibrosis.  The other genes identified in qPCR were collagen-3, cadherin 11, 
cytokeratin 18, vimentin, Par-6, MMP 2, MMP 9, connective tissue growth factor (CTGF) 
and alpha Smooth Muscle Actin (αSMA). 
 
5.4.2.3.1  Phenotypic markers 
 
Figure 5.20.  Graph to show the expression of Cytokeratin 18 mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
TGFβ1 produced a statistically significant differences in cytokeratin 18 mRNA compared with all 
other media, normal (p=0.01), CsA 100 (p=0.00), CsA 500 (p=0.01), CsA 2000 (p=0.05) and CsA 
5000 (p=0.04).  Error bars = 1 SEM 
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Figure 5.21.  Graph to show the expression of vimentin mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
The addition of TGFβ1 produced a statistically significant increase in vimentin mRNA expression.  
Statistically significant differences were observed between TGFβ1 and normal (p=0.01), CsA 100 
(p=0.01), CsA 2000 (p=0.02) and CsA 5000 (p=0.01) and also between CsA 5000 and CsA 500 
(p=0.03).  Error bars = 1 SEM 
 
 
Note the addition of TGFβ1 or CsA, at 5000ng/ml, had opposing effects on the expression 
of vimentin mRNA.  The addition of TGFβ1 to the medium produced statistically 
significant increases in the expression of vimentin mRNA as compared with all the 
concentrations of CsA, barring 500ng/ml.  In addition, the addition of CsA at 5000ng/ml 
produced a decrease in the transcription.  
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Figure 5.22.  Graph to show the expression of αSMA mRNA in medium containing TGFβ1 
(2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only CsA 5000 produced a statistically significant reduction in the production of αSMA mRNA as 
compared with all other media.  Error bars = 1 SEM 
 
 
Figure 5.23.  Graph to show the expression of cadherin 11 mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
None of the additives produced statistically significant changes in cadherin 11 (p>0.05).  Error 
bars = 1 SEM   169 
5.4.2.3.2  Enzymes and Factors 
 
Figure 5.24.  Graph to show the expression of MMP-2 mRNA in medium containing TGFβ1 
(2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only TGFβ1 produced a statistically significant differences in the MMP-2 mRNA expression 
(p=0.00) compared with all other media.  Error bars = 1 SEM 
 
Figure 5.25.  Graph to show the expression of MMP-9 mRNA in medium containing TGFβ1 
(2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only TGFβ1 produced a statistically significant increase in the production of the MMP9 mRNA as 
compared with all other media (p=0.00).  Error bars = 1 SEM   170 
 
Figure 5.26.  Graph to show the expression of CTGF mRNA in medium containing TGFβ1 
(2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only TGFβ1 produced a statistically significant increase in the production of CTGF mRNA as 
compared with all other media (p=0.02).  Error bars = 1 SEM 
 
5.4.2.3.3  Matrix Components 
 
Figure 5.27.  Graph to show the expression of collagen-1 mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Only TGFβ1, at 40.26, produced a statistically significant difference between collagen-1 mRNA 
and all other medium was observed.  Error bars = 1 SEM 
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Figure 5.28.  Graph to show the expression of collagen 3 mRNA in medium containing 
TGFβ1 (2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
Statistically significant differences were observed between CsA 5000 and normal (p=0.02), CsA 
500 (p=0.02) and CsA 2000 (p=0.03).  Error bars = 1 SEM 
 
 
Figure 5.29.  Graph to show the expression of Par-6 mRNA in medium containing TGFβ1 
(2ng/ml) or CsA at 100, 500, 2000 or 5000ng/ml relative to control.  
None of the additives produced a statistically significant differences in the expression of Par-6 
mRNA (p>0.05).  Error bars = 1 SEM 
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For CsA, multiple significant results were observed.  The addition of CsA 5000ng/ml 
produced a statistically significant reduction in the expression of claudin 2 and collagen 1 
mRNA.  At 100ng/ml, CsA produced statistically significant reductions in CTGF and 
collagen 1 mRNA and a significant increase in MMP-2. 
 
5.4.3  Conclusion 
The alterations in transcription observed did not fully represent the EMT transcriptome 
(262).  Inconsistencies in the genes transcribed included the up-regulation of occludin, in 
response to TGFβ1 and the down-regulation of vimentin by CsA, both key genes in the 
process of EMT. 
 
5.4.4  Discussion 
The changes observed in the cultured cells, with redistribution of adherens junction 
proteins, reduction of tight junction proteins and morphological alterations would be 
consistent with a profibrotic response by the cells to exposure to TGFβ1 and CsA.  These 
changes at an intracellular level were further evidenced by the gene expression patterns 
observed in the qPCR data.  The EMT/pro-fibrotic panel of genes (263) that underwent 
increased expression were consistent with the possibility that these cells were, under the 
effects of exposure to TGFβ1 or CsA, undergoing the preliminary changes of an EMT.  
Some of the results from the qPCR did further strengthen the argument for differing 
pathways being stimulated by CsA, rather than simply the stimulation of TGFβ1 synthesis 
for example the E2 protein transcription factors (252). 
 
Dose response experiments were carried out with CsA but not TGFβ1.  This was done to 
try to observe any graded responses that might represent clinical relevance.  In the setting 
of solid organ transplantation, serum concentrations of cyclosporine may vary according to 
individual variation and their compliance to the medication regimen.  TGFβ1 is not a 
therapeutic agent and so dose response studies were not undertaken.  There was also the 
element of time pressures. 
 
Two of the genes investigated had dose responses to CsA that demonstrated differing 
results within the treatment group.  Cytokeratin 18 mRNA underwent an increase in   173 
expression in response to CsA 2000ng/ml (with the error bars remaining above unity), 
while at a concentration of 100ng/ml, the expression of cytokeratin 18 mRNA decreased 
(with the error bars remaining below unity).  Vimentin mRNA also underwent similar 
changes within the CsA treated groups.  At CsA 5000ng/ml, its expression decreased, 
while at 500ng/ml, it rose.  These changes were not in keeping with the types of changes 
expected in an EMT.  What’s more, CsA may be having different effects on the RTECs, 
possibly via different intracellular pathways.  The inability of this model to produce a full 
EMT suggests a failing in the experiment.  A similar result has been published previously 
whereby changes in the expression of mRNA were suggestive of but not consistent with 
EMT.  In these experiments the authors reported no expression of αSMA, a fibroblast 
specific marker (251). 
 
There were, however, some observed results that were not consistent with this.  Occludin 
mRNA expression was seen not to alter in the presence of TGFβ1.  Given the fluorescence 
and the western blotting data, this would appear to be at odds with these data.  The 
significance of this result could be biologically relevant as it may represent a post-
translational effect. 
 
Two other data noted are the response of αSMA to the addition of TGFβ1 and CsA, which 
underwent a significant reduction in its expression to CsA only, and the increased 
expression of collagen 3 to CsA alone and not to TGFβ1.  Again, these observations would 
seem to be at odds with what is understood of EMT (19, 246, 263). 
 
Given the observed changes in morphology, phenotype and western blotting, TGFβ1 and 
CsA appear to have similar effects on RTECs.  However, the qPCR data suggests these 
two additives act through different pathways.  Previously the effects of CsA have thought 
to be a consequence of the expression of TGFβ1.  Certainly, published data demonstrates 
similar effects of the two on RTECs through the addition of CsA and antibody 
neutralisation of TGFβ1 (249).  In this work, data suggests at the transcriptional level these 
two additives generate different responses from the RTECs.  Despite the final endpoints 
appearing similar, the changes in morphology, phenotype and protein expression, the 
qPCR data suggests these endpoints are achieved through a different combination of genes   174 
implying that their combined outcome is similar, or that the cells’ programmed response is 
not that dissimilar.    175 
5.5  Results Summary 
1.  Culture of RTECs in medium containing either TGFβ1 or CsA caused gross 
morphological change to the cells and breaks in the confluency of the epithelial 
monolayer. 
2.  Adherens junction proteins were observed to be redistributed rather than regulated 
by the presence of either TGFβ1 or CsA in the culture medium in both 
immunofluorescence and western blotting. 
3.  Tight junction proteins were down regulated by the presence of either TGFβ1 or 
CsA in the culture medium in both immunofluorescence and western blotting. 
4.  The expression of tight junction proteins was reduced when cultured in the 
presence of CsA and more so with TGFβ1.  This reduction was statistically 
significant for claudin 2 but not for occludin. 
5.  When different molecular weight bands of occludin were identified on western 
blotting, the ratio of upper to lower bands was increased in the presence of TGFβ1 
or CsA. 
6.  On mRNA PCR the expression of N-cadherin, occludin, cytokeratin 18, vimentin, 
MMP 9, CTGF and collagen 1 was seen to be statistically significantly increased, 
while the expression of cadherin 11 and MMP 2 was massively increased. 
7.  On mRNA PCR the expression of collagen 3 was statistically significantly 
increased in the presence of CsA containing culture medium. 
8.  On mRNA PCR the expression claudin 2 was statistically significantly reduced in 
the presence of TGFβ1 containing culture medium. 
9.  On mRNA PCR the expression of vimentin was statistically significantly reduced 
in the presence of CsA containing culture medium.   176 
5.6  Summary 
Both TGFβ1 and CsA had profound effects on RTECs in culture.  Both produced 
morphological and phenotypic changes in the cells.  Changes in the morphology showed 
cells becoming more fibroblast-like and separating from the sub-confluent epithelial 
monolayer.  IF showed the cells altering their protein expression and/or its localisation.  
The changes in expression were further evidenced by the western blotting data.  When 
qPCR data was examined, the effects of TGFβ1 were not mimicked by CsA at a lower 
concentration, or after a short time period. The effects were not the same.  CsA did not 
achieve such a dramatic change in morphology or protein expression/redistribution. TGFβ1 
had its effect directly while CsA required 24 hours of exposure.  These differences may be 
explained to a degree by the differences in qPCR data observed. 
 
This observed difference may go some way to explaining the different responses.  It has 
been shown that non-immune suppressing cyclosporine H has anti-proliferative properties 
independent to immune modulation (264).  This might mean the genes stimulated by CsA 
in this work are those expressed as a direct result of the presence of CsA or are a cellular 
response to the CNI activity.  It may be that at these concentrations of CsA, toxicity is the 
stimulant for the expression of TGFβ1 rather than the CsA stimulating TGFβ1 mRNA 
expression.  Separating these two possibilities would be extremely difficult.  
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6  The effect of TGFβ1 and CsA on a polarised cell culture model of 
human RTECs 
6.1  Introduction 
In the previous chapter, changes were observed in cell morphology, the expression of 
junctional proteins and mRNA when cultures were grown in medium containing either 
TGFβ1 or CsA.  These changes included disruption to the ordered epithelial monolayers, 
characteristic of RTECs in culture (figures 5.1 and 5.2), loss of claudin 2 mRNA (figure 
5.18) and protein (figures 5.6 and 5.13) and loss of a high molecular weight form of 
occludin protein (figures 5.14 and 5.15).  This disruption to the monolayer and the proteins 
involved in cellular adhesion may have an effect on the physical characteristics of the 
epithelial monolayer which, if occurring in the tubule, might be responsible for the tubular 
dysfunction often associated with the introduction of calcineurin inhibitors.  In light of 
these data it was important to grow renal tubular epithelia cells on a semi-permeable filter 
to allow better polarisation of the cells, thus creating a tubular epithelium that more closely 
mimics that found in vivo.  This also facilitated the assessment of the effects of either 
TGFβ1 or CsA on the epithelial monolayer and whether the observed loss in cells from the 
monolayers, seen in earlier chapters, was reflected in these experiments. 
 
6.1.1  Aims 
The aims of this chapter were to culture human RTECs on Transwell membranes and study 
the physical characteristics of the epithelial monolayer in defined medium with or without 
either CsA or TGFβ1.  
 
6.1.2  Hypothesis 
1.  TGFβ1 or CsA alters the barrier properties of a model of the renal tubular 
epithelium such that solute passage across the monolayer will be altered. 
2.  CsA stimulates the release of TGFβ1, and has an effect on cellular integrity, as 
assessed by means of relative cell numbers and LDH concentrations. 
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6.1.3  Objectives 
•   Observe the formation of confluent epithelial monolayers on the Transwell plates. 
•  To record the changes in Transepithelial Electrical Resistance (TER) across the 
RTEC monolayer on Transwell membranes and compare the TER differences 
between those cultured in medium containing TGFβ1, CsA or neither. 
•  To record the percentage passage of different molecular weight dextrans across the 
epithelial monolayer and compare the flux differences between the three 
conditions. 
•  To assess the numbers of cells present on the Transwell membranes during the 
experiments to ensure any differences observed were not the product of differences 
between the numbers of cells in each condition. 
•  To record the concentrations of TGFβ1 in its active and total forms and lactate 
dehydrogenase (LDH) after exposure to medium containing different 
concentrations of CsA.  
•  To record the changes observed in morphology and tight junction phenotype when 
RTECs were cultured in medium containing either TGFβ1 or CsA. 
 
6.2  Assessment of the Effects of TGFβ1 or CsA on the Morphology, Phenotype and 
junctional protein expression in RTECs cultured on semi-permeable Transwell 
plates 
6.2.1  Introduction 
In vivo, renal tubular cells form an epithelial monolayer lining the inside of the nephron 
supported by a semi-permeable membrane, the basement membrane.  When the cells are 
mature they create a confluent monolayer that facilitates the reabsorption of most of the 
filtered solutes back into the host system.  They do this utilising transcellular and 
paracellular passages. 
 
Using the semi-permeable membranes, RTECs were cultured and exposed to medium 
containing either TGFβ1 or CsA.  Comparison with the changes observed in chapter 5 was 
undertaken.  Images of the cultures were captured daily after the exchange of medium.  
Cells were fixed at days 0 and 3 for microscopic examination and immunofluorescent 
staining.  Whole-cell lysates were made and western blotted for claudins, cadherins and 
occludin from cells harvested on days 0, 3 and 6.    179 
6.2.2  Results 
Cultures grown on the Transwell membranes formed confluent epithelial monolayers.  In 
the absence of either TGFβ1 or CsA, RTECs grew to form a layer of cells, adherent with 
one another maintaining their polygonal shape (figure 6.1).  Cells grown in the presence of 
TGFβ1 appeared to undergo morphological alterations (figures 6.2).  The classical 
polygonal shape was replaced, in the majority of cells, by a more elongated larger cell that 
aligned with other such cells forming swathes of parallel larger fibroblast shaped cells.  
These changes were less pronounced in the cultures grown with CsA present in the 
medium (figures 6.3).  Despite the morphological alterations in the cells, discontinuities in 
the epithelial monolayer, witnessed in chapter 5 in cells on plastic tissue culture plates 
(figures 5.1 and 5.2), were not observed when cultured on the Transwell membranes 
(figures 6.1, 6.2 and 6.3).  In this model the domes, or hemicysts, previously reported 
(chapter 4 – figure 4.3) were not observed.  Cells formed fully confluent monolayers with 
no discontinuities.  This phenomenon was observed in all these experiments (n>6). 
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Figure 6.1.  Phase contrast photomicrographs of the cultured RTECs growing on 0.4µm 
pore Transwell membranes in chemically-defined medium at days 0 (A, B), 1 (C, D) and 3 (E, 
F). 
Images show the development of a confluent epithelial monolayer.  A, C, E = 100µm mag bar; B, 
D, F = 50µm mag bar 
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Figure 6.2.  Phase contrast photomicrographs of the cultured RTECs growing on 0.4µm 
pore Transwell membranes in defined medium containing TGFβ1 (2ng/ml) at days 0 (A, B), 1 
(C, D) and 3 (E, F). 
Images show the effects of TGFβ1 on the confluent epithelial monolayer showing the 
morphologically altered RTECs in cultures containing TGFβ1.  A, C, E = 100µm mag bar; B, D, F 
= 50µm mag bar 
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Figure 6.3.  Phase contrast photomicrographs of the cultured RTECs growing on 0.4µm 
pore Transwell membranes in defined medium containing CsA (100ng/ml) at days 0 (A, B), 1 
(C, D) and 3 (E, F). 
Images show the changes in the confluent epithelial monolayer of RTECs cultured in medium 
containing CsA.  A, C, E = 100µm mag bar; B, D, F = 50µm mag bar  
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6.2.2.1 Effect of TGFβ1 and CsA on expression of tight junction proteins: - 
Single staining immunofluorescence was undertaken on three tissue samples, to assess the 
expression and distribution of tight junction proteins present in RTECs Transwell model in 
response to TGFβ1 and CsA.  As seen in the previous chapter, claudin 2 was down 
regulated by the addition of either TGFβ1 or CsA.  This was observed as less 
immunofluorescence at the cell-cell interface.  It was also observed that in the normal 
situation, claudin 2 underwent a degree of redistribution, being labelled more intensely in 
the cytosolic compartment of the cells (figure 6.7).  Occludin also underwent similar 
changes to those observed in chapter 5. On the Transwell plates, occludin was seen to stain 
with less intensity in the presence of TGFβ1 and CsA and staining along the intercellular 
interface was interrupted (both changes were more obvious in the presence of TGFβ1) 
(figure 6.9). 
 
Staining for claudin 4 on Transwell plates produced a different result (figure 6.8).  
Intercellular staining was observed along cell-cell contact regions at day 0 and at 72 hours.  
In the presence of TGFβ1 and CsA, this intercellular staining remained with only a little 
redistribution, evidenced by the increased green hue observed in the cytosolic regions 
(figure 6.8).  Again, staining was most affected by the presence TGFβ1. 
 
The adherens junction proteins N-cadherin and E-cadherin were labelled in the cultures 
and not down regulated but simply redistributed.  This was very evident in the N-cadherin 
positive population (figures 6.5 and 6.6).  On comparing the representation of N-cadherin 
positive staining and E-cadherin positive staining, E-cadherin had a far greater 
representation indicating a predominance of distal epithelial cells in the culture.  The E-
cadherin positive cells also demonstrated two different size populations, possible indicative 
of the region of origin.   184 
 
Figure 6.4.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, anti-mouse secondary antibody alone at day 0 (A) and day 3 
(B, C, D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B).   
Mag bar = 100µm 
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Figure 6.5.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, mouse anti-N-cadherin antibody at day 0 (A) and day 3 (B, 
C, D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B). 
Images show the limited presence of labelled N-cadherin and its loss when cells were cultured in 
medium containing TGFβ1.  Mag bar = 100µm 
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Figure 6.6.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, mouse anti-E-cadherin antibody at day 0 (A) and day 3 (B, 
C, D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B). 
Images show the presence of labelled E-cadherin illustrating the change in morphology observed 
when cells were cultured in medium containing either TGFβ1 or CsA.  Mag bar = 100µm 
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Figure 6.7.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, mouse anti-claudin 2 antibody at day 0 (A) and day 3 (B, C, 
D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B). 
Images show loss of junctional assembly with increased cytoplasmic staining for claudin 2 in the 
control at day 3, which is similar in distribution to the TGBβ1 and CsA treated cells.  When cells 
were cultured in medium containing TGFβ1 there was a reduction in the amount of staining seen.  
Mag bar = 100µm   188 
 
Figure 6.8.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, mouse anti-claudin 4 antibody at day 0 (A) and day 3 (B, C, 
D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B). 
Images show the persistence of claudin 4 despite the exposure to TGFβ1 or CsA (C and D). 
Mag Bar = 100µm   189 
 
Figure 6.9.  Epifluorescent photomicrographs of cultured RTECs labelled with Alexa 
Fluor 488 antibody-conjugated, mouse anti-occludin antibody at day 0 (A) and day 3 (B, C, 
D) grown in the presence of TGFβ1 (C), CsA (D) or neither (A, B). 
Images show the increased presence of occludin in the control at day 3 with consistent junctional 
staining when cells were cultured in medium containing either TGFβ1 or CsA.  Mag bar = 100µm 
 
6.2.2.2 Western Blotting Data 
Western blotting was undertaken, using RTECs (H142 and H147), to assess the expression 
of tight junction proteins that may play a role in the paracellular transport and how that 
expression was affected by the addition of TGFβ1 or CsA to the medium.  Tight junction 
proteins, claudins -2, -3 and -4 and occludin, were examined.  The statistical assessment of 
the changes was made using area under the curve and T test comparisons. 
 
Using the mean normalised total band values for each of the proteins (for two 
experiments), trends were established as to the effects of TGFβ1 and CsA on the expression 
of junctional proteins.  Over the six-day experiments, all the claudin proteins assessed were 
expressed less on day 3 after the initial day 0 analysis.  At day 6, this expression was then   190 
far in excess of the initial expression levels.  The expression of occludin sequentially 
increased at the time-points day 0, 3 and 6. 
 
Claudins 2 and 3 underwent a reduction in expression at time-points day 3 and 6, when 
TGFβ1 was present in the medium (figures 6.11 and 6.12).  This reduction was not 
statistically significant for either claudin (claudin 2, p=0.92 [day 3], p=0.63 [day 6]; 
claudin 3, p=0.77 [day 3], p=0.58 [day 6]).  For both these proteins CsA reduced their 
expression, but not to the same level as TGFβ1, and not to statistical significance (claudin 
2, p=1.0 [day 3], p=0.66 [day 6]; claudin 3, p=0.83 [day 3], p=0.78 [day 6]).  
 
Claudin 4 underwent different changes in its expression (figure 6.13).  From the initial 
level at day 0, the day 3 level was much less.  At day 6, claudin 4 levels rose to those 
higher than observed at day 0.  The addition of TGFβ1 or CsA to the medium produced a 
reduction in the amount of claudin 4 present.  Unlike the other claudins, the reduction 
observed when exposed to CsA was greater than that seen when cells were exposed to 
TGFβ1.  At day 6 the unchallenged levels were in excess of the day 0 levels.  Similarly to 
the other claudins, TGFβ1 produced a more profound reduction on the presence of claudin 
4 at day 6. 
 
In the control experiment, the band intensity for occludin increased over the experimental 
timeframe from day 0 to day 6 (figure 6.14).  On using medium containing TGFβ1, the 
expression of occludin was reduced at the time-points day 3 and 6, compared with control 
medium.  Comparing all conditions, there was increased expression of occludin across the 
6 day time-frame.  This increase was dramatically less with medium containing TGFβ1 or 
CsA.  These changes were not statistically significant (occludin: control vs. TGFβ1, p=0.80 
[day 3], p=0.74 [day 6]; control vs. CsA, p=0.91 [day 3], p=0.96 [day 6]).  When medium 
containing CsA was used, there appeared to be a small increase in the expression of 
occludin at day 6 compared with control that was not statistically significant (see p values 
above).   
 
When looking at H142 specifically, upper and lower bands of occludin were identified on 
the membrane (figure 6.15).  These bands represented different molecular weight (Mr)   191 
occludin proteins identified by the monoclonal anti-occludin antibody (similar to chapter 5, 
figure 5.15).  At day 0 more lower molecular weight (Mr) occludin was present.  In the 
control and medium containing CsA, at day 3, the lower Mr occludin remained the 
predominant form. At day 6 in all conditions the higher Mr occludin predominated. 
 
 
 
Figure 6.10.  Representative digital image captures of western blots of whole cell lysates of 
RTECs grown on Transwells probed for β-actin, N-cadherin, claudin 2, claudin 3, claudin 4 
and occludin at days 0, 3 and 6 grown in cultures with TGFβ1, CsA or neither in them (T, C, 
U respectively).  
The images show how the exposure to medium containing these additives might alter the 
expression of the specific protein being identified.  E-cadherin failed to develop on the blot. 
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Figure 6.11.  Graph to show the relationship between the normalised total band values for 
claudin 2 from RTECs whole cell lysates, the day harvested and the treatment received by the 
cells.  
Neither of the additives produced statistically significant changes in the expression of claudin 2 
(TGFβ1 vs. control, p=0.92 [day 3], p= 0.63 [day 6]; CsA vs. control, p=1.0 [day 3], p=0.66 [day 
6]).  Error bars = 1 SEM 
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Figure 6.12.  Graph to show the relationship between the normalised total band values for 
claudin 3 from RTECs whole cell lysates, the day harvested and the treatment received by the 
cells.  
Neither of the additives produced statistically significant changes in the expression of claudin 3 at 
days 3 or 6 (TGFβ1 vs. control, p=0.77 [day 3], p=0.58 [day 6]; CsA vs. control, p=0.83 [day 3], 
p=0.78 [day 6]).  Error bars = 1 SEM 
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Figure 6.13.  Graph to show the relationship between the normalised total band values for 
claudin 4 from RTECs whole cell lysates, the day harvested and the treatment received by the 
cultured RTECs.  
Neither of the additives produced statistically significant changes in the expression of claudin  
(TGFβ1 vs. control, p=0.97 [day 3], p= 0.53 [day 6]; CsA vs. control, p=0.91 [day 3], p=0.47 [day 
6]).  Error bars = 1 SEM 
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Figure 6.14.  Graph to show the relationship between the normalised total band values for 
occludin from RTECs whole cell lysates, the day harvested and the treatment received by the 
cultured RTECs.  
Neither of the additives produced statistically significant changes in the expression of occludin 
(TGFβ1 vs. control, p=0.80 [day 3], p= 0.74 [day 6]; CsA vs. control, p=0.91 [day 3], p=0.96 [day 
6]).  Error bars = 1 SEM 
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Figure 6.15.  Graph to show the relationship between the normalised higher and lower 
molecular weight band values for occludin identified in the membrane from H142 RTECs 
whole cell lysates, the day harvested and the treatment received by the cultured RTECs. 
 
6.2.3  Conclusion 
Cells underwent similar changes to those observed in chapter 5; initially monolayers on 
either mount were confluent, additives produced morphological changes towards a 
fibroblastic phenotype and claudin 2 appeared down regulated in both the western blots 
and IF.  The morphological and regulatory changes were observed to be more profound 
when TGFβ1 was added.  Staining for occludin and claudin-4 was maintained in a tight 
junction type pattern in response to TGFβ1 and CsA.  The changes observed in western 
blot experiments were not statistically significant, however they suggested reduction in 
total protein for claudins -2, -3, -4 and occludin, particularly with TGF-beta stimulation.  
 
6.2.4  Discussion 
There were similarities between the results from cells grown on plastic in chapters 5 and 
the cells cultured on Transwells.  Both studies identified changes in phenotypic expression 
of junctional proteins at the intercellular level and at the level of expression.  This 
confirmed the morphological changes observed in the RTECs on plastic or glass from 
chapter 5, with the cells assuming a fibroblastic morphology, which was more pronounced 
with TGFβ1 than CsA.  However the junctional protein rearrangements seen on 
immunofluorescence were considerably less. 
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Aside from the similarities, the RTECs cultures were based on semi-permeable 
membranes.  This meant the delivery of medium was via the apical and basal surface.  In 
addition, the presence of pores facilitated the passage of solutes/molecules through the 
RTECs monolayer without the accumulation of fluid at the basal surface of the monolayer.  
Consequently, no domes were created between the monolayer and the substratum (230).  
 
In contrast with culture on plastic, the cellular monolayers on Transwells remained 
confluent.  There were no discontinuations in the culture on light microscopy after 
exposure to TGFβ1 or CsA.  This was unlike plastic or glass where the epithelial 
monolayer appeared to undergo areas of cellular loss, producing islands of intact cellular 
monolayer and areas where the substratum was not covered.  In the current chapter the 
epithelial cells are plated on a semi-permeable Transwell membrane that may act more like 
a basement membrane.  This may influence the binding of integrins with this membrane 
acting to positively enhance the intercellular interactions through the relationship between 
integrins and cadherin adhesion molecules (265-267). 
 
The most striking inconsistency between the data was the apparent reduction in some tight 
junction proteins observed on immunofluorescence but that this change produced no 
statistically significant reduction on western blotting.  This was observed in the claudin 2 
and occludin experiments.  In these, claudin 2 appeared to be down regulated by the 
addition of TGFβ1 or CsA.  Occludin was observed to lose clarity at the cell-cell borders 
and become less intense in its immunofluorescence.  This loss of clarity represented the 
occludin moving out of the cell-cell interface, thus not participating in the properties of the 
paracellular pathway.  On the western blotting data, there was no statistically significant 
difference between any of the experimental conditions used and the presence of claudin 2 
or occludin.  
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In the case of claudin 4, immunofluorescence appeared to be maintained despite the 
addition of TGFβ1 or CsA to the medium.  With this claudin, staining remained intact at 
72hours.  On western blotting this observation was complimented by the apparent up 
regulation of claudin 4 at 72hours in the presence of TGFβ1.  This was not observed at day 
6.  The composition of the tight junction, with regard to the claudins present, may have a 
profound effect on the physical properties of that junction.  The relative loss of claudin 2 
and the maintenance of claudin 4 to the junction may result in a functionally tighter 
junction. 
 
There was a trend observed.  The effect of both TGFβ1 and CsA was to down regulate 
claudin 2 and occludin.  These effects were also noted in chapter 5.  At day 3 this reduction 
was profound, more so with the TGFβ1.  At day 6, these proteins were present at greater 
levels, potentially representing a temporal recovery in the epithelial monolayer after the 
initial insult.  This reduction in protein presence was not statistically significant over two 
experiments (H142 and H147).  Further repeats of this experiment would likely have 
produced statistically significant differences between the groups.  
 
This temporal relationship and the differences observed between the immunofluorescence 
and western blotting prompted the study of the physical barrier properties to examine 
possible temporal changes in the transepithelial electrical resistance, or the passage of non-
charged molecules across the epithelial monolayer.  The apparent loss of component 
proteins from the tight junction complex would have an effect on the epithelial barrier 
properties.  Claudin 2, a known “leaky” tight junction protein, might contribute to the 
properties by effectively tightening the barrier through its absence (57) particularly in the 
context of claudin 4 remaining.  Occludin has a role in the passage of non-charged 
molecules (63).  Given the disruption witnessed to the monolayer in chapter 5 and the 
apparent changes observed in immunofluorescence regarding the tight junction proteins (in 
contrast to the western blotting data) in the current chapter, assessment of the barrier 
properties was undertaken. 
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On the H142 western blot membrane, occludin produced dual bands.  As a single 
experiment, conclusions from these data were impossible, but data were consistent with 
that observed in figure 5.15.  In chapter 5 data showed the higher molecular weight being 
the predominant occludin present after the addition of TGFβ1 or CsA, suggesting occludin 
may have undergone phosphorylation (261).  Data for this chapter showed the lower 
molecular weight occludin predominate to begin with but over time switch to the higher 
molecular weight occludin.  At day 3 the lower molecular weight occludin still 
predominated in both the control and CsA conditions.  This might represent the temporal 
relationship observed in the changes witnessed in morphology through phase contrast 
microscopy.  This may represent changes in the nature of the junctional barrier produced 
by the incorporation of more phosphorylated occludin into the tight junction to produce a 
tighter junction (268).   200 
6.3  Assessment of the Paracellular Barrier Characteristics of the Epithelial 
Monolayer and the Effects of TGFβ1 or CsA. 
6.3.1  Introduction 
When RTECs line the nephron they act to provide a physical barrier.  The transcellular and 
paracellular pathways, that are created and regulated by the RTECs, govern the passage of 
filtered solutes back into the interstitium.  
 
The transcellular pathway is an active process whereby the selected solutes, using ATP-
driven mechanisms, are actively reabsorbed through the epithelial cells.  This then creates 
a concentration gradient that the cells utilise to pass, passively, filtered solute down via the 
paracellular route.  The tight junction proteins, that form junctions between apposing 
epithelial cells (2), regulate this passage. 
 
The characteristics assessed were transepithelial electrical resistance (TER), a measure of 
the sodium flux across the epithelial monolayer, and dextran flux, a measure of the 
movement of non-charged sugar molecules across the cell monolayer.  In order to assess 
whether the effects of TGFβ1 or CsA were causing undue cell death or proliferation, the 
relative cell numbers were measured.  In addition to the effects on relative cell number, the 
potential production of TGFβ1 by exposure of cells to CsA was assayed and the cellular 
toxicity, through the production of lactate dehydrogenase (LDH), assessed. 
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6.3.2  Results 
6.3.2.1 Transepithelial Electrical Resistance (TER) 
 
 
Figure 6.16.  Graph to show the relationship between the TER (ohms/cmsq) in the renal 
tubular model in medium containing TGFβ1, CsA or neither (U – unchallenged) and time 
(days). N=4. 
 
Transepithelial electrical resistance (TER) over the time course of the experiment was 
observed to rise (n=4) in both the TGFβ1 and CsA groups, while there was only a small 
rise in the TER across the control (unchallenged) group.  The changes observed 
demonstrated statistical significance when compared with the control group (TGFβ1 v 
control, p=0.00026; CsA v control, p=0.008873).  Error bars = 1 SEM   202 
6.3.2.2 Dextran Flux Data 
 
Figure 6.17.  Graph to show the effect of TGFβ1 and CsA on cumulative dextran flux across 
the renal tubular model on day 0 and day 3 (n=3). 
No statistical significance was determined between the passage of dextran of different sizes and the 
medium compared to the control.  For TGFβ1 or CsA, 20kDa dextran (P=0.8 and 0.92 
respectively), 40kDa dextran (p=0.738 and 0.92 respectively) or 70kDa dextran (p=0.554 and 
0.788 respectively) showed no significant differences.  Error bars = 1 SEM 
 
 
 
Measurement of the dextran flux was assessed to show how molecular size affected the 
passage of molecules through the paracellular pathway.  Trends were similar for the three 
conditions.  In the unchallenged culture, there was no statistically significant reduction in 
the passage of the differing sized molecules.  In the cultures containing TGFβ1 and CsA 
the 40 and 70 kDa molecules were observed to pass less than the 20kDa.  However, there 
was no significant difference between the treatments of the cells and the passage of dextran 
through the paracellular pathway.  
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On examining the raw data from three tissue samples (done in triplicate), individual values 
for the change in the dextran flux did not show trends.  Changes over the three days 
showed some alterations in flux within certain cells samples, but none produced statistical 
significance.  In addition, those changes witnessed showed no predictable pattern making 
conclusions impossible.  
 
Analysing the data regarding the dextran flux as a matrix revealed no further insight into 
any trends that may be present in a larger sample population.  Identifying positive and 
negative changes within the fluxes for dextran revealed no further patterns.  This was true 
of cell types, i.e. rows, or molecular sizes i.e. columns. 
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20 
kDa         
40 
kDa         
70 
kDa       
                           
Unch          Unch          Unch       
  D0  D3  AUC      D0  D3  AUC      D0  D3  AUC 
H140  0.031416  0.033264  0.09702    H140  0.011629  0.015759  0.041082    H140  0.009488  0.00958  0.028602 
H142  0.126897  0.117157  0.366082    H142  0.066163  0.062989  0.193727    H142  0.047131  0.03833  0.128191 
H145  0.089127  0.101388  0.285772    H145  0.054439  0.045398  0.149756    H145  0.043745  0.073727  0.176208 
Mean  0.08248  0.083936  0.249624    Mean  0.044077  0.041382  0.128188    Mean  0.033455  0.040546  0.111 
StDev  0.048086  0.044586  0.138125    StDev  0.028705  0.02387  0.078575    StDev  0.020825  0.032131  0.07529 
SEM  0.027763  0.025742  0.079746    SEM  0.016573  0.013781  0.045365    SEM  0.012023  0.018551  0.043469 
                           
TGF          TGF          TGF       
  D0  D3  AUC      D0  D3  AUC      D0  D3  AUC 
H140  0.031416  0.054727  0.129215    H140  0.011629  0.019815  0.047167    H140  0.009488  0.018216  0.041556 
H142  0.126897  0.041123  0.252031    H142  0.066163  0.011698  0.116791    H142  0.047131  0.007827  0.082437 
H145  0.089127  0.104576  0.290555    H145  0.054439  0.052224  0.159994    H145  0.043745  0.031376  0.112682 
Mean  0.08248  0.066809  0.223933    Mean  0.044077  0.027912  0.107984    Mean  0.033455  0.01914  0.078892 
StDev  0.048086  0.033407  0.08426    StDev  0.028705  0.021442  0.056927    StDev  0.020825  0.011802  0.035695 
SEM  0.027763  0.019288  0.048648    SEM  0.016573  0.012379  0.032867    SEM  0.012023  0.006814  0.020609 
                           
CsA          CsA          CsA       
  D0  D3  AUC      D0  D3  AUC      D0  D3  AUC 
H140  0.031416  0.031749  0.094749    H140  0.011629  0.01523  0.040289    H140  0.009488  0.012373  0.03279 
H142  0.126897  0.137068  0.395948    H142  0.066163  0.056021  0.183275    H142  0.047131  0.035259  0.123585 
H145  0.089127  0.108609  0.296604    H145  0.054439  0.066846  0.181928    H145  0.043745  0.043  0.130117 
Mean  0.08248  0.092475  0.262433    Mean  0.044077  0.046032  0.135164    Mean  0.033455  0.03021  0.095498 
StDev  0.048086  0.054481  0.15348    StDev  0.028705  0.027219  0.082167    StDev  0.020825  0.015925  0.054404 
SEM  0.027763  0.031455  0.088611    SEM  0.016573  0.015715  0.047439    SEM  0.012023  0.009195  0.03141 
 
Figure 6.18.  The table shows the raw data from percentage dextran flux through the 
confluent epithelial monolayer in medium containing TGFβ1, CsA or neither.  
Note the natures of the changes are positive (increased permeability, yellow) or negative 
(decreased permeability, red). 
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6.3.2.3 Assessing the Relative Numbers of Cells present (MTS assessment) 
The MTS assay [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium)] is the essential component of a cell assay that utilises 
colorimetric changes through cellular reduction of the MTS compound by cellular 
reductases to give a purple coloured soluble formazan reaction product which is measured 
at 490nm in the cell supernatant.  This assay is dependent on the metabolic activity of cells 
and reflects the cell number and therefore can give a relative measure of the numbers of 
cells present.  The method was employed to assess the effects of TGFβ1 and CsA on the 
relative cell number so as to exclude increases in cell number as being responsible for the 
barrier changes observed in the epithelial monolayer.  
 
Over the duration of the experiment there was no significant difference in the relative MTS 
values present within the cultures suggesting that large increases in cell number had not 
occurred between control and experimental groups.  Comparisons were made using area 
under the curve at day 3, day 6 and the total area under the curve.  None produced 
statistically significant results documenting differences between the unchallenged group 
and either TGFβ1 or CsA at day 3 (p=0.911 unch vs. TGFβ1; p=0.924 unch vs. CsA), day 6 
(p=0.769 unch vs. TGFβ1; p=0.769 unch vs. CsA) or total area under the curve (p=0.842 
unch vs. TGFβ1; p=0.934 unch vs. CsA).   Experiments were done using four tissue 
samples done in triplicate. 
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Figure 6.19.  Graph to show MTS assessment of RTECs numbers in culture over time 
(days) in relation to treatment with TGFβ1.  
Note throughout the experiment, changes in relative cell numbers, when compared between 
different groups remained statistically insignificant (p=0.842, unch vs. TGFβ1; p=0.934, unch vs. 
CsA). 
6.3.3  Conclusion 
The paracellular barrier properties of the epithelial monolayer appeared to be enhanced by 
the addition of both TGFβ1 and CsA, more so with the TGFβ1.  This was characterised by 
an increase in the TER but not the dextran flux.  The dextran flux showed no variation with 
the addition of either the TGFβ1 or CsA.  In cultures relative numbers did not alter, 
irrespective of the culture conditions.  Despite this observation, the TER for TGFβ1 
showed the highest increase. 
 
6.3.4  Discussion 
Cultures on the semi-permeable membranes were able to form confluent monolayers 
without the domes observed in chapter 4.  Consequently, cells could function by passing 
solutes through the monolayer as they would in vivo.  In this model, TER increased in both 
cultures exposed to TGFβ1 and CsA.  Despite there being similar numbers of cells present 
in the cultures containing TGFβ1, these cultures produced the greatest resistance to the 
passage of charged molecules.  Assessment of the dextran passage showed no changes in 
the flux in response to TGFβ1 or CsA.  Analysis of the data in matrix form provided no 
trends related to CsA dosing, cell type or patterns combining the two.  
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The role of occludin or claudin in the permselectivity is not fully understood.  Claudins 
have been demonstrated to play a role in the selection of charge (54, 71, 73, 112, 137, 139, 
269).  This may explain some of the human pathologies that affect the kidney.  Certainly, 
there are well-characterised relationships between claudin 16 and the tubular handling of 
magnesium, some of which are responsible for developmental problems with the tubules 
(140, 270-272). 
 
On examining the barrier properties of the RTECs after exposure to TGFβ1 or CsA, both 
conditions produced an elevation in the TER.  Neither affected the flux of non-charged 
dextran molecules across the monolayers.  The rise in TER was statistically significant 
with both TGFβ1 and CsA. 
 
This alteration in TER may be part of the epithelial monolayer's innate response to a 
pathogen.  Studies on renal cell lines have demonstrated similar results (244, 253) but also 
in gut epithelium (273).  This tightening of the surface barrier in gut has been associated 
with shorter transit times (274, 275), as the luminal water content has been higher.  This 
increased flow means the epithelial surface is exposed over a shorter period of time and 
consequently suffers less damage. 
 
The mechanism by which the TER rises is thought to be through the ERK 1/2 MAPK 
pathway for both TGFβ1 (244) and CsA (253).  This cascade pathway has also been shown 
to be involved with the up or down regulation of proteins utilised in the tight junction 
complex.  The nature of those proteins recruited would dictate the physical properties of 
the paracellular pathway (3, 276, 277).  Up regulation of claudin 1 and 4 has been 
associated with tightening of the paracellular pathway (273).  So too has the down 
regulation of claudin 2, occludin and ZO1 (260, 273). 
 
This study presents data to support TER changing independently to alterations in the 
dextran flux.  This observed difference is part of the permselectivity.  Occludin utilisation 
in the tight junction has been thought to influence the passage of non-charged molecules 
independently from the passage of charged molecules (63).  This separation of filtrate 
constituents would be important for creating or regulating the electro-chemical gradient 
across the tubular epithelium created by the active transcellular pathways (2). 
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The increase in TER may play a role in the excretion of toxic metabolites.  The presence of 
TGFβ1 on the luminal side of the epithelium stimulates the tightening of the epithelial 
barrier (244).  This reduces the reabsorption of solute back into the host system, thus 
enhancing the excretion of the molecule.  In the gut, the converse has been observed.  
Enteropathological bacteria, E-coli, have been shown to alter the tight junction 
composition to disrupt the epithelial cell barrier properties (278-280).  Molecular charge 
might also play a significant role in this.  From the data there was no demonstrable 
relationship between molecular size and paracellular passage of solute.  However, sodium 
exposure to the RTECs may influence the claudin composition of the tight junction.  In 
xenopus cell lines, sodium chloride flux effected claudin 1 and occludin recruitment to the 
tight junction (277) and in the gut, both primary cells and HT-29/B6-GR cells, sodium 
exposure led to the up regulation of claudin 8, tightening the tight junction and preventing 
sodium backleak, producing the high transepithelial sodium gradient (276).    209 
6.4  Assessment of cellular toxicity of RTECs (Lactate Dehydrogenase) and 
production of TGFβ1 when cultures are grown in medium containing different 
concentrations of CsA 
6.4.1  Introduction 
CsA has been accepted to cause renal fibrosis.  A possible target for the instigation of 
fibrosis by CsA is TGFβ1 (8, 170, 244, 247, 249, 250).  In this experiment, the aim was to 
demonstrate that the concentration of TGFβ1 in cultures was related to the concentration of 
CsA in the medium.  Lactate dehydrogenase (LDH) was assayed as a surrogate marker for 
cellular integrity.  
 
LDH has four isoforms responsible for different actions in the human body.  It is primarily 
used in glycolysis and the interconversion of NADP and NAD
+ (2).  This means there is an 
abundance of LDH present within cells.  If CsA is toxic to the RTECs, they will begin to 
lyse and the intracellular enzyme will be present in the extracellular fluid, in this case the 
medium.  The concentration of LDH represents the proportion of cells that have lysed 
through exposure to CsA.  The half-life of this isoform of LDH is approximately ten hours, 
so it was used as a chronological assessment of cellular integrity over the course of the 
experiment. 
 
Cultures were grown with medium containing increasing concentration of CsA; 100ng/ml, 
500ng/ml, 2000ng/ml and 5000ng/ml.  The medium was then collected at day 1, 2 and 3 
and analysed for both TGFβ1 and LDH.  Day 0 was determined as the day when cells were 
fully confluent on the Transwell membrane.  (Data courtesy of Sara Campbell) 
 
6.4.2  Results 
The aim of the experiment was to demonstrate the concentration of TGFβ1 was related to 
the concentration of CsA in the medium and that those concentrations had a direct effect 
on cellular integrity.  In all the observations made, the concentrations of TGFβ1 and LDH 
followed the same trend.  At day 1 the LDH was at its highest, followed by a rapid decline 
to day 2 and then a further reduction to day 3.  TGFβ1 underwent changes revealing at day 
1 a low level of expression followed by a rise to the day 2 levels, then a reduction at day 3.  
In the control experiments (n=3), the day 3 level of TGFβ1 was lower than the day 1,   210 
whereas in all the other experiments, day 3 was marginally higher than day 1.  These 
differences were not statistically significant. 
 
As the concentration of CsA present in the medium increased, so too did the TGFβ1 
concentration.  However, this was not true for the concentration of LDH.  The larger the 
concentration of CsA in the culture, the larger the concentration of TGFβ1 generated, but 
an inverse relationship was observed with LDH in that it was seen to reduce.  Though the 
reductions were not significantly different in each of the experiments, the highest levels of 
LDH were observed in the medium with no CsA. 
 
In addition to these observations, the ratio of active to total TGFβ1 (expressed as a 
percentage) did not alter significantly with the changing concentrations of CsA.  There 
appeared to be a reduction in the ratio, but this trend did not include the results at CsA 
500ng/ml.  Whether this was error or a true result requires further repetitions of the 
experiment. 
 
Figure 6.20.  Graph to show the relationship between the concentrations of LDH present in 
different medium assayed over time (days) from cultures grown in the presence of varying 
concentrations of CsA. 
 None of the changes observed showed statistical significance (p>0.05). 
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Figure 6.21.  Graph to show the relationship between the concentrations of activated 
TGFβ1 present in medium assayed over time (days) from cultures grown in the presence of 
varying concentrations of CsA.  
None of the changes observed showed statistical significance (p>0.05) 
 
 
Figure 6.22.  Graph to show the relationship between the concentrations of total TGFβ1 
present in medium assayed over time (days) from cultures grown in the presence of varying 
concentrations of CsA.  
Only comparisons between the control and CsA at 2000ng/ml and 5000ng/ml showed statistically 
significant differences (p=0.02 and p=0.02 respectively). 
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6.4.3  Conclusion 
On exposure of the RTECs in culture to medium containing different concentrations of 
CsA, TGFβ1 was observed to rise between days 1 and 2, and then fall to day 3.  The final 
concentration of TGFβ1, in either its activated or total assay, was greater at day 3 than at 
day 1.  LDH concentration was greatest at day 1 and fell thereafter.  The dose of CsA did 
affect the release of TGFβ1 but the only observed statistically significant differences were 
between the control and the concentrations of TGFβ1 when RTECs were exposed to either 
2000ng/ml or 5000ng/ml of CsA, which are well above therapeutic levels. 
 
6.4.4  Discussion 
This final experiment demonstrated the relationship between increasing doses of CsA in 
the RTECs tubular model, cell integrity (through LDH concentrations) and the expression 
of TGFβ1 (active or total).  Previously published data has always reported the profibrotic 
effects of TGFβ1 causing damage to the established parenchyma of the renal system (8, 
170, 173, 177, 243).  This data may support the argument that TGFβ1 is acting as a 
protective factor against the toxic effects of CsA.  On initial exposure to CsA, the LDH 
concentration was less than that observed in the control, suggesting a lesser degree of 
disruption to cellular integrity.  At the second time point, the concentration of TGFβ1 has 
risen and the concentration of LDH fallen considerably.  From that point, the concentration 
of both then reduces to the final time point (day 3).  
 
In this experiment, a time delay was observed between the initial exposure to high 
concentrations of CsA and the rise in the concentration of TGFβ1.  This may be the time 
required to initiate the synthesis of TGFβ1 to facilitate its protective properties.  Certainly, 
in previous published work from the Ryan group, CsA has produced a rise in the 
concentration of TGFβ1 and been thought to play a significant role in the changes in 
epithelial monolayers attributed to their exposure to CsA.  This has been further evidenced 
by the addition of anti-TGFβ1 antibodies reducing the effect of the CsA on the epithelium 
(170, 176, 244).  This period of time would certainly agree with the results from chapter 5 
and this chapter.  (Figure 5.3 – demonstrating the change in morphology observed as a 
consequence of CsA being added to the culture medium).  In published data, TGFβ1 has 
been demonstrated to play a significant role in epithelial cell survival.  Work published by 
Lehmann et al (281) studied the induction of TGFβ1 through the protein Raf, a   213 
serine/threonin kinase utilised in the MAPK/ERK signal transduction pathway.  Results 
showed that Raf induced TGFβ1 blocked the apoptotic tendency of TGFβ1 but facilitated 
the invasive tendencies of the cells leading to a greater amount of malignancy but avoiding 
cell death (281).  Other published data illustrated a much more specific role for TGFβ1 in 
the repair of epithelial layers.  Podolsky et al demonstrated the initial stages epithelium 
repair included restitution and then a rapid repopulation of the epithelium by other 
epithelial cells.  Responsible for the instigation of restitution were epithelial growth factor, 
transforming growth factor and fibroblast growth factor alongside interleukins 1, 2, 4, 15 
and interferon γ.  All these factors utilised the TGF dependant signalling pathway (282).  
Both papers establish the delayed response to CsA but not the direct toxicity of CsA. 
 
CsA has been shown to be toxic to proximal tubular cells and cortical fibroblasts through 
the inhibition of interstitial matrix degradation and the stimulation of the cortical 
fibroblasts to produce collagen, further increasing the interstitial mass and tubular 
separation (243).  These pathological changes came as a consequence of 24 hours exposure 
to therapeutic levels of CsA.  In data produced by Rezzani et al, two proximal tubular cell 
lines were assessed in the presence of CsA, namely LLCPK-1 and MDCK cells.  The 
authors looked at the production of acid phosphatase, alkaline phosphatase, lactate 
dehydrogenase and succinate dehydrogenase.  Using parallel experiments, the authors 
reported acid phosphatase and LDH elevating in the presence of CsA for the LLCPK-1 
cells.  For the MDCK cells, the lactate dehydrogenase only rose (174).  These changes 
reported took place within the first 24 hours. 
 
Thus from the data it still remains impossible to tease out whether the initial damage to the 
epithelial monolayers is due to the toxic effects of CsA directly, or through the stimulation 
of TGFβ1 expression.  The two molecules are so intimately linked through the mechanism 
of action and the messengers utilised (8, 206, 244, 249, 250).  Unfortunately the 
experiment lacked data pertaining to day 0.  This would have provided data that would 
have given an indication as to whether it was the exposure to CsA that stimulated the 
expression of TGFβ1, or whether it occurred as a consequence of the stress of being in 
culture.  This would not provide a completely satisfactory explanation as the RTECs 
cultures were mounted on a semi-permeable membrane and confluent prior to exposure.  
Observations also showed a dramatic reduction on the concentration of LDH in concert 
with the TGFβ1 concentration changes.   214 
Summary of Results: - 
•  Cells underwent morphological changes when exposed to medium containing either 
TGFβ1 or CsA, with TGFβ1 having the most profound effect on the cells.  On the 
Transwell membranes however, discontinuities in the epithelial monolayer were 
not seen. 
•  Single staining immunofluorescence revealed similar data to that of the previous 
chapters with some apparent redistribution of the adherens junction proteins and a 
reduction in the staining for tight junction protein claudin 2, which appeared to be 
present in the cytosol at day 3 rather than at the cellular periphery.  
•  Claudin 4 appeared not to be so affected by the addition of TGFβ1 or CsA to the 
medium and remained at the cell-cell junction at 72hours. This in conjunction with 
the reduction of claudin 2 may play a role in the physical characteristics observed 
at 72hours in the conditions. 
•  On Western blots N-cadherin appeared to undergo no significant alterations in its 
expression as a consequence of cellular exposure to medium containing TGFβ1 or 
CsA.  Claudins 2, 3 and 4 underwent similar changes with the total amount being 
less at day 3 than day 0 and then increasing at day 6.  TGFβ1 appeared to have the 
greatest affect on the expression of these proteins.  These relationships were not 
statistically significant though.  Occludin showed a gradual increase in its 
expression over the experimental time period and in one experiment demonstrated 
multiple bands, possible representing the phosphorylated and unphosphorylated 
components of occludin. 
•  TER was demonstrated to increase over time when either TGFβ1 or CsA was 
present in the culture medium.  This was more profound in the presence of TGFβ1. 
•  Dextran flux assessment across the epithelial monolayer showed no significant 
change in response to either TGFβ1 or CsA present in the medium. 
•  Relative numbers of cells present in the culture were not significantly different 
between treatments with TGBβ1 or CsA. 
•  Exposing the RTEC cultures to different concentrations of CsA produced similar 
trends in the response regarding LDH and the active and total components of 
TGFβ1.  LDH appeared to have an inverse relationship with CsA with its 
concentrations becoming less with the higher concentrations of CsA.  TGFβ1 
showed the same trends in its expression in the medium assayed and the ratios of 
active to total TGFβ1 did not significantly alter despite the increasing 
concentrations of CsA (data not shown). 
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6.5  Discussion: - 
Despite the statistically significant decline in the numbers of cells present in the cultures 
associated with medium containing TGFβ1, the TER values continued to rise over the 
experimental timeframe.  The rise in TER was also witnessed in the cultures exposed to 
CsA, though this increase was less profound but remained statistically significant.  This 
observation has been witnessed before in cell lines.  Kiely published work demonstrating 
in MDCK cells exposed to CsA underwent a similar rise in their TER.  In their work they 
identified the role of ERK1/2 MAPK pathway in being responsible for regulating the 
changes in the barrier properties.  In text (un-referenced), they comment that the 
phosphorylation of occludin may play a role (253).  
 
The physical changes associated with exposure to these additives may well represent an 
important physiological adaptation.  The presence of a toxin within the tubule would 
require prompt excretion with minimal to no reabsorption through the tubular epithelium.  
The changes witnessed in the epithelium would facilitate this.  The absence of a change in 
dextran flux may well have been part of this response.  This result may represent the 
relationship between the epithelial tight junctions and the permselectivity regarding 
molecular size rather molecular charge. 
 
Over the three decades that CsA has been used in transplantation, its effects on renal 
epithelial cells have been documented.  Long-term solid organ transplantation has always 
been complicated by the instigation of renal fibrosis, which whether the graft is a 
transplanted kidney or other organ, means there are always associated problems.  The main 
effecter of CsA-associated fibrosis has been TGFβ1.  Data in this chapter demonstrate that 
the release of TGFβ1 is associated with the exposure of RTECs to medium containing CsA.  
Further, the cellular response to different doses of CsA is to increase the release and 
activation of TGFβ1.  
 
   216 
7  The Final Discussion 
 
The work in this thesis demonstrates the possibility of working with renal tissue using 
novel immunohistochemical techniques, and RTECs rather than renal tubular epithelial 
cell-lines, as utilised in such work as Ryan et al (176, 177).  The use of “proximal tubular 
epithelial cells,” which are virally transformed cells that represent RTECs of specific 
regions, facilitates a full EMT (176, 177).  Although not fully representative of the in vivo 
situation, RTECs provide a more realistic representation of what might be taking place 
when kidneys do undergo a prolonged pathological threat.  RTECs did not undergo a full 
EMT in this work, only changes towards an EMT, results that concur with other authors 
(251, 283). 
 
On mapping the junctional proteins along the tubule, using GMA embedded native renal 
tissue, regional variations in the expression of proteins were observed.  While N-cadherin, 
claudin 2 and EMA were stained in their recognised regions (29), Dolichos bifluorus was 
observed more readily in the thick ascending limb of the Loop of Henle.  E-cadherin was 
observed along the entirety of the tubule, being stained more intensely in the distal.  The 
latter two observations were variations on current understanding of the regional expression 
of tubular junctional proteins.  
 
The presence of E-cadherin in the proximal tubule raises the question as to why it might be 
there.  Recognised as the typical epithelial cell marker, E-cadherin’s role in the proximal 
tubule was unclear.  Whether its presence is to offer further support to the N-cadherin 
junction (38), or to facilitate epithelial plasticity is not known (21, 43, 202, 203).  In this 
setting, E-cadherin may be present to facilitate the creation of tight junctions (11), rather 
than N-cadherin. 
 
Immunohistochemistry using 2µm GMA embedded serial sections facilitated comparison 
of the staining of like tissue structures.  This method of immunohistochemistry had not 
been used with lectins or the labelling of regional proteins (185).  Demonstrating the 
changing repertoire of claudins along the tubule (143) may represent further knowledge   217 
regarding regional functional variation.  Confirmation of claudin 2 being present in the 
proximal tubule alongside claudins 10 and 11 and claudin 3, 4 and 8 being in the distal 
tubule, would concur with this observation and also that the extracellular domains of these 
differing claudins provide the differing permselectivity properties (49, 54, 55, 73). 
 
RTECs produced confluent epithelial monolayers on both solid and semi-permeable 
surfaces (see chapters 4, 5 and 6).  When on solid surfaces, cells created monolayers with 
domes present (52, 227, 240) and discontinuities in the confluence probably as a 
consequence of producing fully functional epithelial membranes.  These cells also 
demonstrated a degree of self-sorting as homophilic junctions were observed on IHC and 
IF (11).  This was further evidenced by the use of dual staining, demonstrating the 
mutually exclusive nature of the staining when comparing N-cadherin and EMA (see 
chapter 4) and their cellular localisation through the utilisation of confocal microscopy. 
 
On challenging the cultures with either TGFβ1 or CsA, cells did very similar things on 
solid or semi-permeable surfaces.  Cadherins were redistributed, while tight junction 
proteins followed a similar trend; to be down regulated by TGFβ1 and less so by CsA.  
When looking at the mRNA of the EMT transcriptome (19), TGFβ1 up regulated many of 
the factors that would be associated with a more fibroblastic cellular environment.  
Occludin, however, was up regulated.  On western blotting this protein was significantly 
reduced.  This result may represent an example of post-translational modification as on 
both solid and semi-permeable surfaces, occludin underwent a degree of phosphorylation 
that may be relevant to its involvement in the tight junction (61, 62, 284). 
 
Culture on semi-permeable membranes produced fully functional confluent monolayers of 
RTECs.  This was characterised by the immunohistochemistry and the physical properties 
demonstrated.  Challenges with TGFβ1 and CsA effected similar but less profound changes 
in the morphology of the cells.  Again, similar changes in the junctional proteins were 
observed, but physical characteristics altered unexpectedly in the experimental model.  
 
Despite the tight junction proteins undergoing similar down regulations on western 
blotting, to those seen when cultured on the solid surface, the resistance to the passage of   218 
sodium increased (TER).  This appeared independent of the relative numbers of cells 
present in the culture (MTS).  In addition to this, the nature of the cells present was also 
changing to a more fibroblastic type, a cell-type responsible for supporting tissue rather 
than playing a role in the formation of monolayers.  Given the changes observed in chapter 
5 (discontinuities on the solid surface) versus chapter 6, one might have expected the 
barrier properties to be lost.  This was not the case.  
 
Possible explanations for this might be that the fibroblast-like cells enhance the barrier 
properties of those cells remaining, rather than creating gaps in the monolayer.  In this 
work claudin 4 was observed not to be redistributed away form the cell-cell junction but 
remain.  A reduction on western blotting was observed but at 72hours, but when exposed 
to TGFβ1 the magnitude of the down regulation appeared less than seen with other 
experiments.  Claudin 1 has been associated with intercellular adhesion between 
fibroblasts (285) and also linked with the increased TER attributed to the response to CsA 
and TGFβ1 (244) in conjunction with claudin 2 and claudin 3.  In Feldman’s work claudin 
2 did not change when challenged, but claudin 1 and 3 were both up-regulated.  In this 
work the regulation of claudins 1 and 3 was not investigated, but down-regulation of 
claudin 2 in response to both TGFβ1 and CsA was reported.  This might contribute to an 
increase in the TER alongside the maintenance of claudin 4. 
 
Another possible explanation for the greater TER is the possible selection bias.  On 
exposure to the CsA or TGFβ1 in the culture medium, proximal RTECs may more readily 
undergo a phenotypic switch, having already been predisposed through the expression of 
N-cadherin.  This would have two effects. Firstly, the N-cadherin expressing cells would 
be the proximal populations that utilise claudin 2, the least tight claudin (57, 238).  
Secondly, the remaining cells would be distal tubular cells that utilise claudins 3, 4 and 8, 
more tight claudins (102).  This would also mean the average TER between cells would 
rise due to the elimination of claudin 2 containing junctions. 
 
The assessment of cellular response to medium containing CsA with regard to the 
production of TGFβ1 revealed similar responses irrespective of the concentration of CsA 
present.  The AUC remained relatively constant between the different experiments (see 
chapter 6).  The utilisation of LDH was to represent the cellular integrity of the RTECs.    219 
As the concentration of TGFβ1 rose, the concentration of LDH fell.  This relationship may 
have indicated a possible protective role for the expression of TGFβ1 against the effects of 
CsA.  In other published work, TGFβ1 immunoneutralisation has been demonstrated to 
reduce the deleterious effects on the increase in interstitial cell mass and the loss of renal 
microvasculature; both these factors may promote the development of chronic kidney 
disease (286).  
 
In this work, a major area of concern is the mixed population of epithelial cells.  This 
situation produces cultures of cells that express both the proximal and distal junctional 
proteins with their independent physical properties.  If one is satisfied the IHC is correct, in 
that proximal RTECs express claudins 2, 10 and 11 and not 3, 4 and 8, and vice versa for 
distal RTECs, then this will affect the outcome of the physical assessments of the 
monolayer.  Given the leakiest claudin, claudin 2 (57), being present on the proximal cells, 
then the TER will be a reflection of the resistance created by claudin 2 alone.  
 
A second area of concern regarding the mixed population of cells is the explanation for the 
increased TER.  If the relative components of the tight junction are altering as a 
consequence of exposure to either TGFβ1 or CsA, given that these are regionally specific 
proteins, can an in vitro RTEC monolayer utilise multiregional protein expression to 
produce these characteristics?  In the same experiment using a regionally pure population 
of RTECs, would the same explanation be possible as claudin 2 is a proximal tight junction 
protein and claudin 3 is distal?   
 
In the same way, the mixture of regional cells may be affected differently by the exposure 
to either CsA or TGFβ1.  In other published works it has been proposed that TGFβ1 inhibits 
the regeneration of proximal tubular cells through its anti-proliferative effects when the 
cells are exposed to exogenous mitogenic growth factors such as EGF and FGF (287-290).  
In Humes et al, the data shown proposed that TGFβ1 produced morphological alterations 
that were similar to those described in chapters 4 and 5 (287).  Similar data do not exist for 
distal tubular cells. 
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The expression of both proximal and distal tubular epithelial junctional proteins meant that 
the effects of either CsA or TGFβ1 on either population could not be fully assessed 
independently.  Ryan et al (176, 177), suggest that there is a change in the expression of 
claudins in proximal tubular cell lines and it is that relationship that might explain the 
alterations in the physical properties of the epithelial barrier.  This however challenges the 
regional specificity demonstrated in this work.  Epithelial cells were from the proximal or 
distal tubule and expressed those junctional proteins.  The ability to switch regional 
phenotype has not been demonstrated in primary cell culture.  Additionally, the nature of 
homophilic claudin bonds means the degree of self-sorting that occurs and was 
demonstrated by dual staining might not represent the in vivo situation where cells might 
alter their phenotype in order to bond with the neighbouring cells (to form a truly confluent 
epithelial monolayer).   
 
The advantage of using the mixed unselected population of distal and proximal RTECs 
was that it represents more accurately the proximity experienced in vivo.  Certainly in the 
in vivo situation, the proximal and distal tubules work together to produce the environment 
needed for the kidney to function (2).  There may also be a paracrine relationship not yet 
identified, that facilitates the maintenance of the epithelial barriers. 
 
The role of TGFβ1 in this situation is a complex one.  Its release must have a role to play in 
the survival of the local cell population, but its relationship with other growth factors does 
not appear to concur with this, nor does its effect on the epithelial morphology.  However, 
in the tubular situation, the tightening of the epithelial monolayer to the transepithelial 
passage would aid the excretion of a filtered toxin by preventing its reabsorption.  The 
causation of interstitial expansion and reduced micro-vascularity would also aid the 
protection of local parenchyma by producing a more robust surrounding structure with less 
access to the vascular system and means to disseminate the toxin.  The deleterious 
consequences of this are the reduction of available nutrients to the local epithelial 
population and thus their subsequent demise causing the dysfunction of the tubular system. 
 
The hypothesis stated - Staining normal renal tissue will reveal the regional expression of 
junctional proteins along the tubule that may be responsible for the functional variation 
observed along the nephron. The addition of CsA or TGFβ1 to culture medium for normal   221 
RTECs will disrupt the epithelial monolayer and the physical properties created in the 
normal situation.  In this work, regional expression of the epithelial junctional proteins was 
demonstrated using novel techniques.  Given the current knowledge base regarding the 
properties of the family of claudins, this may go some way to further understanding the 
regional functions of the tubule.  The addition of CsA or TGFβ1 to the culture medium 
produced a gross change in the epithelial morphology towards a more fibroblastic 
phenotype.  It did not produce an EMT.  Despite the disruption to the epithelial monolayer 
by these additions, CsA and TGFβ1, the TER of the monolayer increased, which may be a 
result of the changing relationships between the claudins expressed and their relative 
concentrations.  It did not produce a dysfunctional epithelial monolayer. 
Future work in this field based on this work might include 
1.  Cell sorting –  By means of either FACS or MACs separation, isolating cells from 
one population may provide a more accurate representation of what might occur in 
vitro.  This may however deprive the culture of cytokines secreted by the 
population of epithelial cells missing from the culture (these types of separation 
produce cells that are extremely difficult to culture successfully afterwards - 
experience from our laboratories).  An alternative to these types of cell sorting 
methods might be to undertake laser micro-dissection from regions of the nephron.  
This would provide a skilled operator, cells of a specific type of tubule.  However, 
this may incur inaccuracies due to the difficulty in both the dissection and the 
reliable recognition of tubules of a specific origin. 
2.  Characterisation of these cultures would then be essential to identify the cells 
captured, again repeating the staining and physical assessments to demonstrate the 
successful isolation of a particular cell type and its physical characteristics. 
3.  Time-lapse phase microscopy of the epithelial cells in culture.  Having identified 
single cell populations, it might be possible to tag a component of one population 
of epithelial cells.  This would identify it as distinct from the second population of 
cells.  Such a tag might be a fluorescent label attached to the lectin component in 
the apical surface (as this would not be involved in the cell-cell adhesion process).  
This label would then act to identify the cell population and its movement during 
the creation of a confluent epithelial monolayer.  It would facilitate the study of 
self-sorting that might take place within an establishing culture.  
4.  IF of cultured RTECs on semi-permeable membranes labelling for TβRI/II and the 
tight junction proteins at time intervals in the creation of an epithelial monolayer.  
This would identify components of the cell-cell adhesion complex and the   222 
relationship with the TβRI/II complex, which plays a pivotal role in cells signalling 
for differentiation, proliferation, etc.  It might also explain the differences in the 
response to the culture additives between the semi-confluent monolayers produced 
on the solid membranes (glass, plastic) and the semi-permeable membranes 
(Transwell plates).  
5.  To identify a translational element to this work, the use of occludin 
phosphorylation as a marker of tight junction functionality might be an option.  The 
relationship between the phosphorylation of occludin and its utilisation in the tight 
junction is becoming clearer (15, 61, 62, 259, 261, 291, 292).  Analysis of the 
physical characteristics of the epithelial monolayer and the relative amounts of 
phosphorylated occludin present in the culture may give some idea to the properties 
of the membrane when different glomerular pathologies are present.  Using primary 
biopsy tissue from archival pathology specimens, IHC could identify 
phosphorylated and un-phosphorylated occludin and its localisation to tight 
junctions.  Quantification and localisation of these components of occludin could 
then be statistically analysed to see whether there is any relationship between the 
ratios and the type of pathology present in the specimen.   223 
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